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SUM&BX
1) Hepatic cytochrome P 4 5 0  and b^ concentrations 
and the activity of NADPH-cytochrome c reductase, 
six mixed function oxidase enzymes (ethylmorphine 
N-demethylase, biphenyl 2-, 3- and 4-hydroxylases, 
ethoxyresrufin O-deethylase and benzo(a)pyrene 
hydroxylase) and two non-mixed function oxidase 
enzymes (UDPGA tranferase and alcohol 
dehydrogenase) were determined in vitro in 15 
different mammalian species (ranging in body weight 
from mouse to man) and 4 rat strains. The kinetics 
of the binding of hexobarbital (type 1  substrate) 
and aniline (type 2 substrate) (Ks and A max) to 
cytochrome ,P^ 2 0  were also determined in liver 
microsomal preparations of most of these animal 
species and rat strains, Aminopyrine N-demethylase 
and biphenyl 4-hydroxylase activities in vivo were 
determined in 6 animal species (ranging in body 
weight from mouse to rabbit) and in the 4 rat 
strains. The possible relationship between species 
differences in these parameters and body weight and 
the importance of strain differences were 
determined.
2) Species differences in cytochrome P 4 5 0  levels, 
ethylmorphine N-demethylase, and biphenyl 2-, 3- 
and 4-hydroxylase activities in vitro showed a 
signficant inverse correlation with body weight (on
a logarithmic scale). No such relationship was seen 
with the other enzymes studied. A significant 
direct correlation with body weight was seen with 
aniline A^ax* Studies in vivp showed a highly 
significant inverse correlation between body weight 
and both aminopyrine N-demethylase and biphenyl 4- 
hydroxylase activities (logarithmic scale) .
3) Strain differences in vitro were small 
compared to species differences for the cytochrome 
P450 mediated enzymes. Whereas for the enzymes 
catalysed by the P 4 4 Q forms of cytochrome P 4 5 0  the 
fold variation between strain and species 
differences were smaller. In vivo the strain 
differences were much smaller than the species 
differences.
4) Determination of the rank order of species 
differences for the diffferent parameters studied 
showed many significant correlations between 
parameters which may indicate the involvement of 
common rate-limiting factors in different enzyme 
reactions.
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INTRODUCTION
For many years it has been known that 
different animal species metabolise drugs and other 
xenobiotics differently. In 1877 Jaffe found that 
hens excreted benzoic acid as dibenzoylornithine 
(ornithinic acid) while man and other mammals 
excreted it as hippuric acid. Since that time 
species differences in drug metabolism^;both 
qualitative and quantitative have been seen with 
practically all drugs and environmental chemicals 
studied. In addition to species differences the 
drug metaoolising enzymes can De affected (mainly 
quantitatively) by factors such as age, strain, 
sex, nutritional status, hormonal status, stress, 
disease, exercise, circadian and seasonal 
variations (Vesell, 1980) . The rate of metabolism 
of drugs may determine the duration of action and 
toxicity of a compound. Quinn et al. (1958) first 
showed that the rate of metabolism of a drug was 
correlated with its pharmacological action. In 
studying the metabolism of hexobarbital in the 
mouse, rat, rabbit, dog and man they found a direct 
relationship between the biological half life and 
the duration of action (sleeping time) and an 
inverse relationship between the duration of action 
and the rate of metabolism of hexobarbital (table
1). Some drugs are themselves inert and are 
metabolised to the active component within the
6
body, so that if the drug is not metabolised , is 
metabol(s.ed slowly, or by a different route in an 
animal species then the therapeutic or possible 
toxic effects are not seen in this species.
However, the majority of drugs are active in the 
parent form and are detoxicated by metabolism so 
that a species which only poorly metabolises the 
drug has a prolonged duration of action of the drug 
which may result in toxicity. These species 
differences are important in the toxicity testing 
of environmental chemicals and new drugs where the 
extrapolation of animal data to man is required. 
Other factors which affect the metabolism such as 
the age, sex, strain and environmental factors can 
be controlled to a certain extent when testing a 
compound in animals but at present it is impossible 
to fully account for the effects' of species 
differences. Precise extrapolation of the 
metabolism of a compound in animals to that in man, 
would require an animal species which metabolises 
the compound via the same pathways and at the same 
rate as man. When the problem of species 
differences in toxicological testing began to be 
realised in the 1950-1960S there was-wide interest 
in finding the ideal animal model whose metabolism 
was very similar to man. For some time there has 
been a great interest in non-human primates, 
particularly the Rhesus monkey and the marmoset 
since these are relatively small and therefore 
easier and cheap to maintain, as the group of
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animal species which the nearest to man in 
metabolic function including drug metabolism. This 
appears to be true of conjugation reactions but 
with oxidation, reduction and hydrolysis reactions 
the non-human primate does not resemble man any 
more closely than other mammals (Smith, 1967; 
Williams, 1967) . It is often found that one animal 
species will metabolise one drug in a similar 
manner to man but the same species will metabolise 
another drug in a completely different manner.
METABOLISM ££ DRUGS M U  QTSEB, XENOBIOTICS
The metabolism of drugs and xenobiotics may 
occur via a number of pathways and in a number of 
tissues. The liver is the major site of metabolism 
but metablism also occurs to a lesser extent in the 
kidney, skin, intestine and adrenals (Kato, 1966; 
Bend et al., 1972; Chhabra et al 1974; Zampaglione 
and Mannering, 1973) . Drug metabolism occurs in 
two phases; phase 1 , the asynthetic stage involving 
oxidation, hydrolysis or reduction, and phase 2 , 
the biosynthetic stage involving conjugation 
reactions. The aim of the phase 1 reactions is to 
provide a handle onto which the conjugating agent 
could be- attached resulting in a more polar 
compound which is more readily excreted.
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Drug Phase 1^ Metabolised Drug Phase ^ Conjugated Drug 
Oxidation conjugation
reduction
V
hydrolysis Excretion
However, often conjugation of the parent compound 
occurs without prior metabolism or metabolism 
occurs without consequetive conjugation, hence the 
terms phase 1 and 2 are often inappropriate.
Phase 1 Reactions
Phase 1 reactions consist mainly of 3 types; 
oxidations, reductions and hydrolyses. Table 2 
shows for each group the different pathways of 
metabolism and distribution within the cell, of 
xenobiotics known to occur. The microsomal 
oxidation reactions are carried out by the mixed 
function oxidase system.
The mixed function oxidase system
The majority of the oxidative metabolism of 
drugs and other foreign compounds and also of 
steroid hormones occurs in the microsomal fraction 
of the liver. Microsomal oxidations are catalysed 
by a membrane bound enzyme complex which results in 
the binding of molecular oxygen to the complex and 
one oxygen atom beirlg incorporated into the drug
9
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water. This enzyme complex was termed the mixed 
function oxidase system Oy Mason (1959).
The mixed function oxidase system catalyses 
the metabolism of a wide number of foreign 
compounds and also a number of compounds occurring 
naturally in the body such as cholesterol, 
corticosteroids and sex hormones, prostaglandins 
and thromboxanes, biogenic amines, indoles, 
thyroxine, Vitamin D and in the W-hydroxylation of 
fatty acids (Parke, 1981; Nebert et al., 1981).
Components of the mixed function oxidase system:- 
Coon and coworkers have shown that the liver 
microsomal mixed function oxidase system consists 
of cytochrome £ 4 5 0 , NADPH-cytochrome P 4 5 0  reductase 
and phosphatidylcholine (Lu & Coon 1968; Lu et al., 
1969; Strobel et al., 1970). NADPH, molecular 
oxygen and Mg^+ are required for activity of the 
oxidase system (Gillette et al., 1957).
Cytffch.rome £ 4 5 0  is the name given to a group 
of heme proteins which have a sulphur atom ligand 
to the iron and form carbon monoxide complexes that 
have a peak absorption at approximately 450nm. The 
active site of liver' microsomal cytochrome P 4 5 0  
contains an iron protoporphyrin IX moiety in a 
relatively large, open hydrophobic cleft or 
depression in the surface of the apoprotein. The
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iron is Dound Dy s or b ligands, 4 or which are to 
the planar, tedradentate porphyrin ring. The fifth 
ligand is thought to be a thiolate anion 
contributed by a cysteine residue of the 
polypeptide chain. In the susbstrate-free ferric 
state of the hemo protein the sixth ligand is 
occupied by a readily exhangeable ligand eg. water 
or -NH (White and Coon, 1980). The binding site of 
the oxygen molecule may either be the sixth ligand 
(White and Coon, 1980) or between the thiolate and 
iron at the fifth ligand (Chevion et al., 1977).
NADPH~cyj^chrome 2^50 reductase is a 
flavoprotein containing flavin mononucleotide (FMN) 
and flavin adenine nucleotide (Iyanagi and Mason, 
1973). This reductase also reduces cytochrome c 
and since the rate of reduction of Cytochrome c is 
easier to measure than that of cytochrome P 4 5 0  
microsomal NADPH-cytochrome P 4 5 0  reductase is often 
determined using cytochrome c as the susbstrate and 
hence termed NADPH-cytochrome c reductase.
Cytochrome P 4 5 0  molecules are thought to occur 
in the endoplasmic reticulum membrane as 
heterogeneous clusters (Matsuura et al., 1978). The 
spatial arrangement of cytochrome P 4 5 0  reductase 
within the membrane is unknown but it is known that 
the stoichiometry of cytochrome P 4 5 0  molecules to 
reductase molecules ranges between 1 0 : 1  and 1 0 0 : 1  
(Estabrook 1971; Sato and Omura 1978) .
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The mechanism of drug oxidation via the microsomal
mixed function oxidase systems is shown in Fig, 1.
The steps in the oxidation process are thought to
occur as follows
1) The drug or foreign compound binds to the 
oxidised cytochrome £ 4 5 0 *
2) The ferric state cytochrome P^g-susbstrate 
complex undergoes a one electron reduction via 
NADPH-cytochrome P 4 5 0  reductase to the ferrous 
state cytochrome,
3) The ferrous state cytochrome P ^ ^ - s u b s t r a t e  
complex then binds oxygen. Evidence for this 
oxygenated intermediate has been obtained by 
spectral studies with liver microsomes 
(Estaorook et al,, 1971).
4) This oxygenated cytochrome P450-substrate 
complex accepts a further electron resulting in 
splitting of the oxygen-oxygen bond, one atom 
being lost as water.
5) The other oxygen atom, which is thought to exist 
as an “activated oxygen" is inserted into the 
substrate to produce the corresponding 
oxygenated product.
12
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oxidised cytochrome P 4 5 0  is available for 
further binding.
The input of the second electron is thought to 
be mediated via cytochrome b 5 (Hildebrant and 
Estabrook, 1971). NADH is known to have a 
synergistic effect on mixed function oxidations 
(Gonney et al., 1957). More recently, Miki et al. 
(1980) have purified from rabbit liver microsomes a 
form of cytochrome P 4 5 0  with a high affinity for 
cytochrome b^ and showed that the reduction of 
cytochrome £ 4 5 0  by NADH required NADH-cytochrome b^ 
reductase, cytochrome b 5 and suitable 
concentrations of detergents. The NADPH-cytochrome 
P 4 5 0  reductase activity was dependent on the 
concentration of cytochrome b^ when NADH-cytochrome 
reductase was present in excess. Studies using 
reconsituted systems have suggested that cytochrome
b 5 is not an essential component of the mixed 
function oxidase since reconstituted systems in
which cytochrome b^ is absent will still metabolise 
substrates at rates equal to or greater than those 
observed in intact microsomes (Haugen et al., 1975) 
Lu and West, 1978; French et al., 1980). However, 
Werringloer & Kawano (1980) measured the kinetics 
and extent of reduction of cytochrome £ 4 5 0  and b$ 
in a CO atmosphere and showed that the redox 
properties of cytochrome b 5 are favorable for the 
reduction of membrane bound ferrous cytochrome
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P450-oxygen complex but the redox properties are 
different for the purified cytochrome.
The iron of cytochrome P 4 5 0  exists in 2 spin 
states designated high and low spin. The ferric 
high and low spin states have very different 
spectra with the high spin state having an 
absorbance maximum at 394nm and the low spin state 
at 418nm (Haugen and Coon, 1976) . Substrate 
binding to cytochrome P 4 5 0  alters the spin state of 
the heme iron. This change in spin state can be 
seen from the difference spectra of the substrate 
-cytochrome P 4 ^ 0 complex. When substrates such as 
aminopyrine ethylmorphine, and hexobarital bind to 
cytochrome P 4 5 0  there is a shift from the low to 
high spin state. This results in a difference 
spectrum with a peak at 387nm and a trough at 
420nm. This spectrum is known as a type 1 binding 
spectrum. Compounds such as aniline, 
phenobarbital, acetanilide and nicotinamide on 
binding to cytochrome P 4 5 0 cause a shift from the 
high to low spin state of the cytochrome producing 
difference spectra with a peak at 425nm and a 
trough at 400nm known as a type 2 binding spectrum 
(Ebel et al., 1978; Goldstein et al., 1974). Some 
substrates produce a "modified" type 2 binding 
spectra with the wavelength of the peak and trough 
falling well outside the usual range (peak, 
509-445nm and trough 365-410nm) (Schenkman et a l .,
1967) . Sasame and Gillette (1969) suggested that 
the atypical
spectrum was due to the compound binding with both 
the type 1 and type 2 binding sites. When the 
ferric heme is in the high spin state it is more 
readily reduced and hence the rate of reduction of 
cytochrome P 4 5 0  by NADPH is accelerated by type 1 
substrates and slowed by type 2 substrates (Gigon 
et a l ., 1969) .
Since the spectral changes produced with 
substrate binding to cytochrome P ^ g  are dependant 
on the concentration of free substrate in the 
microsomal suspensions and the substrate binding i 
reversible, Michaelis-Menton kinetics have been 
applied to measure maximal spectral change (A.max) 
and the spectral dissociation constant K s by 
plotting the reciprocal spectral changes against 
reciprocal substrate concentrations (Lenk, 1976) . 
Some workers have shown that the kinetic constants 
(Ks and A max) for aniline and hexobarbital binding 
paralleled the kinetic constants for the rate of 
hydroxylation of these compounds, suggesting that 
drug binding is an obligatory step in drug 
oxidations (Remmer et al., 1966; Imai and Sato, 
1969). However, Lenk (1976) has pointed out that 
number of reports have shown that for the 
N-demethylation of a number of compounds including 
ethylmorphine, (+) and (-) amphetamine, 
benzphetamine and for the N-oxygenation of 
N-ethylaniline and N,N-dimethylaniline either no 
binding spectrum was
ooservea or no correlation netween ivs ana jvm  or 
Amax and V max was found.
Sepcies differences in phase 1. reactions
Species differences in phase 1 reactions are 
numerous hence only examples of species differences 
for a number of the more common types of reactions 
will be given. Species differences in phase 1 
metabolism may be regarded as:-
a) Qualitative, ie due to either the absence of an 
enzyme in a species, or to the drug being 
preferentially metabolised by different routes in 
different species;
or b) quantitative, ie. drugs being metabolised via 
the same route but at different rates in different 
animal species.
£l Qualitative differences in Ox i dation reactions 
Aromatic hydroxvlation;- qualitative differences in 
aromatic hydroxylations in different species occur 
due to, differences in the site of hydroxylation of 
the aromatic ring. Aniline is metabolised by 
hydroxylation at the para- and ortho-positions.
The extent of hydroxylation in each position varies 
with different species (see table 3). Carnivores 
tend to hydroxylate in the ortho-position whereas 
rodents hydroxylate mainly in the para-position.
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Biphenyl may be hydroxylated at the 2-, 3- and 
4- positions and in some species the 
2-hydroxybiphenyl is further hydroxylated at the 5 
position (Creaven et a l „ , 1965b; Meyer & Scheline, 
1976; Halpaap et al., 1978; Halpaap-Wood et al., 
1981a,b). The 3- and 4-hydroxybiphenyls are also 
further metabolised in vivo to di-and 
trihydroxybiphenyls but these metabolites are not 
always seen in vitro (Halpaan-Wood et al., 1981b). 
Species differences occur in the extent of 
hydroxylation at the different positions (table 3). 
Also in vitro studies have shown that in some 
species ie. rat and rabbit, biphenyl 2 -hydroxylase 
activity is age dependent being present in the 
young but not in the adult animal (Creaven et al., 
1965b; Basu et al., 1971). However, in vivo 
studies have shown biphenyl 2 -hydroxylase activity 
in adult rats (Halpaap et al., 1978; Meyer and 
Scheline 1976). Biphenyl 2-hydroxylase activity 
also appears to be absent in the adult fox, hen and 
possibly the guinea-pig (Creaven et al., 1965b) 
although in vivo studies have shown 
2 -hydroxybiphenyl to be excreted in the adult 
guinea-pig after an oral dose of biphenyl (Meyer, 
1977).
Coumarin is also hydroxylated at more than one 
position and species differences occur in the ratio 
of the two metabolites. In man, 7-hydroxycoumarin
17
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rat and rabbit 3-hydroxycoumorin and its 
degradation products predominate (39-49%) (Kaighen 
and Williams, 1961) .
An example of species differences in the 
position of hydroxylation resulting in species 
differences in toxicity of a compound is seen with 
2-naphthylamine. In the cat the ortho-hydroxylated 
product of 2 -naphthylamine, 2 -amino-l-naphthol is 
preferentially formed whereas in the rabbit and rat 
6-amino-2-naphthol is the major product. In the 
cat, and also dog and man, 2 -naphthylamine is a 
potent bladder carcinogen, whereas in the rabbit, 
rat and guinea-pig 2 -naphthylamine is only weakly 
carcinogenic (Radomski, 1979).
Oxidative dealkylation:- the oxidative removal of 
alkyl groups, especially methyl groups, is a common 
metabolic reaction of 0-, N-, and S-alkyl ethers. 
Oxidative dealkylation has been shown to occur in 
mammals, birds, fishes and reptiles, but only in 
mammals are the enzymes located in the liver 
microsomal fractions (Parke, 1968) .
Species differences have been found in the 
substrate specificity of enzymes involved in 
oxidative de-alkylations.Creaven et al., (1966) 
showed that the 0 - demethylation of 2 -methoxy- and 
4-methoxy-biphenyl and the 0-deethylation of
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2-ethoxy- and 4-ethoxy-biphenyl occur m  a number 
of different species. They found that in the 
rainbow trout, frog, rat, rabbit and chicken the 
same enzyme catalyses both the O-demethylation and 
the O-deethylation of 4-0-alkyl ethers of biphenyl
but a different enzyme was involved in the
dealkylation of the 2-0-alkyl ethers. Whereas in 
the mouse there is a separate and distinct enzyme 
for O-demethylation and O-deethylation and in the
guinea-pig there is one enzyme for all 
dealkylations.
Diazepam is metabolised by two oxidative 
metabolic pathways; one is ring hydroxylation, 
which is the main pathway in the rat, and the other 
is oxidative N-demethylation, which is the main 
pathway in the mouse. The N- demethylated 
metabolite of diazepam has potent antimetrazol 
activity and although the levels of diazepam in the 
blood and brain are similar in the rat and mouse 
the antimetrazol activity is longer lasting in the 
mouse than in the rat due to the N-demethylated 
metabolite being predominately formed in the mouse 
out not in the rat (Marcucci et al., 1968) .
Amphetamines are metabolised by 4 major 
metabolic routes, ring hydroxylation,
N-dealkylation, <*--carbon oxidation and N-oxidation, 
the latter two result in deamination of the 
sidechain. Table 4 shows the species variation in
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the relative extent of each pathway of amphetamine 
metabolism (Caldwell, 1982) .
0) Quantitative differences in phase 1 reactions
The most common species differences in phase 1 
reactions are due to quantitative differences ie. 
differences in rates of metabolism between species. 
Work carried out in the present study is centred 
mainly on the quantitative differences in 
metabolism in different animal species. Examples 
of quantitative differences already reported for 
different species are given below.
Ill Qxidet.i.on xg£c.t.ipjQ_s
Aromatic hydroxylation:- species differences in the 
rate of aromatic hydroxylation occur with nearly 
all compounds tested. Aniline hydroxylase activity 
varies from 9.8-24.1 nmol p-aminophenol formed per 
mg microsomal protein per 15mins in the rabbit and 
mouse respectively (Chhabra et al., 1974).
Biphenyl 4-hydroxylase varies from 0.9-5.0 ^moles 
per g liver per hour in the cat and mouse 
respectively (Creaven et al., 1965). Harper et al 
(1975) found a 11-fold difference in benzo(a)pyrene 
hydroxylation between the rat and hamster liver 
microsomes.
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Aliphatic hydroxylation:- the alkyl side chain of 
barbiturates and other drugs are oxidised to 
primary and secondary alcohols. Further oxidation 
to aldehydes and carboxylic acids requires the 
soluble enzymes, alcohol dehydrogenase and aldehyde 
dehydrogenase, which are found in the cytosol 
(Gillette, 1959).
Species differences .in the rates of metabolism 
of the barbiturates are well known and result in 
species differences in their duration of action eg. 
hexobarbital see table 1 .
Oxidative dealkylation:- wide interspecies
variations are known to occur in the rate of both
demethylation and deethylation. Kato (1966) found
a 18-fold difference in hepatic aminopyrine
N-demethylase activity between mice and cats.
Castro and Gillette (1967) found a 5-fold
difference between the rat and rabbit in V formax
hepatic N-demethylation of ethylmorphine, and Burke 
and Upshall (1976) found a 6 -fold difference in 
Vmax for hepatic O-demethylation of harmine between 
the guinea-pig and cat.
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(ID Hydrolysis reactions
Drug metabolism by hydrolysis is confined to 
esters and amides. Ester groups occur in a great 
number ot different types of drugs including 
stimulants such as methyl phenidate, the 
anticoagulant ethyl biscoumacetate and widely in 
local anaesthetics, atropine substitutes and 
analgesics. Esters are hydrolysed in mammalian 
tissues by a number of esters which are widely but 
unevenly distributed in the body, and the 
distribution shows species differences. A number 
of amides are also hydrolysed in the body but the 
rate of hydrolysis is very much slower than that of 
esters. This phenomenon has been exploited in the 
case of the local anaesthetic procaine. Procaine 
being an ester is rapidly metabolised whereas 
procaine amide is only slowly metabolised and 
therefore has a longer duration of action (Parke,
1968).
An example of species differences in the rates 
of hydrolysis is shown with the insecticide 
dimethoate. Dimethoate contains both an ester and 
amide link and is hydrolysed by esterases and 
amidase. Mice and rats hydrolyse both linkages 
while sheep hydrolyse only the amide link and 
guinea-pig only the ester link. The rate of 
metabolism of the compound by the liver from
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airrerent species is m  the decreasing order of 
rabbit, sheep, dog, rat, cattle, hen, guinea-pig, 
mouse and pig. The toxicity of the insectide in 
different species relates reasonably well to their 
metabolic rates.
(H i )  Reduction reactions
Two types of reductases occur in liver 
microsomes, azoreductases and nitroreductases.
A z o r e d u c t a s e s an example of species differences 
in azoreduction is that of the drug Prontosil which 
undergoes azoreduction to the antibiotic 
sulphanilamide. Fouts et al., (1957) showed that 
the species differences in activity of Prontosil 
was due to the species differences in azoreduction 
of the drug. Prontosil was highly active in the 
guinea-pig which had a high azoreductase activity 
but in the chicken azoreductase activity was low 
and prontosil was only weakly active as an 
antibiotic.
Nitroreductases;- under anaerobic conditions the 
nitro groups of compounds such as p-nitrobenzoic 
acid, nitrobenzene and chloramphenicol are reduced 
to primary amino groups, probably through the 
corresponding nitroso and hydroxylamine compounds 
(Fouts and Brodie, 1957).
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R-N02 > R - N O    R-NHOH >  R-NH2
Nitro- Nitroso- Hydroxyl- Amino-
amino-
Nitro reductase is dependant on NADPH, NADH 
and cytochrome P 4 5 0  and is completely inhibited by 
carbon monoxide. Species differences in 
nitroreductase activity are seen with the reduction 
of p-nitro benzoic acid to p-aminobenzoic acid.
The activity in the dog is approximately 6 % that in 
the mouse (Fouts & Brodie, 1957)
Phase 2 (Conjugation Reactions)
Conjugation reactions occur in two steps; 
first the drug or the conjugating agent forms part 
of an "activated" nucleotide, and secondly the 
activated form is transferred to the other 
component of the conjugating system. For example, 
in glucuronide conjugation the conjugating agent is 
activated to form uridine diphosphate glucuronic 
acid (UDPGA), or in acetyl conjugation the 
activated form is acetyl CoA. Whereas in the 
conjugation of benzoic acid with glycine it is 
benzoic acid, ie the drug, which is activated by 
combining with coenzyme A to give benzoyl-CoA. 
Glycine is then transferred to the activated 
benzoyl groups to form hippuric acid which is then 
excreted.
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Species differences in reactions
Species differences in conjugation reactions 
will depend on:-
1 ) the ability of the animal to synthesize 
the necessary active intermediate 
nucleotide.
2 ) the nature and activity of the 
transferring enzyme
3) the availability of the conjugating agent
4) the nature of the foreign compound being 
conjugated
5) the rate of the conjugating reaction
Qualitative differences in coniuaation reactions 
The main compounds involved in conjugation are 
glucuronic acid, glycine, glutathione, methionine, 
acetyl, sulphate and thio groups, other conjugating 
agents are found in individual species e.g. 
ornithine conjugation occurs in birds and 
glycyltaurine conjugation occurs in cats (see table 
5). Unique species differences due to the absence 
of the necessary transferring enzyme are also known 
e.g. the cat has a poor ability to form glucuronic
25
acia conjugates aue to a lacx ot glucuronyl 
transferase which is required for forming ethereal 
and ester glucuronides (Williams, 1964; Goldstein 
et al., 1974? Mulder & Bleeker, 1975) A strain of 
rat, the Gunn rat, is also deficient in this e n z y m e s 
(Arias, 1961). However, both the cat and Gunn rat 
form N-glucuronides indicating that a different 
enzyme is involved in N-glucuronide formation 
(Goldstein et al., 1974; Arias, 1961).
Mercaptunic acid synthesis occurs at a very 
low level in man, guinea-pig and hen, but readily 
occurs in the rat, rabbit, dog, cat and pig. Hence 
mercapturic acid conjugation is only a minor 
pathway in the former compared to the latter 
species (Williams, 1964) .
Some compounds are conjugated by more than one 
conjugating agent and species differences occur in 
the extent of conjugation via the different 
pathways. For example, 2 naphthylacetic acid is 
excreted conjugated to either glucuronic acid or 
amino acids. Species differences not only occur in 
the relative proportion of the two types of 
conjugates but also in the amino acids excreted.
In the rat, rabbit and ferret conjugation with 
glycine, glutamine and taurine occurs, whereas in 
the gerbil and mouse only glycine and taurine 
conjugates are found and in the guinea only glycine 
conjugates are seen (Caldwell, 1982).
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For conjugation reactions primates tend to 
resemble man in the pattern of metabolism more 
closely than they resemble non-primates (Caldwell, 
1982). An example is seen with the metabolism of 
sulphadimethoxine. Sulphadimethoxine is either 
conjugated with glucuronic acid or acetate. Table 
7 shows the species differences in the production 
of the two conjugates. In man 70% of the 
sulphadimethoxine is excreted in the urine as the 
glucuronide conjugate compared to 30-70% in 
primates and 0-19% in non primates.
fljjaiitj,tatiy_e diff^Lenc^s in conjugation ££actignsj_
An example of quantitative differences in
conjugation reactions in different animal species
is shown by sulphanilamide. Sulphanilaraide is
1 4acetylated at N and N positions and then 
deacetylated. The extent of the acetylation at the 
different positions varies with species (Bridges, 
1963) . Table 6 shows that in the cat, dog and fox 
the drug is primarily excreted in the free form and 
the lack of conjugation results in the drug having 
a longer duration of action in these species and 
hence these species are more susceptible to toxic 
reactions. The cat has a greater extent of 
acetylation than the dog and fox and this may be 
representative of the cat belonging to the felidae 
family whereas the dog and fox belong to the 
canidae family.
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Within species there is a genetic difference 
in the rate of acetylation. It was found during 
the use of the anti-tubercular drug isoniazid, 
which is deactivated oy acetylation, that there 
were genetically 2  populations of acetylators, fast 
and slow (Hughes et al., 1954; Eidius et al.,
1971) . Fast acetylators inactivate the drug very 
quickly and its therapeutics action is therefore 
short lived, whereas slow acetylators have higher 
plasma levels of the drug and respond more readily 
to is therapeutic action, but are also susceptible 
to the toxic side-effects. The distribution of the 
2  types of acetylators among the world population 
showed that they were genetically determined. The 
proportion of the population that are fast 
acetylators is high among the Eskimoes, the 
Japanese and the Chinese but is low among the 
Scandinavian people, Sudanese and Israelies 
(Szorady, 1973).
Lunctjon oxjdas^ systg.rp
Many workers have studied the components of the 
mixed function oxidase system in a number of 
different animals in order to establish any link 
oetween species differences in the mixed function 
oxidase system and the species differences in drug 
metabolism. Kato (1966) found that aniline 
hydroxylase and aminopyrine N-demethylase activities
\
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in the mouse, rat, rabbit and cat correlated with 
the levels of cytochrome P 4 5 0  and NADPH-cytochrome 
c reductase. However, Flynn et al., (1972) 
studying the mouse, rat and guinea pig did not find 
such correlations but from studies after 
pretreatment of the animals with phenobarbital or 
3-methyl-cholanthrene the authors suggested that 
aminopyrine N-demethylase activity was dependent 
upon the level of cytochrome P 4 5 0  and aniline 
hydroxylase activity upon the level of 
NADPH-cytochrome P 4 ^ 0 reductase. This is in 
contrast to the work by Schenkman (1972) and 
Archakov et al (1974) who found that 
NADPH-cytochrome c reductase in the rat was not the 
rate limiting step in aniline hydroxylation.
Davies et al., (1969), however, found ethylmorphine 
N-demethylase activity paralleled quite closely to 
that of NADPH-cytochrome P 4 5 0  reductase in the 
mouse, rat, guinea pig and rabbit but not with 
NADPH-cytochrome c reductase.
It has been suggested that species differences 
in the metabolism of drugs and other xenobiotics is 
due to differences in substrate binding to 
cytochrome P 4 5 0 . Substrate binding to cytochrome . 
P 4 5 0  is dependent on the content and binding 
capacity of cytochrome P450. Kato et al. (1970) 
looked at species differences in aniline and 
hexobarbital hydroxylations and the binding of 
these two substrates to cytochrome P 4 5 0 . They
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rouna cnau arcnougn m e  spectral cnanges (Ziuuj w i m  
aniline and hexobarbital varied widely between 
different species when the spectral change was 
expressed per nmole cytochrome P 4 5 0  the species 
differences were greatly decreased. Also the 
species differences in hexobarbital hydroxylation 
were not seen when the activity was expressed per 
unit of spectral change. A similar effect was not 
seen with aniline and this may be due to the fact 
that aniline is a type II binding substrate and 
hence exerts a different effect on the spin state 
of cytochrome P 4 5 0  when bound to this hemoprotein 
compared to the type I substrates such as 
hexobarbital (Kato et al, 1970) . However, Davies 
et al. (1969) did not find species differences in 
ethylmorphine N-demethylase activity to be related 
to type I spectral change caused by ethylmorphine.
Specigg differences la cytochrome £ 4 5 0 :- From 
studies with microsomes obtained from animals 
treated with various inducers of the mixed function 
oxidase system there is considerable evidence 
indicating that there is more than one form of 
cytochrome P 4 5 0 . When animals are treated with 
3-methylcholanthrene (3-MC) a cytochrome which has 
a CO-reduced cytochrome absorption maximum at 
4 4 7 - 4 4 8  rather than 450 is seen in the microsomes 
and has been termed cytochrome P 4 4 3 . The substrate 
specificity of these two forms of cytochrome also 
differs. Cytochrome P450 preferentially catalysed
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et n y i m o r p n m e  ana a m m o p y r m e  w-aemecnyiarion 
whereas cytochrome preferentially catalysed
benzo(a)pyrene and 7-ethoxycoumarin hydroxyJLation,
2-acetylaminofluorene N-hydroxylation, 
7-ethoxyresorufin O-deethylation and biphenyl
2-hydroxylation (Levin et al,, 1977a; Atlas et al., 
1975; Burke and Mayer, 1975) . Many of the 
reactions catalysed by cytochrome P 4 4 3  generate 
metabolites more toxic than the parent compound, ie 
oxygenated reactive intermediates which react 
chemically with vital intracellular molecules such 
as DNA and cytochrome P 4 5 0  (Parke and Ioannides, 
1982). Hence species differences in the cytochrome
P448 levels are important in determining the 
susceptibility to potential carcinogens, mutagens 
etc. Studies involving the purification of 
cytochrome P 4 5 0  have shown there to be further 
forms of the cytochrome present in many species.
Six different endogenous forms of cytochrome P 4 5 0  
have been purified from rabbit liver microsomes, 
four forms from rat (Guengerich, 1977) and seven 
forms from mouse (Lang & Nebert, 1981) . These 
cytochromes purified from different species have 
been shown to be distinctly different hemoproteins 
(Nebert et al., 1981). Strain differences in the 
forms of cytochrome P 4 5 0  also occur. Guengerich et 
al. (1981) showed that the major form of cytochrome
P 4 5 0  in phenobarbital treated Long Evans and 
Sprague-Dawley rats were immunologically different 
whereas in 3-MC treated rats the major form of
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^r4 4 gj was immunoj.ogica±±y cne same 
in the two rat strains. Hence species and strain 
differences in microsomal mixed fucntion oxidase 
activity is dependant not only on the amount but 
also the type of cyrochrome P 4 5 0  present. Such 
heterogenicity in enzymes is commonplace and should 
oe expected. For example there are at least 5 
forms of lactate dehydrogenase in man alone (Bell 
et al, 1972)
Strain differences in drug metabolism
In addition to species differences, strain 
differences in drug metabolism are known to occur. 
In 1949 Marrow et al, showed that the liver 
glucuronidase activity of 7 strains of mice varied 
10-fold. Nebert and Gelboin (1969) found a similar 
variation in aryl hydrocarbon hydroxylase activity 
in 6 strains of mice. Lee et al. 1982 found a 2- 
fold variation in cytochrome P 4 5 0  levels in 3  
strains of mice. Gay (1955) and Lush et al. (1978) 
found strain differences in hexobarbital and 
phenobarbitone sleeping times in the mouse although 
this wa§ not found by Graham et al. (1981). Large 
strain differences (1 0 -fold) have also been found 
in rabbits (Gram et al., 1965). Rats tend to show 
smaller strain differences in drug metabolising 
activity (2-to3-fold) (Quinn et al., 1958; Furner et 
al., 1969; Page and Vesell, 1969; Jori et al., 1970; 
Gold and windell, 1975; Rush et al., 1981).
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ioanniaes et a±. (iy / /; studied two strains or 
ferret and found no marked differences between the 
albino and polecat ferrets. Among the human 
population large interindividual differences occur 
in the metabolism of aflatoxin B, benzo (a)pyrene, 
antipyrine, hexobarbitone, coumarin and 
benzo(a)pyrene 7, 8 -dihydrodiol (Conney et al.,
1979) . Pelkonen et al. (1973) also found large 
interindividual differences in cytochrome P 4 5 0  
levels, benzo(a)pyrene hydroxylase, aminopyrine 
demethylase, hexobarbital oxidase and aniline 
hydroxylase. Davies et al. (1973) however found 
only small interindividual differences in 
cytochrome P 4 5 0  levels ethylmorphine demethylase 
activity, NADPH-cytochrome P 4 5 0  reductase activity 
and In vivo antipyrine metabolism.
The strain differences seen in laboratory 
animals, whose environment and diet are closely 
controlled, can be regarded as genetically 
determined. Human interindividual differences may 
be due to genetic factors and/or environmental 
factors such as diet, occupational exposure to 
chemicals, exercise, alcohol consumption and 
cigarette smoking (Vesell, 1980). Studies 
involving identical and non-identical twins suggest 
that interindividual variation in drug metabolism 
are mainly due to genetic factors (Vesell and Page, 
1968a,b, 1969) .
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sex airrerences in drug metapoiism
In some species sex differences in the rate of 
microsomal mixed function oxidase activity occurs. 
The rat shows a marked sex difference in 
aminopyrine and ethylmorphine N- demethy lations, 
hexobarbital and benzo(a)pyrene hydroxylations (the 
activity in the males being more than twice that in 
the female), but no differences in aniline or 
Diphenyl hydroxylations(Kato et al., 1970; Litterst 
et al., 1976). A sex difference was also seen with 
the tupaia with respect to biphenyl and 
benzo(a)pyrene hydroxylation, but in this species 
the activity was higher in the female and the 
difference was much smaller than seen in the rat 
(Litterst et al., 1976). Sex differences have also 
bee shown with some strains of mice (Catz and Yaffe, 
1967; Castro and Gillette, 1967) .
Species and strain differences in the induction of 
the microsomal mixed function oxidases
A numDer of xenobiotics when administered in 
vivo will induce the microsomal mixed function 
oxidase system. The two most widely used inducers 
are phenobarbital which induces cytochrome P 4 5 0  and 
enzymes catalysed by this cytochrome, and 
3-methylcholanthrene which induces cytochrome £ 4 4 3  
and related enzymes (Conney, 1967) . However there 
are more than 2 0 0  drugs, carcinogens, other
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enviromentai pollutants ana steroias tnat are Known 
to induce their own metabolism and/or that of other 
compounds via -the induction of forms of cytochrome
P 4 5 0  (Nerbert et al., 1981). Strain and species 
differences occur in the induction of various drug 
metabolising enzymes by different inducers. Gram 
et al. (1965) found a 2-to 3 -fold difference in the 
effect of phenobarbital administration on the in 
vitro drug metabolism in six strains of rabbits. 
Page and Vesell (1969) also found a 2-fold 
difference among 1 0  strains of rat in the 
phenobarbital induction of aniline hydroxylase and 
ethylmorphine N-demethylase activies. Gold and 
Windell (1975) studied the effect of phenobarbital 
on the induction of cytochrome P 4 5 0  level and 
NADPH-cytochrome c reductase activity in the 
Fischer and Sprague Dawley strains of rat and found 
a 5 -fold difference in induction between the two 
strains. However the strain differences in 
induction were substrate dependant in so much that 
the phenobarbital induction of cytochrome P 4 5 0  was 
5-fold greater in the Fischer strain than in the 
Sprague Dawley strain but the reverse was true for 
the induction of NADPH-cytochrome c reductase. 
Nebert and Gelboin (1969) found that 
3-methyl-cholanthrene induction of benzo(a)pyrene 
hydroxylase varied 1 0 -fold among 6 strains of mice.
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Similar differences in induction occurs 
between species. Phenobarbital treatment caused a
3- fold increase in benzo(a)pyrene hydroxylase 
activity in the mouse, guinea-pig and rabbit but 
only a 50% increase in the rat.
3-Methylcholanthrene treatment, however, resulted 
in no significant increase in benzo(a)pyrene 
hydroxylase in the rabbit, a 2 - fold increase in 
the mouse and guinea-pig, and a 4 to 5- fold 
increase in the rat (Alvar*es et al., 1970). Nebert 
and Gelboin (1969) found that 3-methylcholanthrene 
treatment caused a 2 to 3- fold increase in 
benzo(a)pyrene hydroxylase activity in the rat, a 4 
to 1 0 - fold increase in the mouse ( 6 strains) , but 
no significant increases were seen in the monkey 
and hamster.
x elutions hip kehwe.en drug metabolism and body 
wgighh
With the advances in medical and industrial 
technology the number ot drugs and environmental 
chemicals to which the human population are being 
exposed is increasing at a great rate. In the 
United States the number of toxic substances in 
industrial use increases at a rate of 1000 per year 
(Reichsman and Calabrese, 1978). With each 
chemical to which man is exposed there is the risk 
of toxic effects, hence it is of vital importance
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tnat. cnese toxiu eneucscina tne minimal permissiDie 
dose are accurately assessed before humans are 
deliberately exposed to these agents. To assess 
the effects of new chemicals studies are carried 
out in animals (normally two rodent and one 
non-rodent species) and from these results the 
effect of the chemical in man is calculated. This 
extrapolation of experimental data from animals to 
man is often difficult and uncertain (Reischman and 
Calabrese, 1978). Understanding the inter- and 
intra-species differences in metabolism, 
toxicokinetics and biochemistry (affinities for and 
reaction with cellular receptors) enables a more 
accurate extrapolation of animal toxicity data into 
risk assessment for man.
Species differences in a number of 
physiological parameters are known to be related to 
body size. Rubner (1883) showed that small animals 
had a relatively greater oxygen consumption and 
produced relatively more heat than larger animals. 
He found that small animals had a larger surface 
area (relatively to body weight) than larger 
animals and if based on body surface area oxygen 
consumption and heat production were similar in all 
animals large and small. Since then a number of 
physiological parameters have been found to have a 
direct linear relationship with body surface area 
including those which would be expected to affect 
in vivo drug metabolism. Plasma volume and total
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relationship with body surface area hence the size 
of the animal would be expected to effect the 
plasma concentration of free drug (Mellet, 1969) . 
Freireich et al, (1966) explored the possible 
relationship between drug activity and body size.
He studied the toxicity of a number of anticancer 
drugs in different animal species and found that 
the ratios of animal: human toxicity when the dose
was given on a body surface area basis (i.e.,mg per
2
mnr) was very close to unity for the mouse, 
hamster, dog and monkey. Similar results were 
found by Mellet (1969) with the anti-cancer drug 
cytoxan. However, Rail (1969) has pointed out that 
the anticancer agents used in the study by 
Freireich et a l . (1966) generally do not undergo 
biotransformation by the drug metabolising enzymes 
and hence this study tested the variation in 
absorption, distribution, excretion and mechanism 
of action rather than in metabolism as a function 
of body size. However studies of the rate of drug 
oxidations suggest that the metabolism of drugs is 
also related to body size. Quinn et al. (1958) 
found that the half-life of hexobarbital in the 
mouse was 7 times shorter than in the rat and 18 
times shorter than in man, similar results were 
also seen with the antipyrine half-life (Quinn et 
al., 1958) Chloroform metabolism also shows a 
correlation with body weight which is important in 
respect to the toxicity of the compound in
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due to the formation of a reactive metabolite hence 
the greater the rate of chloroform metabolism the 
greater its toxicity in a species. The conversion 
of ^ C - c h l o r o f o r m  to ^ C C ^ ,  an index of overall 
metabolism, is about 80% of the dose in the mouse, 
70% in the rat and 2 0 % in the squirrel monkey 
(Brown et al., 1974). This species differences in 
the rate of chloroform metabolism is reflected in 
the species differences in toxicity, chloroform 
being a hepatocarcinogen in the mouse but not in 
the squirrel monkey (Parke, 1979) .
Krasovskii (1976) studied the conditions for 
extrapolating toxicological data from animals to 
man. He found that the logarithms of many 
biological parameters (including relative organ 
weight, water consumption, tidal volume, life span) 
and of the activity of many liver enzymes 
(including cytochrome P 4 5 0 , aminopyrine demethylase 
and aniline hydroxylase) for a number of animal 
species are inversely linearly related to the 
logarithm of body weight. Walker (1978) using data 
from the literature also found an inverse linear 
relationship between the logarithm of the relative 
rate of hepatic mixed function oxidation in vitro 
and in vivo, and the logarathm of the body weight. 
The relative hepatic mixed function oxidase 
activity for each species was obtained by taking 
the combined activity (relative to the activity in
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the rat) of a number of different enzymes.
Aims of the present study:- Workers often only 
study a limited number of animal species and enzyme 
activities and comparison of different studies is 
complicated oy the fact that there is often wide 
variation in the species differences seen from one 
study to antoher (e.g. the literature indicates that 
hepatic cytochrome P 4 5 0  levels in the mouse varies 
from 60-370% that in the rat). For this reason a 
large single study was carried out to determine in 
more detail the relationship between body weight 
and drug metabolism. A number of mixed function 
oxidase and components of the mixed function 
oxidase system were studied in vitro using hepatic 
microsomes from a number of mammalian species 
ranging in body weight from the mouse to man. A 
number of non-mixed function oxidase enzymes were 
also studied. Two mixed function oxidase enzymes 
were also studied in vivo in species ranging in 
body weight from the mouse (50g) to the ferret 
(1.5kg). The aim of the study was to determine 
whether the relationship with body weight exists 
for a range of different mixed function in vitro 
and In vivo. non-mixed function oxidase enzymes, 
and possible causes for the relationship.
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Table 1. SPECIES DIFFERENCES IN THE DURATION OF
ACTION AND METAROLISM OF HEXOBARBITAL
Species Sleeping Biological R e la tive  enzym e
t ime V 2  life activi ty
(min) (min) (p g /g  liver hour )
Mouse 12 18 19 1 7 598 i  184
Rabbit 49 ±12 60 1 11 196 1 28
Rat 90 ± 15 140 1 54 134 1 51
Dog 3 1 5 i1 0 5  2 6 0 1 20 36 1 30
From Quinn et a l . , 1958
The resu lts  are m ean iS .D . from 8-12 an im a ls .
Table 2. DISTRIBUTION OF THE "PHASE T  ENZYMES
Reaction
Oxidations:-
Reductions:-
Hydrolysis:-
THE CELL
D istribu tion  of the E n z y m e s  
Microsomal Non-Microsom al
aliphatic hydroxylation 
aromatic hydroxylation 
epoxidation  
deamination  
dealkylation ( 0 - , N - S - ) 
dehalogenation  
N -hydroxy la tion  
N -oxidation  
sulphoxidation  
desu lphuration  
nitroreduction  
azo reduction  
reductive dehalogenation 
metal alkyl dealkylation
a m in e  oxidation  
alcohol oxidation  
aldehyde oxidation
aldehyde reduction
ester hydrolysis 
amide hydrolysis
^
Table 3. SPECIES DIFFERENCES IN THE SITE OF AROMATIC
HYDROXYLATION OF ANILINE AND BIPHENYL
SEE.C.1E.S l K m n  IN VITRO
H vdroxvlation of.aniline^ 
o-/p -  ratio in urine 4 - /2 -  ratio
Trout - n.d.
Hen 4 0 n.d.
Frog - 8.0
Cat 0.4 4.0
Dog 0.5
Fox - n.d.
Ferret 1.0
Rabbit adult 6.0 n.d.
young - 27.0
Rat adult 6.0 n.d.
young - 8.0
Mouse 3.0 3.0
H am ster 10.0 2.0
Guinea pig 11.0 n.d
Geril 15.0
Coypu - 2.0
n.d. - no detectable 2 -hydroxybiphenyl
1 - From Parke (1960)
2 - From Creaven et aL, (1965a)
Table 4. SPECIES DIFFERENCES IN THE METABOLISM
OF AMPHETAMINES
Relative extent of m etabolism  pathw ay  
S pecies Arom atic  N-Dealkylation Deamination Excreted
hydroxylation unchanged
Rat +++ +++ + ++
Guinea pig absent ++ ++ + + + +
Rabbit ♦ ++ ++++ +
Marmoset + no data + ++ + +
Rhesus. no data +++ + +
monkey
M an ++ + +++ +++
+ to + + + + -a r b i t r a r y  quantitation  
From C a ldw ell (1982)
Table 5. SPFCIES DIFFFRFNCFS IN CONJIKTATION- REACTIONS
Coniuaatina aaent Species differences
Major conjugating agents;-
Glucuronic acid - deficient in cats and pigs
Glycine - deficient in chickens
Glutathione - deficient in guinea pigs, m an  
and chickens
Acetate - deficient in dogs
Sulphate - deficient in pigs
Minor conjugating agents:-
Glucose - occurs in insects
N - Acetylglucosamine - occurs in rabbits
Ribose - occurs in rats and mice
Glutamine - occurs in man and insects
Ornithine - occurs in birds
Arginine, agmatine - occurs in ticks and spiders
Glycyltaurine - occurs in cats
Serine -occurs in rats and rabbits
Formyl - occurs in rats and dogs
Phosphate - occurs in dogs, insects and sheep
Valine - occurs in Malard duck
Taurine -occurs in rats, rabbits, hamsters  
and ferrets
Table 6. SPECIES DIFFERENCES IN THE EXTENT OF N-ACETYLATION
OF SULPHANILAM IDF
Species 7 .  Dose excreted in urine in 24 hours as:
Free drug N-acetvl N-acetyl N^N^diacetvl
Hen 47 3 24 1
Turkey 25 9 47 4
Pigeon 60 6 23 1
Mouse 49 4 13 7
Rat 36 10 36 2
Guinea pig 65 9 7 7
Coypu 36 4 39 5
Rabbit 22 1 39 4
Cat 65 6 8 6
Dog 82 9 0 0
Fox 70 10 0 0
Rhesus monkey 27 1 56 4
Man 36 7 24 2
From Bridges 1963,
Table 7. METABOLISM OF SULPHIMETHOXINE IN VARIOUS SPECIES
Species %  dose excreted %  composition of the 24 hour urine
per 24 hours N^alucuronide N^acetvl
Rat 9 7 46
Guinea pig 2 0 5 66
Rabbit 43 0 94
Dog 23 19 0
Man 25 70 21
Rhesus monkey0 42 70 21
Green monkey0 12 30 61
Baboon 42 73 16
Squirrel monkeyb 9 51 37
.Capuchin^ 8 48 15
Giant bush baby 26 48 2
Slow Ion's 19 62 35
Tree shrew 26 52 18
a - Old world monkeys 
b -N e w  world monkeys
From  W il l ia m s  (1967).
MATERIALS AND METHODS
MIHALS
Male animals were used throughout the in vivo 
studies. Liver samples for the in vitro studies 
were ootained from male animals except for those 
from the serval, leopard and sheep. The pig liver 
samples were from animals of unknown sex.
Animals used in the study were Wistar albino 
rats, Zucker lean rats and Lister black hooded 
rats, C.D. mice, mongolian gerbils (Animal Unit, 
University of Surrey), Dunkan Hartley guinea pigs 
(Animal Virus Research Institute, Pirbirght,
Surrey) & Suffolk Cross sheep (Haywards Heath Farm, 
maintained for 6 months at Manor Farm Animal Unit, 
University of Surrey). The ferrets (mustela 
putorius furo) and raobits (Dutch) were kindly 
donated by Biorex Laboratories Ltd. Pig liver 
samples were obtained from the local abattoir. 
Beagle dog liver samples were a gift from Fisons 
Ltd., Pharmaceutical Division, and Allen & Hanburys 
Ware, Herts. Liver samples from a serval, leopard, 
fallow deer and sooty mangabey (old world monkey)
were kindly donated by the London Zoological
£
Society (Regents Park London. NWl 4RY).
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The laboratory animals were allowed free 
access to water and food (Spratts Laboratory Animal 
diet, Barking Essex was given to all animals except 
the ferrets which received BP Nutrition Beta Diet 
B, Witham Essex) prior to the experiments.
1)
[-^C-dimethyl] Aminopyrine (5-15Ci/mmol) was 
obtained from the Radiochemical Centre, Amersham, 
Bucks, England.
2) Special Chemicals
Aniline hydrochloride, biphenyl,
2-hydroxybiphenyl, 4-hydroxybiphenyl and heparin 
(mucous) were obtained from BDH Chemicals Ltd, 
Poole, Dorset, England. Ethylmorphine was obtained 
from May and Baker Ltd, Dagenham, Essex, England. 
Ethoxyresorufin was obtained from Pierce Chemical 
Company, Rockford, Illinois, USA. Resorufin was 
obtained from Pierce and Warringer, Chester, 
England. Benzo(a)pyrene, hexobarbital, urethane, 
glucose 6-phosphate, glucose 6-phosphate 
dehydrogenase (from torulor yeast, type XII), 
nicotinamide adenine dinucleotide (NAD) and the 
reduced form (NADH), uridine 5'diphosphoglucuronic 
acid (di-sodium salt, UDPGA) were obtained from 
Sigma Chemical Company, St. Louis, USA.
Nicotinamide adenine dinucleotide (NADP) and the 
reduced form (NADPH) were obtained from Cambrian 
Chemicals, Croydon, England. 3-Hydroxybiphenyl and
3-hydroxybenzo(a)pyrene were a gift from Dr. D.J. 
Benford (Dept, of Biochemistry, University of
lJUJ. L  ) , L.XIC x a u u c i .  U C i l i y  i S U ^ l i C U  kJJ U i X C
Carcinogenesis Research Program (National Cancer 
Institute, Bethes.da, USA) .
3) Qtngr Reagents
Tris (hydroxymethyl) amino methane (pH 7-9) 
and dithiothreitol were obtained from Sigma 
Chemical Company, USA. All inorganic chemicals, 
<x-naphthol, glycine, isoamyl alcohol (all of analar 
grade), 2-ethoxyethanol, thymolphthalein indicator 
and triethylamine were obtained from BDH Chemicals 
Ltd, England. Hydrochloric acid AR, n-heptane, 
diethyl ether, trichloracetic acid, acetone and 
toluene (Doth of Pronalys grade) were obtained from 
May and Baker Ltd, England. 2,2,4-Trimethyl 
pentane (isooctane), acetonitrile (both of HPLC 
grade) and acetylacetone (SLR grade) were obtained 
from Fisons Scientific Apparatus, Loughborough, 
England. Ethanol (95%) was obtained from James 
Burrough Ltd, London, England. Quinine sulphate,
2 ,5-di-phenyloxazole (PPO) and
1,4-di[2-methyl-5-phenyloxazolyl)]benzene (dimethyl 
POPOP) were obtained from Koch-Light Laboratories 
Ltd, Colnbrook, Bucks, England.
4) Other Materials
Intravenous cannula tubing (0/D 0.6mm) was 
obtained from Portex Ltd, Hythe, Kent, England.
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METHODS
a) IE VITRO METHODS 
Preparation of Microsomes
All laboratory animals except the ferrets were 
killed by cervical dislocation. The ferrets were 
killed by lethal inhalation of diethyl ether. The 
livers were removed immediately and rinsed in 
ice-cold 1.15% KC1 (pH 7.4). The dogs and all 
animals (except the leopard) obtained from London 
Zoo were killed by anaesthetic. Liver samples from 
these animals were removed 15-45 mins after death, 
cut into sections, wrapped in foil and transported 
frozen in cardice. The longest period of 
transportation was 4 hours. The sheep and pigs 
were killed at the local abattoir. The livers were 
removed 20-40 mins after death. Liver samples from 
these animals were wrapped in plastic and packed in 
ice during transportation (approximately 30 m i n s ) .
The leopard liver sample was taken from an 
animal which had died of natural causes at London 
Zoo. The animal had been dead for approximately 3 
hours before the liver was removed and the liver 
sample (approximately 60g) was frozen wrapped in 
foil for 3 days before microsomes were prepared.
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The frozen liver samples were allowed to thaw 
slowly in ice cold 1.15% KC1 (pH 7.4). All liver 
samples were washed in this medium to remove excess 
bloody the livers were then blotted dry and 
weighed. With the small animals the whole liver 
was taxen for the preparation of microsomes while 
with the larger animals only part was used. Where 
possible a section from each lobe of the livers 
were, used. The livers were homogenised in 1.15%
KC1 (pH 7.4) (25% liver w/v) using a Potter
E l v e h j e m  teflon homogeniser mechanically driven 
and employing 2 up and down strokes. However the 
livers from the larger animals (with the exception 
of the pig) were more fibrous and homogenisation 
was more difficult. As a result these liver 
samples were finely scissor minced prior to 
homogenisation. With the leopard and serval liver 
the samples were minced using a Spong mincer. Even 
s o ,homogenisation of livers from the larger animals 
was poor and the resultant homogenate was not a 
true 25% liver mixture. The homogenate was 
centrifuged for 20 mins at 9000g (11,000 r.p.m.) 
and 4°C in a 8x50ml rotor using a MSE HS 18 
centrifuge. The resultant supernatant (post- 
mitochondrial supernatant or microsomal 
supernatant) was decanted and a small volume kept 
on ice to be used (within 1 hour) for the 
determination of biphenyl hydroxylase and alcohol 
dehydrogenase activities. The remaining
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supernatant was rurtner c e n t n r u g e a  at ±//,/ 0 0 g 
(50,000 r.p.m.) and 4°C in a 8x25ml rotor for 40 
mins using a Beckman L5-65 ultra centrifuge. The 
microsomal pellet was resuspended in 0.1M phosphate 
Duffer (pH 7.6) to the original volume (ie. 25% 
liver w/v) using a hand teflon homogeniser. This 
microsomal suspension was further centrifuged at 
177,700g (50,000r.p.m.) at 4°C for 40 mins. the 
resultant pellet of washed microsomes was 
resuspended in a minimal volume of 0.1M phosphate 
Duffer containing ImM EDTA, ImM dithiothreitol and 
20% glycerol. This concentrated microsomal 
suspension (containing 40-100mg protein/ml) was 
stored frozen as small aliquots at -80°C until 
required. Each aliquot was made up to a 25% liver 
(w/v) microsomal suspension with ice cold 0.1M 
phosphate buffer (pH 7.6) prior to use.
The human liver samples were kindly donated by 
Dr. P. Beaune (Laboratoire de Biochimie,
INSERM-U-75, Faculte de Medecine, Necker Enfants 
Malades, 156 rue de Vaugirard., 75730 Paris,
France). The samples were from renal donors of 
Doth sexes and ages ranging from 25-50 years. The 
liver samples had been frozen on dry ice 
immediately after removal from the donor and stored 
at -80°c for Detween 2-16 months before they were 
received at Surrey. Storage of the liver whole for 
6 months did not affect the cytochrome P 4 5 0  or 
enzyme activity of the liver (Kremers et al.,
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The human microsomes were prepared by the method of 
Beaune et al.(1979). The frozen liver samples were 
allowed to thaw in 0.1M phosphate buffer pH 7.4 
containing 0.2M sucrose and 0.1mM EDTA. The liver 
samples were rinsed with this medium to remove 
excess blood. The livers were homogenised in the 
same medium using the method described for the 
animal species except the resultant homogenate 
contained 20% liver (w/v) instead of 25%. Human 
microsomal supernatant and microsomal suspension 
were prepared in the same manner as described for 
the animal species except the microsomal pellet 
obtained after the first spin at 50,000 r.p.m. was 
resuspended in 0.1M sodium pyrophosphate (pH 7.4) 
to remove the haemoglobin. The washed microsomes 
were stored concentrated in 0.1M phosphate buffer 
(pH 7.6) containing 0.1mM EDTA, 0.1mM 
dithiothreitol and 20% glycerol at -80°C. The 
human microsomes were made up to 25% liver (w/v) 
microsomal suspension with 0.1M phosphate buffer 
(pH 7.6) prior to use.
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Protein Determination
The Bradford protein dye method (Bradford 
1976) was used for the determination of the protein 
concentration of the microsomal suspension samples. 
This method is much quicker than the Lowry method 
(Lowry et al., 1951) taking approximately 10-20 
mins to determine the protein content of 1 0  samples 
in duplicate compared to 60-90 mins with the Lowry 
method. For all animal species the concentration 
of microsomal protein used for a particular assay 
was kept constant, hence a protein determination of 
the microsomal suspension was required before any 
assays could be carried out. For this reason the 
quick Bradford method was a more useful method than 
the Lowry method. For initial studies on rat and 
mice microsomes the protein concentrations were 
determined by both methods and the results were 
comparable. For the Bradford method the extinction 
was linear with protein concentration within the 
range 0-30pg protein/ml.
Preparation of the protein dye reagent: 100mg
Coomassie brilliant blue G-250 were dissolved in 
50ml ethanol (95%) and to this solution 100ml 85% 
(w/v) orthophosphoric acid was added and the volume 
made up to 100ml with distilled water. This stock 
dye reagent was kept at 4°C and used as required.
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Protein assay: To 100pl microsomal suspension
diluted to 100-300jug protein/ml (1:20-1:40 
dilution) were added 5ml protein dye reagent and 
the contents mixed by vortexing. Standards were 
prepared using bovine serum albumin solutions 
containing between 0-30pg protein/100ul with 5ml 
protein dye reagent. The absorbance at 595nm was 
measured between 5-20mins after the addition of the 
protein dye reagent, using a Perkin-Elmer SP1800 
spectrophotometer (the colour is - stable for lhr 
(Bradford, 1976)).
Cy&P-Qhrpnis £ 4 5 0  and Content of Washed Microsomes
Both cytochrome P ^ g  and cytochrome b^ were 
determined in the same microsomal suspension sample 
using the method of Omura and Sato (1964). 
Spectrophometric analysis was carried out on a Cary 
219 split-beam recording spectrophotometer (Varian 
Instruments).
Cy£pchrpmg t w o  quartz cuvettes (path length 
lcm) containing 0.5ml microsomal suspension diluted 
with 2.5ral 0 ,1M phosphate buffer (pH 7.6) were 
placed in the spectrophotometer and a base line 
recorded between 390-450nm. The base line corrects 
for differences in the 2 cuvettes. To the test 
cuvette 100/al NADH (10mg/ml) were added and the 
difference spectrum recorded. NADH reduces
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cytochrome b^ and the difference in absorbance 
between the trough at 410nm and the peak at 424nm 
(corrected for baseline differences) was measured. 
Using a molar absorbance coefficient of 185mM“^cm“^ 
(Omura & Sato, 1964) the concentration b^ was 
calculated.
Cytochrome E 450; a few milligrams of sodium 
dithionite were added to the 2  cuvettes to reduce 
all the microsomal cytochromes. A base line was 
recorded between 400-500nm. Carbon monoxide was 
bubbled slowly through the test cuvette for 
approximately 30 seconds and the difference 
spectrum recorded between 400-500nm. The 
difference in absorbance between 490nm and the peak 
at 450nm (corrected for difference in base line) 
gives a measure of the cytochrome P 4 5 0  content 
(using the molar absorbance coefficient for 
cytochrome P 4 5 0  of 91mM_'^cm”^) (Omura & Sato,
1964).
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Ethylmorphine Demethylase Activity
Ethylmorphine demethylase activity was 
measured in the microsomal suspension using a 
modification of the method of Holtzman et al.
(1968) • The demethylase activity was determined by 
measuring the rate of formaldehyde formation. The 
formaldehyde was trapped by semicarbazide.
h 2 c =o ♦ NH2 NHC0NH
formaldehyde semicarbazide
h2c =n n h c o n h 2 * h 2o
The deproteinised supernatant containing the 
formaldehyde-semicarbazide complex is heated with 
Nash reagent (a mixture of ammonium acetate and 
ac'etylacetone) and the formaldehyde released from 
semicarbazide reacts with the Nash reagent to form 
a colour complex 3 ,5 -diacety1-1, 4-dihydrolutidine
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CH3COONH4
HCHO + CH 3 C0CH 2 C0CH3- ------- >
N a s h  ft \ /H ?reagent
3,5-diacetyl 1 ,4-dihydrolutidine 5 jij ♦
3
The incubation mixture consisted of:-
Phosphate buffer (pH 7.6, 0.1M) 0.5ml
Magnesium sulphate (0.1M) 0.1ml
Ethylmorphine (60mM) 0.25ml
Semicarbazide HC1 (pH 7.0, 2%) 0.2ml
Glucose 6 -phosphate (30mM) 0.5ml
NADP (2.5mM) 0.5ml
Glucose 6 -phosphate dehydrogenase(2units) 0.1ml 
Microsomal suspension (2.5mg protein) 0.5ml
A blanx and 2 standard tubes were set up in 
duplicate. To the standard tubes 0.2 and 0.4 jamole 
formaldehyde were added after the reaction had been
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terminated.
In all enzyme assays the incubation mixture 
was pre-incubated at 37°C in a shaking water bath 
for approximately 5 mins except where stated 
otherwise.
The reaction was started by the addition of 
the microsomal suspension. After 10 mins 
incubation the reaction was terminated by the 
addition of 15% zinc sulphate (1 .0 ml) followed by lmlof a 
mixture (2 ;1 ) of saturated solutions of barium 
hydroxide and disodium tetraborate. The tubes were 
centrifuged using an MSE bench centrifuge (maximum 
speed) for approximately 5 mins to remove the 
denaturated protein. Aliquots of the supernatant 
(2 .0 ml) were added to 2 .0 ml of freshly prepared 
Nash reagent (4M ammonium acetate containing 4ml 
acetylacetone / litre). The solution was mixed by 
vortexing and incubated in a shaking water bath at 
37°C for 40 mins. The resultant yellow colour was 
measured in a Perkin-Elmer SP1800 spectrophometer 
at 412nm.
Biphenyl Hydroxylase Activity
A modification of the high pressure liquid 
chromatography (HPLC) method of Burke et al. (1977) 
was used. Assays were carried out using the 
microsomal supernatant. The incubation system
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consisted of:-
Tris-HCl buffer (pH 7.6, 0.5M) 
Magnesium sulphate (0.1M) 
Potassium chloride (1.15%) 0 .3ml
0.5ml
0 .2 ml
Biphenyl in 4% Tween (12mM) 0 .25ml
NADP (6 mM) 0.25ml
Microsomal supernatant 0.5ml
After preincubation at 37°C for 5 min the 
reaction was started by the addition of the 
microsomal supernatant. After 10 min incubation 
the reaction was terminated by the addition of 
4M-HC1 (0.5ml). The hydroxybiphenyls and the 
unmetabolised biphenyl were rotary extracted for 1 0  
mins with 7ml n-heptane. These tubes were 
centifuged at 2500 rpm for 5 min using a Beckman J 6
centrifuge to break the emulsion and were then
stored in the dark at 4°C until analysed. Suitable 
blanks and standards (containing 50pl of 0.1M and 
1.0M solutions of 2-, 3- and 4-hydroxy biphenyl 
added after the addition of 4M HC1) were carried 
through the same procedure.
For analysis of the hydroxy biphenyls by HPLC 
the organic layer was passed through a millipore 
filter (0.5jum); the filtrate was evaporated using a
rotary vacuum evaporator and the residue was
dissolved in 100jul of HPLC eluent ( 
iso-octane-isoamyl alcohol-acetonitrile; 1 0 0 :8 : 6  by
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approximately 0.5 hour before use to ensure 
complete mixing of the 3 solvents. All HPLC 
solvents were filtred using a millipore filter 
(0.5/im) before use. The 2 - f 3- and 
4 -hydroxy-biphenyls were separated using a bonded 
phase silica-NH 2  column 25 cm (Phase Separations 
Ltd) attached to a high pressure liquid 
chromatograph (Laboratory Data controls) . 50^il of
the solvent sample containing the redissolved 
residue was injected onto the column and eluted 
with the above mentioned solvent (flow rate 
1.5ml/min: pressure approximately 800psi). The 
column was kept at room temperature. The eluted 
samples were analysed at 254nm in a flow through 
spectrophotometer and the peaks recorded on a 
Tekman pen recorder. The peak heights of the test 
samples were measured relative to the extracted 
standard peak heights and the hydroxy-biphenyl 
content of the test samples calculated. A sample 
150jul of eluent containing 0.5pg 2-, 3- and
4-hydroxybiphenyl was injected on the column at 
intervals to check for variation in column 
efficiency. Pig 2 shows an HPLC trace of biphenyl 
metabolites formed after incubation of biphenyl 
(3jLimole) with guinea-pig liver microsomes.
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Ethoxyresorufin Deethylase Activity
Ethoxyresorufin deethylase activity was measured in 
the microsomal suspension using a modification of 
the method of Burke and Mayer (1974).
In a fluorimeter cuvette were placed:-
Phosphate buffer (pH 7.6, 0.1M) 2.0ml
Ethoxyresoruf in (50juM in methanol) 0.01ml 
Microsomal suspension (2.0mg protein) 0.2ml
The cuvette was placed in a Perkin-Elmer MPF3 
fluorescence spectrophotometer equipped with a 
thermostatically controlled heated jacket and pre 
incubated at 37°C for 2-3 min. The reaction was 
started by the addition of 50mM NADPH (10jj1) . The 
increase in fluorescence was recorded (excitation 
510nmf emission 586nm, slit width 3.5nm). To the 
same sample, once the reaction had slowed or 
stopped, was added 0.1M resorufin standard (10jul) 
and the further increase in fluorescence recorded. 
The initial velocity of the reaction after the 
addition of NADPH was measured and the rate of 
resorufin production per min determined. Fig 3 
shows a fluorimeter trace of resorufin production 
in mouse liver microsomes.
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Benzo(a)pyrene Hydroxylase Activity
Benzo(a)pyrene hydroxylase activity was measured in 
the microsomal suspension using the fluorimeter 
method of Wiseman and Woods (1979). The incubation 
mixture consisted of:-
Phosphate buffer (pH 7.0, 0.1M) 0.7ml
NADP (16mM) 0.25ml
Glucose 6 -phosphate (80mM) 0.25ml
Glucose 6 -phosphate dehydrogenase (4 units) 0.2ml 
Benzo (a) pyrene (0.79juM in acetone) 0.1ml
Microsomal suspension (2.5mg protein) 0.5ml
The reaction was started by the addition of 
benzo(a)pyrene and the mixture incubated in a 
shaking water bath at 37°C for 1 hour. The 
reaction was terminated by the addition of 1 ml 
ice-cold acetone and the tubes centrifuged in an 
MSE bench centrifuge for approximately 5 min to 
precipitate the denatured protein. 0 .6 ml of the 
supernatant was added to 1.4ml triethylamine (10.7% 
w/v) (further centrifugation was often required to 
obtain a clear solution). This mixture was placed 
in a fluorimeter cuvette and scanned from 500-560nm 
(emission 467) in a Perkin-Elmer MPF3 fluorescence 
spectrophotometer. The peak height at 520nm was 
calculated relative to quinine sulphate (1 0 jug/ml in 
1M sulphuric acid). 3-Hydroxy-benzo(a)pyrene
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standard (fcj.bmi or 00 pmoie/mi) was added to ±.4m± 
triethylamine solution and the fluorescence of the 
standard determined as for the test. The 3-hydroxy 
benzo(a)pyrene content of the test was determined 
from the standard values.
The enzyme activity was measured in the 
microsomal suspension using a modified version of 
the method of Williams and Kamin (1962). Reduced 
cytochrome c has an absorption maximum at 550nm 
whereas oxidased cytochrome c does not. The 
difference spectra in absorption between oxidised 
and reduced cytochrome c at 550nm is used to 
determine the activity of NADPH-cytochrome c 
reductase in microsomes.
In 2 quartz cuvettes the following were added
Test Reference 
Phosphate buffer (pH 7.6, 0.05M 1.8ml 1.9ml
containing 10”^M KCN)
Cytochrome c (0.1mM) 1.0ml 1.0ml.
Microsomal suspension (0.5mg 0.1ml 0.1ml
protein)
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The curvettes were warmed to 37°C by placing 
in a shallow water bath. They were then placed in 
the cuvette holders (maintained at 37°C) of a Cary 
219 slit-beam recording spectrophotometer (Varian 
Instruments). The reaction was commenced by the 
addition of 3 jumole NADPH (0.1ml). After rapid 
mixing the reaction was followed by an increase in 
absorption at 550nm. The initial gradient was 
measured and the rate of reduction of cytochrome c 
was determined using the molar absorpance 
coefficient for cytochrome c (18.5mM~^cm“^ ) .
Binding of Aniline and Hexobarbital to Washed 
Microsomes
A modification of the method of Schenkman et 
al. (1967) was used. The microsomal suspension was 
diluted with 0.1M phosphate buffer (pH 7.6) to give 
a concentration of lnmole cytochrome P ^ g / m l .
2 .5 ml of the diluted microsomal suspension were 
added to 2 quartz cuvettes and placed in a Cary 219 
split-oeam recording spectrophometer (Varian 
Instruments) and a case line was recorded between 
370nm and 470nm. For aniline binding studies 
microlitres of a stock dilution of aniline (1M) 
were added to the test cuvette by means of a 
Hamilton 10pl syringe. The same volume of 
distilled water was added to the reference cuvette. 
The contents were mixed and the binding spectrum
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recorded between i70-47l0nm. Further additions or 
the stock solution were made until the binding 
sites were saturated (2-72pl stock solution). The 
difference in absorbance (AOD) between the peak and 
the trough of the binding spectrum was measured and 
a Lineweaver-Burke plot was constructed from which 
Amax and Ks values were determined (Lineweaver and 
Burke, 1934)•
For hexobarbital binding the same procedure 
was used except the stock solution was 0.05M 
hexobarbital in 0.1M NaOH and hence 0.1M NaOH was 
added to the reference cuvette instead of water (pH 
of final solution was approximately 8.0) The 
volume of stock solution added ranged from 2-52>il.
UBPGA^Transferase Ac£iyi£y
UDPGA transferase activity using oC-naphthol as 
substrate was determined in washed microsomes using 
a modification of the method of Hollman and Touster 
(1962). The incubation mixture consisted of:-
Tris-HCl buffer (pH 7.6, 0.25M) containing
UDPGA (12.5mM) 0.2ml
Magnesium chloride (25mM) containing
0.5% Brij 35 detergent 0.1ml
<*-Naphthol (2mM) 0.1ml
Microsomal suspension (further
diluted 1:40) 0.1ml
62
After a 5 min pre-incubation at 37°C the 
reaction was started by the addition of <*-naphthol 
and further incubated for 4 min. The reaction was 
terminated by the addition of 1ml ice-cold 0.5M 
glycine-trichloroacetic acid buffer (pH 2.2) and 
the tubes placed in ice. Aqueous <*•-naphthol 
glucuronide (10jul of a 10mM solution were added to 
the two standard tubes and 0.1ml o£-naphthol (2.0mM) 
to the standards and blanks. The mixtures were 
rotary extracted with chloroform (6 ml) for 1 0  min 
to remove the unconjugated oc-naphthol. A 1ml 
sample of the aqueous layer was placed in a 
fluorimeter cuvette and 1ml 1.0M glycine hydroxide 
buffer (pH 10.6) was added. The fluorescence was 
measured in a Perkin-Elmer MPF3 fluorescence 
spectrophotomer (emission 334nm, excitation 303nm, 
slit width 0.6nm). The 1-naphthol glucuronide 
content of the test samples were determined from 
the standards.
AlgohgJ, Cghydrpggnasg Activity
Alcohol dehydrogenase activity was determined 
in the microsomal supernatant.
The method measures the rate of NADH 
production since NADH, which is produced during the 
oxidation of ethanol, has an absorption maximum at 
340nm.
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NAD
NADH
ch 3 ch2oh
ethanol
>  CH 3 CHO
acetaldehyde
2  quartz cuvettes containing:
Sodium pyrophosphate buffer (100mM, pH 9,0)
containing 2 0 nM glycine 2  .0 ml
NAD freshly prepared in the above
buffer (6 mM) 0.25ml
Microsomal supernatant 0.05ml
were warmed to 30°C by placing in a shallow water 
bath. They were then placed in the cuvette 
(maintained at 30°C) of a Cary 219 slit-beam 
recording spectrophotomer (Varian Instruments).
The reaction was started by the addition of 20>il 
ethanol (95%) to the test cuvette, the contents 
mixed rapidly, and the increase in absorbance at 
340nM recorded. The initial gradient was measured 
and the rate of NADH production per min was 
calculated using the molar absorbance coefficient 
for NADH (6220M“^cm~1 ) (ref The Merck Index 1976) . 
Since one mole of NADH was produced for every mole 
of ethanol oxidised the alcohol dehydrogenase 
activity was expressed as pmole ethanol oxidised 
per min.
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Aminopyrine N-Demethylase Activity
The major route of metabolism of aminopyrine 
in the body is demethylation and subsequent 
N-acetylation of the demethylated product (Brodie a n d  
Axelrod 1950) . The methyl groups are removed 
oxidatively as CC>2 which are then excreted from the 
body via the lungs in the exhaled air. Using 
aminopyrine in which the two methyl groups have 
been labelled with the rate of excretion of CO 2  
derived from aminopyrine can be determined. The 
rate of excretion of 1 4 C0 2  has been shown to 
parallel the rate of disappearance of (^4C methoxy) 
glycodiazine,• a compound which also undergoes 
demethylation in the body (Platzer et al., 1978) 
and has been widely used as a measure of 
aminopyrine demethylase activity in vivo (Hepner 
and Vesell 1974; Bircher et al 1976; Galizzi et 
al., 1978) .
In vivo aminopyrine demethylation studies in 
all animals except the ferrets and rabbits were 
carried out using air-tight "Metabowl" cages 
(Jencon. Herts, England) which enabled the 
collection of expired air (fig. 4). For the 
ferrets and rabbits a large desiccator was adapted 
for use. For measuring aminopyrine demethylase
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activity in the mouse an adaptation of the Jencon 
MetaOowl was used. The normal Metabowl cage was 
unsuitable for mice and hence they were placed in a 
fine wire mesh basket with a perspex lid. Food was 
placed inside the basket and a water bottle fitted 
through a hole in the lid. The basket was placed 
inside the Metabowl and the expired air collected 
as for the other animals (fig 5 )• To ensure 
sufficient CO 2  collection 2  mice were used for each 
experiment. The smaller animals were housed in the 
metaoowl for a 1 2  hour acclimatisation period prior 
to the experiment. A steady air flow 
(approximately 80ml/min) was maintained throughout 
the experiment; the air was passed through a soda . 
lime column to remove CO^ before entering the 
metabowl. Respiratory C0 2  was trapped in two 
scintillation vials arranged in series containing a 
mixture of ethanolamine: 2-ethoxyethanol 1:3 v/v 
(5ml)^ 12.5M NaOH (30jul) and thymolphthalein
indicator which turned colourless when 0.375mmol 
CO 2  were dissolved. The vials were changed after 
the 1st vial had turned colourless. (Initial 
studies showed that 2  vials in series were 
sufficient for trapping the C0 2  expired). After 
collecting a control sample of CO 2  the animal was 
injected intraperitoneally with lpCi
C-aminopyrine (in 0.5ml 0.9% saline) and 
respiratory CO 2  collected at intervals over a 
period of 2 hours. With the mice 0.5/uCi 
aminopyrine and with the ferrets and rabbits 10pCi
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aminopyrine were administered to eacn animal, to 
measure the expired, 0 .5 ml samples of
trapping agent from both vials (the mixture in the 
2 nd vial was decolourised by bubbling through with
CO 2  gas) were added to 5ml of scintillant (0.08g 
dimethyl POPOP and 4g PPO/litre toluene) and the 
DPM counted using a LKB Ultrabeta liquid 
scintillation counter. The counts from the 2 vials 
in series were combined and the total radioactivity 
(DPM)/0.375 mmoles CO 2  expired were plotted against 
time. The LKB Ultrabeta liquid scintillation 
counter automatically converted the counts per min 
to disintegrations per min (DPM) using the 
following parameters
a 0
— 6 8 . 1
al + 548.5
a 2
- 733.5
a3 + 343.1
These parameters were determined from a quench 
curve produced using ^ C - h e x adecane and 2- 
ethoxyethanol as the quenching agent. From this 
the efficiency (E=^ p ^  x 1 0 0 ) and the external
standard channels ratio (r) were obtained. Then 
from the equation
E = a 3 r3 + a 2 r2 + a fr, + a 0  
the a values can be calculated.
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Hydroxylase Activity
Biphenyl hydroxylase activity In vivo was 
determined after both oral (by gastric intubation) 
and intravenous (i.v.) administration of biphenyl.
For oral administration the biphenyl was dissolved 
in corn oil (1 0 0 mg/ml) while for the i.v. 
administration an emulsion of 1 0 % corn oil 
(containing 100mg biphenyl/ml) in 0.9% saline was 
prepared by sonication. Biphenyl was administered 
orally (1 0 0 mg/kg body weight) and i.v. (1 0 mg/kg 
body weight) and blood samples were collected over 
a period of up to 4 hours. Blood collections in 
the rat were taken from the tail (0 .2 ml samples) 
and in the rabbit from the ear vein (0.5ml). All 
other animal species prior to oral administration 
of biphenyl and all species prior to intravenous 
administration of biphenyl were anaesthetised using 
a 25% solution of urethane in 0.9% saline (mice - 
1.5g/kg; hamster - 1.6g/kg; rat - 1 .8 g/kg 
guinea-pig - 2 g/kg; ferret - lg/kg body weight).
In the mouse,blood (50;ul) was collected from the 
tail, in the hamster from the femoral vein, in the 
guinea-pig from the carotid artery and in the 
ferret from a minor artery branching from the 
femoral artery. For the i.v. studies biphenyl was 
administered via the femoral vein in the rat and 
hamster, via the carotid artery in the guinea-pig 
and via a minor artery branching from the femoral
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artery in the ferret. Due to difficulties in 
cannulation in the ferrets, guinea-pigs and one 
hamster, blood was collected from the same cannula 
used to administer the biphenyl, after the cannula 
had been flushed through with heparinised saline 
and the first blood samples discarded. Blood was 
collected in a small volume of haparin in saline(10 
units/ml) and the samples centrifuged to obtain 
plasma. The plasma samples were stored frozen at 
-20^ until required for assay.
Assay of biphenyl metabolites in plasma
The plasma samples were mixed with 1ml 1M-HC1 
and boiled for 15 min to hydrolyse the 
hydroxybiphenyl conjugates. The hydrolysed plasma 
was extracted with 7ml n-heptane and the organic 
extract analysed for 2-, 3- and 4-hydroxybiphenyl 
using the same method as for the An vitro studies 
(page 56) .
Statistical Analysis of Data
All results are expressd as the mean value + 
standard deviation. Graphical results show the 
mean value ± standard error. The significance of 
the difference between data was determined using 
the Students t-test. The product-moment 
coefficient of correlation (r) was determined to 
assess the relationship between enzyme activity and
69
body weight. The Spearman rank correlation 
coefficient (rs ) was used to assess the correlation 
between enzyme activities in the animal species 
studied.
Formulae us£d_Lz
Standard deviation (S.D.)
Standard error (S.E.)
S.D.
s/FT
Students t-test (t)
* A  - XB  / N a  * n B
s d a  * s d b  V  n a  ♦ n b
Degrees of freedom = N* ♦ N g  - 2
Product-moment correlation coefficient (f)
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r =
Z ( x - x ) ( y - y j - 
n-1  
Jsx2 * Sy2
where r ^ , Y  = raean * and y
S x ., Sy = standard deviation of X and y
Spearman rank correlation coefficient (Ts)
N -
6 lb\2
i - —
s ' m 3.N - N
where ai = the different in rank value of x and y.
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Fig. 2 . HPLC TRACE OF BIPHENYL METABOI 1TFS FORMED
AFTER INCUBATION OF HEPATIC M1CROSOMES WITH BIPHENYL
(a  = unm etabolised biphenyl and other cellular extracts 
2 = 2-hydroxybiphenyl; 3 = 3-hydroxybiphenyl;
A = A-hydroxy biphenyl; inj = injection of sample on the co lum n)
Fig . 3. FLUO RIM ETER TRACE SHOW ING RESORUF1N
PRODUCTION A FTE R  INCUBATION OF W A S H ED
HEPATIC MICROSOMES WITH ETHOXYRESORUFIN
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Liver samples from the laboratory animals were 
removed immediately after death and the microsomes 
prepared without delay. However, with the larger 
animals the liver samples could not always be 
obtained immediately after death and there were 
delays due to collection and transportation before 
the microsomes were prepared (for details see 
section 2). Also, due to the large number of 
assays carried out on each sample a period of time 
(1 - 1 0  days) elapsed before all assays were 
completed, during which the microsomes were stored 
at -80°C. Because of the differences in.the 
storage period of the whole liver samples and 
microsomes it was necessary to assess the effect of 
storage on the activity of the hepatic microsomal 
mixed function oxidases.
Washed microsomes were prepared from fresh 
liver samples from 4 rats (Wistar albino) and 
stored at -80°C as described in section 2.
Cytochrome P 4 5 0  and b^ content, ethylmorphine 
N-demethylase, ethoxyresorufin O-deethylase and 
NADPH-cytochrome c reductase were determined in the . 
freshly prepared microsomes (day 0 ) and following 
1, 3, 6 , 13, 32, and 64 days of storage at -80°C
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using tne metnods descrioed m  section 2. (results 
for 3, 13 and 64 days are from one animal only). 
Benzo(a)pyrene hydroxylase activity were determined 
following l f 6 and 32 days storage.
To determine the effect of storing liver 
samples at -80°C on the microsomal enzyme activity 
samples of pig liver were stored at -80°C for 1.5 
and 4 days. After each time period the liver 
samples were allowed to thaw slowly in 1.15% KC1 
and microsomes were prepared as normal. The 
microsomes were assayed for cytochrome P 4 5 0  and b^ 
content, ethylmorphine N-demethylase, 
ethoxyresorufin O-deethylase, NADPH-cytochrome c 
reductase, benzo(a)pyrene hydroxylase,biphenyl 
hydroxylase and UDPGA transferase activity and the 
activities compared to that of microsomes prepared 
from the fresh liver.
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RESULTS
Effect of Age of Rat Hepatic Washed Microsomes
Stored at -80°G
Table 8 shows the effect of storage on the 
cytochrome P 4 5 0  and b^ content, ethylmorphine 
N-demethylase, ethoxyresorufin O-deethylase, NADPH- 
cytochrome c reductase and benzo(a)pyrene 
hydroxylase activities. Storage for 3 days did not 
affect the activity of the microsomes. By 13 days 
there was approximately 2 0 % loss of activity 
(except for NADPH-cytochrome c reductase). By 64 
days cytochrome P 4 5 0  and b 5  levels and NADPH- 
cytochrome c reductase activity had decreased by 
approximately 50%, whereas ethylmorphine 
N-demethylase and ethoxyresorufin O-deethylase were 
decreased only 20% and 30% respectively. The 
results for ethoxyresorufin O-deethylase and NADPH- 
cytochrome c reductase are from one animal only and 
the variability of the results may be due in 
addition to the effects of storage, to variability 
in the assays from one day to another.
Effect of Etoxins Whole Liver at z M ° £
Table 9 shows the activities of the microsomal 
enzymes after storage of the whole liver for 1 . 5  
and 4 days at -80°C. Since only one liver was
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studied tne results oniy yive indications or tne 
effects of storing the liver at -80°C on microsomal 
activity. After 1.5 days storage cytochrome P 4 5 0  
and b^ content and ethylmorphine N-demethylase 
activity were decreased by 25-35%, further storage 
only caused a small additional decrease in 
activity. Ethoxyresorufin deethylase, 
benzo(a)pyrene hydroxylase, biphenyl 2-, 3- and 
4-hydroxylase and UDPGA tranferase activities were 
not greatly affected by storing the liver at -80°C. 
Biphenyl hydroxylase activity appeared to be 
induced by storage of the liver at -80°C. This may 
have been due to variability in the biphenyl assay. 
NADPH-cytochrome c reductase activity was greatly 
decreased in the frozen liver samples. After 1.5 
days the activity was reduced by approximately 65%. 
Further loss of activity did not occur with further 
storage.
Human liver samples which had been stored at 
-80°C for between 2-16 months were also studied. 
Microsomes prepared from these samples showed n.o 
correlation between the length of storage and 
enzyme activity (table 10). Also, the enzyme 
activity and cytochrome content of these 
microsomes, including NADPH-cytochrome c reductase, 
were similar or even higher than reported 
activities for human microsomes (see section 4 for 
details).
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Storage of Microsomes
In the present study microsomal activity was 
stable.for 3 days following storage at -80°C, and 
after 13 days there was only approximately 20% loss 
in cytochrome content, ethylmorphine N-demethylase, 
ethoxyresorufin O-deethylase and NADPH-cytochrome c 
reductase activities; but by 64 days storage 
cytochrome P a n d  b^ content and NADPH-cytochrome 
c reductase activity decreased to approximately 50% 
of the fresh microsomal value. Similar results 
have been reported by Leadbeater & Davis (1964) who 
found that washed microsomes made up in buffer and 
frozen at .-40°C lost 35% of the morphine 
N-demethylase and diethyltryptamine hydroxylase 
activities by 1 0  days and by 30 days the values 
were reduced to 50%. Levin et a l . (1969), however, 
found no loss in testosterone hydroxylase, 
phenobarbital hydroxylase and ethylmorphine 
N-demethylase activities when microsomes were 
stored as a pellet at -15°C for 20 days. Bartosek 
et a l . (1980) also found no loss in microsomal 
activity when stored at -20°C or -196°C. Hence the 
present study and literature data suggest that rat 
microsomes are stable frozen at -80°C for 
approximately 1 0  days but further storage may 
result in significant losses . In the experiments 
described in this report microsomes from different
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animal species and rat strains were analysed within
2 - 1 0  days of the preparation of the microsomes.
Ethoxyresorufin O-deethylase and 
Denzo(a)pyrene hydroxylase are both dependant on 
cytochrome rather than cytochrome P 4 5 0  (Burke
& Mayer, 1974; Atlas & Nerbert, 1976; Levin et al., 
1977). Both these enzymes showed a slightly 
greater stability to storage in washed microsomes 
at -80°C than cytochrome P 4 5 0  and ethylmorphine 
N-demethylase (which is cytochrome P 4 5 0  dependant), 
particularly the benzo(a)pyrene hydroxylase 
activity.
The majority of studies on the effects of 
storage on the viability of microsomes (including 
the present study) have been carried out in rat 
microsomes. Species differences in the stability 
of microsomes stored frozen has not been studied 
extensively. Litterst et al.(1974) studied the 
effect of storing microsomes from the mouse at 
-20°C (as a pellet overlaid with buffer). The 
results for the mouse microsomes were very similar 
to those found for the rat in the present study. 
Cytochrome P 4 5 0  and NADPH cytochrome c reductase 
activity were quite stable up to 1 0  days then 
decreased to 65% of the value in fresh microsomes 
by 20 days. Ethylmorphine demethylase had 
decreased by 25% after 10 days and by 60% after 20 
days, storage. Flynn et al.(1972) compared storing
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microsomes (made up in buffer) from mouse, rat and 
guinea-pig at 5°C for 5 days. Cytochrome P 4 5 0  
decreased by a similar extent in both mouse and 
guinea-pig microsomes (results for the rat were not 
given). Loss of aminopyrine N-demethylase activity 
was similar in rat and mouse microsomes but the 
loss of activity in the guinea-pig microsomes was 
less than half of that in the other 2  species, 
although the level of activity after 5 days was 
similar in all 3 species. Von Bahr et al.(1980) 
found that storage of human microsomes at' -80°C did 
not cause loss of enzyme activity.
Hence it appears that mouse and rat microsomes 
are equally stable to storage at temperatures below 
freezing. Guinea-pig and human microsomes appear 
to be more stable to storage.
Storage of Liver
Liver samples obtained from outside the 
University were stored frozen during the period 
between removal of the liver from the animal and 
preparation of microsomes (this was for all animals 
except the pig and sheep livers which were stored 
on ice). This period of storage was between 2-6 
hours for all animals except for the leopard liver 
which was stored frozen for 3 days. During storage 
of pig liver at -80°C for up to 4 days 
benzo(a)pyrene hydroxylase, biphenyl 2, -3-, and
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4-hydroxylase and ethoxyresorufm deethylase 
remained staole Out cytochrome P 4 5 0  and 
ethylmorphine N-demethylase activity were decreased 
oy approximately 40%. Hence, similarly to storage 
of the microsomes, the cytochrome £ 4 4 3  dependent 
enzymes show a greater stability to storage than 
cytochrome P 4 5 0  and cytochrome P 4 5 0  dependent 
ethylmorphine N-demethylase.
NADPH-cytochrome c reductase was the enzyme 
most greatly affected by storing liver at -80°t. 
After 1.5 days the activity had diminished to 
approximately 35% of the fresh liver value.
However, the human liver samples stored for 2-13 
months at -80°C did not show a low reductase 
activity. Pelkonen et al (1974) also found human 
liver microsomes to be stable for at least 2  months 
when stored at -20°C and Kremers et al (1982) found 
that mixed function oxidase activity of human 
microsomes was stable to storage of the liver 
samples at -80°C for up to 6 months.
Post Mortem Stability of the Mixed Function Oxidase 
System
Liver samples from some of the larger animals 
were not removed immediately after death. The 
period between death and removal of the liver was 
less than 1  hour for most animals, except in the 
case of the leopard when it was 3 hours. Also the
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human samples were unlikely to have been removed 
immediately after death. Leadbeater & Davis (1964) 
studied the post mortem stability of mixed function 
oxidase activity in rabbits. After death the 
rabbit was kept at 0-3°C and the liver samples were 
removed after 3, 24 and 52 hours. After 3 hours 
diethyltryptamine hydroxylase, morphine
N-demethylase and codeine O-and N-demethylase
\
activities were reduced by 10-15%, after 24hrs they 
were reduced by 60-80%. Similar results were found 
by Creaven and Williams (1963); also using rabbits, 
but the livers were removed and kept at room 
temperature. They found a loss of less than 10% of 
coumarin and biphenyl hydroxylase activities after
\
1 hour and approximately 20% loss after 3 hours. 
Guengerich et al.(1981) obtained human liver 
autopsy samples between 3-12 hours after death, but 
found no correlation between the length of time and 
cytochrome P 4 5 0  content.
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smzLusism
It appears that a period of 1-3 hours between 
the death o^ the animal and removal of the liver, 
freezing the liver sample for 2 - 6  hours and storage 
of the washed microsomes for 1 - 1 0  days does not 
significantly decrease the mixed function oxidase 
activity of the microsomes. Hence comparison of 
mixed function oxidase activity of microsomes 
treated in the above manner and those prepared 
immediately after death of the animal are valid.
It also appears that storage of the liver at -80°C 
for between 3 days and 16 months does not 
significantly alter mixed function oxidase activity 
and hence values for the leopard and human can be 
taKen as true values.
These preliminary studies also suggest that 
cytochrome P 4 4 Q dependant enzymes are more stable 
to storage at -80°C, either washed microsomes or 
whole liver, than both cytochrome P 4 5 0  dependant 
enzymes and the cytochrome P 4 5 0  levels. Cytochrome 
P448 known to be more stable than P 4 5 0 .
82
Ta
ble
 
8- 
TH
E 
EF
FE
CT
 
OF 
ST
OR
IN
G 
FR
OZ
EN
 
RA
T 
LIV
ER
 
MI
CR
OS
OM
ES
 
ON
 
TH
E 
CO
M
PO
NE
NT
S 
O
F
2  
Ll! ?— 
LD >- 
Lf)
Ll)
CO
<Q
Xo
o
I—o
z
Z>
Ll
Q
LU
X
LU
I
CD
_ 3
3>
> *
3
TO
CD
cn
3
C
CD
CDv_
CD
CL
l/V
CJ
TO
CDj—»c
CD
W
CDY_
C L
Wj —>
3in
CD£T
CD
E
e
JZ
CD
O-i—' 
> -  o
X
Q_
Q
<
\ _
CUT! 1
3 d £
u o c
-3 "aXJ u ■*- 
CD . o
'->*CL 
u a)
°-5£
E 
c
r dP“£■<4—
3 cD'v.El_ in c p
O 3cz
in
CD
£ 8  a>. CD 2 0Xo
JZ4—■
L-^O ' £
LU o *5
CD
CD ^
•--E x:e <d 
cdO°o
E EF,CD X  
>* TD—
a  • |
u  zl,
CD
E
o
\_
J Z
CDO
> *O
«-Oc
JO —  
o
CD
EO
U)
E
o
LD-rJZ 
u Q_^
■4—> .
> so
o  3 
CT>
U  O  V)
Q  § •
o
CD in 
CL
~o
o
o
ro
ro
ro
+ i
ro
ro
ro
ro
+ i
LO
o
LDO Ocn oooo
ro
-<r
ro
oo
cn
ro
cn
oo
rsiO cno uo*<r
c^.
ID
a
L O
cd
+-i
ro
cn
c^.
K
+ i
oo
ID
*<r
oo
ro (1) (D **T a
)
O LD CO
<r LD rsi ld *<r
+i cn + i + 1 L O
00 cn cnLD ro
(D v? .
(I) 2
(I)
ID
+ i^r
oo
o
o
UD 
00 
+ i
O
LD
[> -
CO
+ i
r s j
LD
oo
LD
ro LD ro •<rro
rsj
LD
Q
L0
+ i
c
3
CD
£
CD
L_
3
in
~S
in
CD
> >
TO3
4 -J
in
sz
CDa
CD
c
jn
CJ
E.
c
CJ
o
CD
JO CDE
3 3
C CD
"CL
CD 3
JZ
■ M
T O
CD
■*— >
C
CJ •4— *
u 3
TOc
O
TO
CDin L_
'in L_CD 3
JZ
-4— *
CD
C CD
CD i_
L_ CD
CJ
CL 5
c in
a
in in
CD in
\_
3 3cn .— *
Ll <
Ta
bl
e 
9. 
TH
E 
EF
FE
C
T 
OF
 
ST
OR
IN
G 
OF
 
W
HO
LE
 
PIG
 
LI
VE
R 
SA
M
PL
ES
 
AT
 
-8
0°
C 
ON
 
TH
F 
C
O
M
PO
N
FN
IT
P
LU
lo
<
cn
LU
LL.
m
z
<1on
3CL
O
ZD
Q
z!
<
LU
l—
IT)
>-
LO
LU
LO
2
Xo
o
z
D
Ll
Q
LU
X
UJ
1
Ll
O
a»
JD
a
>
o
>*
o
"O
a»
CT>
o•*—>
c
<u
uI—
CD
CL
WCJ
•o
CD
c
a»
in
CDv_
CL
ZJin
CD
DC
CD QJ CT'
c in\>
a!
s  i fs
CU °E
m X
i
'..
...
. 
' 
"■ 
1
NA
DP
H 
C
yt
oc
hr
om
e
I 
c 
re
du
ct
as
e
1 (
nm
ol
. 
cy
t.
 c 
.r
ed
uc
.e
d/
i 
a 
lv 
mq
 
pr
ot
ei
n 
mi
n 
1 
)
ro
ro ro
E
th
o
xy
re
so
ru
fi
n
 
0 
-d
ee
th
yl
as
e
(n
mo
l,
 
re
so
ru
fi
n 
/ 
. 
_i
\ 
|v 
mq
 
pr
ot
ei
n 
mi
n 
']
O  ^  
o  oo
CL)
CJ (/) ^
E  CJ CD' 
J=
O l
L- -*—’0  C
E EVo
£  i § *
UJ zf.
67 60
C
yt
oc
hr
om
e
^
5
»g 
pr
ot
ei
n)
LO
t
CD
E
■c !S!
o
>s
o
LO /«—  
O- LO
Pe
rio
d 
of
st
or
ag
e
(d
ay
s)
LO ^
U
D
P
G
A
1
tr
an
sf
er
as
e
U
9
76
to
ta
l-
11
3
13
8
d>—in L i _o_c ■^r
>*c
£$*<D
->T
l d  ro
ny
l 
hy
dr
c
/
m
g
 
pr
ot
3- 57 13
5
B
ip
he
( 
n
m
o
l
.
 
2- OO
Pe
rio
d 
of
 
st
or
ag
e 
(d
ay
s)
l o
Al
l 
as
sa
ys
 
w
er
e 
ca
rr
ie
d 
ou
t 
in 
du
pl
ic
at
e.
"1- 
pm
ol
. 
1-
na
ph
th
ol
 
gl
uc
ur
on
id
e/
m
g 
pr
ot
ei
n 
pe
r 
m
in
Ta
bl
e 
10
: 
EF
FE
C
T 
OF
 
ST
O
RA
G
E 
OF
 
W
HO
LE
 
HU
M
AN
 
LI
VE
R 
SA
M
PL
ES
 
AT
 
-8
0°
 
ON
 
M
IC
R
O
S
O
M
A
L
M
IX
ED
 
FU
N
C
TI
O
N
 
O
XI
D
A
SE
 
A
C
TI
V
IT
Y
CD
£
O mi_ CD
JZ 1/1u ao
-4— > C >
>*
o "O
CD
X
n
o o
<
X
v_ a> 
o  i/i
{/) a
£ >>
> > £
o  CD
±z ~o
LU
CD
C "~<D
X  w
Q. C5
O
E
^  EZ3 CD 
LU *o
a>
E
E  x
JZ x _ o LD
o -Q »>-
o
CD
E
o X
L_
C" oo ld
o
-4— > CL
>
O
v»—
o <D ^
X3
O
cn-C
S c
v_ o o
CD
CL s.
co CH T— cn -4-
C D C N o cn T-
-4 " C D C D C D C D
CD
cn
CN
oo LD
CD LD
O O O
o' O' O
ld CN
ld
o o
o' o'
C D
C D
o
>- CD o CO
JZ cn cn CD
-4— >
CD o' o' o'
LD o CN
CD ld LD
o' o' o'
o T_ C N 0 0 T—
C D C D C D C N C D
o' o' o' o ' o'
OO LD 
CD LD
O  O
LD LD C-
LD LD C-
o' O O O
CN C D ID C D LD CD
C
CD
£
C l
"5
E
o
uo
oL_
CJ
cn
E\
i/i
CD
O
E
c
i—
Z5
o
JZ
L-
CD
C l
C
CD
-4— ’
o
i_
C L
"o
E
ocn
o
cn
E
o
X
o
X
1/1
JD
o
E
o n
m
ol
es
 
re
so
ru
fi
n
/m
g
 
m
ic
ro
so
m
al
 
pr
ot
ei
n 
pe
r 
m
in
nm
ol
es
 
cy
to
ch
ro
m
e 
c 
re
du
ce
d/
m
g 
m
ic
ro
so
m
al
 
pr
ot
ei
n 
pe
r 
m
in
A
ll 
as
sa
vs
 
w
er
e 
ca
rr
ie
d 
ou
t 
in 
d
u
p
lic
at
e
SPECIES DIFFERENCES IN HEPATIC MICROSOMAL 
DRUG METABOLISM IN VITRO
INTRODUCTION
Most previous studies on species differences 
in drug metabolism have concentrated on small 
laboratory rodents, lagomorphs, dog and monkey. In 
order to make a comprehensive study of the possible 
trends in species differences in drug metabolism in 
vitro. studies were carried out in a large-number 
of animal species whose body weights spanned fairly 
uniformly'from mouse to man and which included a 
diversity of species, e.g, vegetarians, carnivores, 
omnivores, domesticated and non-domesticated 
animals. The major pathways of mixed function 
oxidase metabolism such as aromatic hydroxylation, 
N-demethylation and O-deethylation and also two 
non-mixed function oxidase enzymes, alcohol 
dehydrogenase and UDPGA transferase, were studied.
RESULTS
The activities of a number of drug metabolising 
enzymes were determined in hepatic microsomes from 
15.mammalian species ranging in body weight from 
the mouse to man. Table 11 shows the body and 
liver weight data for all the animals studied. For 
the sooty mangabey, leopard and man liver weight 
data was not available, also the body weight for ' 
the pig and man were estimated. Values for the 
liver:body weight ratio showed that with the
84
exception of the fallow deer the ratio tended to be 
lower in the larger animals. The microsomal 
protein content per g liver varied markedly between 
species, variation within a species was also quite 
high. The larger species tended to have a lower 
microsomal protein content. This may be due in 
part to the preparation of the microsomes since the 
liver from larger animals tended to be more fibrous 
which not only reduced the cellular content per g 
liver but also resulted in poor homogenisation and 
hence an incomplete recovery of microsomes. For 
this reason the results calculated per mg 
microsomal protein were considered to be a more 
accurate assessment of the activity. The results 
were also calculated per total liver weight and, 
where relevant, per nmole cytochrome P450.
CytQChrpffe £ 4 5 0  Content
Species difference in hepatic cytochrome P 4 5 0  
content are -shown in Table 12. The highest levels 
were found in the hamster and guinea-pig and the 
lowest in the serval and leopard. When the log of 
the cytochrome P 4 5 0  levels were plotted against log 
body weight (fig 6 ) a significant inverse 
correlation (r= -0.635) between the two parameters 
was seen (P<0.01). This relationship also existed 
when the cytochrome P 4 5 0  levels were expressed per 
g liver (see table 27). For a number of parameters 
studied the human liver sample had a high activity
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compared to tne otner species or large ooayweignt 
studied. For this reason the correlation with body 
weight was determined with and without the values 
for man (see table 27). However for the cytochrome
P 4 5 0  levels excluding the values for man did not 
alter the correlation coefficient significantly.
£ytp_chrom£ ^  Content
Species differences in cytochrome b^ levels 
were similar to those seen with cytochrome P 4 5 0 , 
with high levels in the rabbit, hamster and 
guinea-pig and low levels in the serval and leopard 
(table 13). However unlike cytochrome P 4 5 0  there 
was no signficant correlation between cytochrome 
b^ levels and body weight (r= -0.371).
Ethylmorphine N-Demethylase Activity
Table 14 shows the species differences in 
hepatic ethylmorphine N-demethylase activity. The 
lowest N-demethylase activity was seen in the 
leopard. The highest activity was seen in the 
mouse when the results were expressed per mg 
microsomal protein but in the guinea-pig and rat 
when expressed per g liver. The hepatic 
N-demethylase activity in the human was higher than 
seen in the livers of other animals of comparable 
body weight. This difference was not seen when the 
results were expressed per g liver. Figure 7 shows
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the relationship between log oody weight and log 
ethylmorphine N-demethylase activity. When the 
values for man were included there was a 
significant inverse correlation between body weight 
and N-demethylase activity (r = 0.51; P<0.05).
When the human results were omitted the level of 
significance was increased to 1% (r = 0.655). The 
relationship with body weight also existed when the 
N-demethylase activity was expressed per g liver (r 
= -0.54; P<0.05). However when the activity was 
expressed per nmole cytochrome P 4 5 0  the range of 
activities in the various species were decreased 
considerably (48-and 63-fold difference when 
expressed per mg microsomal protein and per g liver 
respectively compared to a 1 0 -fold difference when 
expressed per nmole cytochrome P450) , and there was 
no longer a significant relationship with body 
weight (r = 0.268) .
NADPH-cytochrome c Reductase Activity
Species differences in NADPH-cytochrome c 
reductase activity in washed hepatic microsomes are 
presented in table 15. Similar to the other 
parameters so far mentioned the lowest activities 
were found in the serval and leopard and the 
highest in the hamster and guinea-pig. However no 
signficiant relationship was seen between 
NADPH-cytochrome c reductase activity and body 
weight (r = -0.419).
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Hydroxylase Activity
The activities of biphenyl 2-, 3- and 
4-hydroxylases were determined in different species 
and the results are shown in tables 16, 17 and 18 
respectively. Table 19 shows the total biphenyl 
hydroxylase activity (i.e. the sum of the 3 
hydroxylases) for each species. Figs 8, 9, 10 and 
11 show the relationship with body weight (log) of 
the 2-, 3 - f 4-, and total biphenyl hydroxylase 
activity (log) (per mg microsomal protein) 
respectively. All 4 activities showed a 
significant negative correlation with body weight.
A similar negative correlation was seen when 
biphenyl hydroxylase activity was expressed per g 
liver (see table 27). For the 3 - f 4- and total 
biphenyl hydroxylase activity the values for man 
were somewhat higher than expected from the 
relationship with body weight and hence the 
correlation coefficients were calculated with and 
without the values for man. When the values for 
man were excluded the correlation coefficients were 
increased to the 1 to 0.1% level of significance (see table 27) 
When the results were expressed per nmole 
cytochrome 0 the relationship with body weight 
no longer existed with any of the biphenyl 
hydroxylases. The extent of species variation in 
biphenyl 2- and 4- hydroxylases were significantly 
decreased when the activities were expressed per
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nmole cytochrome P 4 5 0  but there was no similar 
decrease in species variation in biphenyl
3-hydroxylase activity (see Table 28). Table 20 
shows the species differences in the ratio of 
Diphenyl 2-, 3-, and 4- hydroxylase activity. In 
the majority of species 4-hydroxybiphenyl is the 
major and 3-hydroxybiphenyl the minor in vitro 
metabolite of biphenyl. However in the leopard, 
fallow deer and serval 2 -hydroxybiphenyl is the 
major metabolite. Low levels of 4-hydroxybiphenyl 
were also seen in the sooty mangabey and ferret.
In the sheep and man 3-hydroxybiphenyl was produced 
in excess of 2-hydroxybiphenyl. The lowest 
2 -hydroxybiphenyl production relative to
4-hydroxybiphenyl was seen in man.
Ethoxyresorufin O-Deethylase Activity
Species differences in ethoxyresorufin 
O-deethylase activity in hepatic microsomes are 
shown in table 21. The highest activities were 
seen in the fallow deer, dog, ferret and 
guinea-pig, the lowest in the sooty mangebey, man, 
sheep and pig. No relationship was seen between 
ethoxyresorufin O-deethylase activity (log) and 
body weight (log) (r = -0.178).
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Benzo (alpyrene Hydroxylase Activity
Benzo(a)pyrene hydroxylase activity was 
determined in 1 2  mammalian species (see table 2 2 ). 
The highest activities were seen in the sheep and 
dog; the lowest in the serval, sooty mangabey and 
fallow deer. No relationship was seen between 
benzo(a)pyrene hydroxylase activity (log) and body 
weight (log) (r = +0.095). When benzo(a)pyrene 
hydroxylase activity was expressed per nmole 
cytochrome P 4 5 0  the magnitude of the species 
variation was not altered significantly (see table 
28).
UDPGA Transferase Activity
UDPGA transferase activity using c<-napthol as 
substrate was determined in 9 animal species (see 
table 23). the lowest activity was seen in the 
serval and leopard. A very high activity was seen 
in the sooty mangabey. No relationship with body 
weight was seen (r = -0.003).
Alcohol Dejjydrpggriasg Acti vity
Table 24 shows the alcohol dehydrogenase 
activity in 9 mammalian species. The highest 
activities were seen in the pig and hamster and the 
lowest in the serval. No linear relationship was
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seen between the logarithms of the alcohol 
dehydrogenase activity and body weight (r=+0.334).
Aniline and Hexooarbital Binding to Washed Hepatic 
Microsomes
The species differences in binding kinetics 
(Ks and A m a x) for aniline and hexobarbital binding 
to cytochrome P 4 5 0  are shown in tables 25 and 26 
respectively. Aniline, which gives a type 2 
binding spectra (fig 12) had Ks ranging from 1.02mM 
in the gerbil to 3.70mM in the pig and A m a x ranging 
from 0.64 X 10“^ to 4.2 x 10"^ AOD/nmole cytochrome
P 4 5 0  in the serval and leopard respectively. The 
serval microsomes, however, had an unusual aniline 
binding spectra with a peak at 435nm and a trough 
at 420nm (see fig 13).
With hexobarbital, which gives a type 1 
binding spectra (fig 14), the Kg values ranged from
0.09mM in fallow deer to 0.39 mM in man. A max
\
values ranged from 0.47 x 1 0 “^ to 2.00 x 10“^
AOD/nmole cytochrome P 4 5 0  in the mouse and pig 
resepctively. Both samples of dog hepatic 
microsomes studied did not produce a binding 
spectrum with hexobarbital. The sooty mangabey 
hepatic microsomes produced an unusual binding 
spectrum with both aniline and hexobarbital (see 
figs 15 and 16). With both substrates a peak in 
absorbance occurred at approximately 410nm and a
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trough at approximately 4zk)nm and the &OD between 
the two wavelengths was substrate concentration 
dependant. However, since the spectrum bore no 
relationship a type 1  or type 2  binding spectra the 
binding kinetics were not determined.
Aniline A max showed a signficant direct 
relationship with body weight but no relationship 
was seen with aniline Ks or hexobarbital A max or K s 
(table 27).
Trends in £pggigs Hiff^r^ncgs Amgng Different 
Components of Nix^d Emotion Qxidas^ System
The trends in species differences for 
different mixed function oxidase components were 
compared using the spearman rank correlation 
coefficient. The results are shown in table 29. 
Ethylmorphine N-demethylase was significantly 
positively correlated with biphenyl 4-hydroxylase 
and biphenyl 3-hydroxylase, i.e. animal species 
that had a high ethylmorphine N-demethylase 
activity also had a high biphenyl 4- and 3- 
hydroxylase activity. Ethylmorphine N-demethylase 
however, was not correlated with biphenyl 
2-hydroxylase, ethoxyresorufin O-deethylase or 
benzo(a)pyrene hydroxylase enzymes. All three 
biphenyl hydroxylase activities were significantly 
correlated with each other. Ethoxyresorufin 
O-deethylase activity showed a significant
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correlation only with biphenyl 2 -hydroxylase 
activity and this was at a low level of 
significance, Benzo(a)pyrene hydroxylase similarly 
showed a significantly correlation only with 
Diphenyl 3-hydroxylase, Cytochrome P 4 5 0  levels 
were correlated with ethylmorphine N-demethylase, 
Diphenyl 4-hydroxylase and biphenyl 3-hydroxylase 
but not with biphenyl 2 -hydroxylase, 
ethoxyresorufin O-deethylase or benzo(a)pyrene 
hydroxylase, A similar pattern was also seen with 
NADPH-cytochrome c reductase except that a 
significant correlation was also seen with 
Denzo(a)pyrene hydroxylase. Cytochrome b^ showed 
no significant correlation with any of the drug 
raetaoolising enzymes studied but a highly 
significant correlation was seen with the other two 
components involved in the electron transport of 
the mixed function oxidase system, i.e, cytochrome
P 4 5 0  and NADPH-cytochrome c reductase. The 
kinetics of spectral binding of cytochrome P 4 5 0  
with aniline and hexobarbital were also compared 
with the various enzyme activities studied. Only 
the aniline Amax showed & significant correlation 
with cytochrome P 4 5 0  and the correlation was 
inverse. Significant inverse correlations with 
aniline A m a x  were also seen with ethylmorphine 
N-demethylase, biphenyl 4- and 3- hydroxylases. 
Biphenyl 2-hydroxylase showed a significant inverse 
relationship with aniline Ks and hexobarbital A m a x .  
Hexobarbital A m a x  was also significantly inversely
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correlated with ethoxy r e s o r u t m  o-aeetnyiase. 
Benzo(a)pyrene hydroxylase showed a significant 
direct correlation with hexobarbital K s .
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In the present study eleven components and 
activities of the mixed function oxidase system, 
and two enzyme activities involved in drug 
metabolism but distinct from the mixed function 
oxidase system, were studied in fifteen animal 
species representing a broad range of species in 
the mammalia. Very few studies have compared in 
vitro drug metabolising enzyme activities in such a 
wide range of species.
Species Differences in In V_i£rg Drug metabolism;- 
Comparison With Current Literature
Most of the data on drug metabolising enzyme 
activities in different species reported in the 
literature are confined to the common laboratory 
animals, dog and man.
Small laooxaiony animals
Differences in strain, diet and even the 
animal supplier (Pelkonen and Nebert, 1982) are 
known to result in differences in enyzme activity 
in the same animal species. This makes comparison 
of literature data difficult. For many of the 
enzyme activities studied in the present study the 
differences in activity among the small laboratory 
animals (i.e. from mouse to guinea-pig in body
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weight) were small compared to those seen for 
example between mouse and man. Hence for the small 
laboratory animals the trend in species differences 
in enzyme activity may well differ from one study 
to another due to factors such as differences in 
strain; age, diet, environment and animal supplier. 
This variation between studies is very evident in 
the literature. For example in the present study 
the highest cytochrome P 4 5 0  levels among the small 
laboratory animals (including rabbit) were seen in 
the hamster, guinea-pig and mouse, and the lowest 
in the rat and rabbit. Similar results were found 
by Chhaora et al. (1974) and Davies et al.(1969) 
but Litterst et al. (1975) found the highest
cytochrome P 4 5 0  levels in the rabbit and Oppelt et 
al. (1970) found the lowest levels in the guinea-pig.
One notable difference which did emerge 
between the present study and that reported in the 
literature was the presence of biphenyl 
2 -hydroxylase activity in all the animal species 
determined. This is in contrast to the results of 
Creaven et al. (1965b) who found biphenyl 
2 -hydroxylase activity to be present in the livers 
of young rats and rabbits but absent in the adult 
animals and in the guinea-pig. This is possibly 
due to improvements in sensitivity of the method 
when using modern spectrophoto-fluorimeters. 
However, in vivo studies using adult rats and 
guinea pigs have found 2 -hydroxybiphenyl in the
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ui.iiie aitei uidi sumiiubttdtion ot oipnenyj. iraeyer 
and Scheline, 1976, Meyer, 1977; and Halpaap et 
al., 1978). Only trace amounts of 
2 -hydroxybiphenyl, however, was found in the urine 
of adult rabbits (Meyer, 1977) . These results 
suggest that biphenyl 2 -hydroxylase activity is 
present in adult rats and guinea-pigs but in the 
adult rabbit it is very low. The In vitro results 
of the present study tend to confirm this.
Very few extensive studies on the drug 
metabolising enzyme activities have been carried 
out in the ferret. In 1977 Ioannides et al. 
reported a study which compared the activities of a 
number of drug metabolising enzymes in the albino 
ferret, polecat ferret and rat. Some differences 
were seen between the activities determined in the 
present study in the albino ferret and that 
reported by Ioannides et al. (1977). The latter 
reported that the cytochrome P 4 5 0  level in the 
albino ferret was approximately 2 -fold greater than 
the cytochrome b^ level whereas in the present 
study little difference was seen between the two 
cytochromes. Large differences between the two 
studies were seen in ethymorphine N-demethylase, 
NADPH-cytochrome c reductase and the ratio of 
biphenyl 4-: 2-hydroxylase activities. In the 
present study the ethylmorphine N-demethylase
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activity determined was approximately 7-fold less 
than that in the study of Ioannides et al. (1977) , 
and the NADPH-cytochrome c reductase activity was 
greater in the present study. The 
biphenyl- 2 -hydroxylase activity was similar in the 
two studies but the biphenyl 4-hydroxylase activity 
was lower in the present study. The differences 
seen between the two studies may be due to the 
ferrets being obtained from different sources and 
reared on different diets; the ferrets in the study 
by Ioannides et al (1977) had been fed on 
commercial animal feed whereas those in the present 
study had been fed animal flesh until approximately 
2 months prior to the study when they were fed 
commercial feed.
When the drug metabolising activities of the 
ferret were compared with those of the rabbit, a 
species of similar body weight, large differences 
between the two species were seen. Cytochrome P 4 5 0  
and b^ levels, NADPH-cytochrome c reductase and 
biphenyl 4-hydroxylase activities were 2 to 3-fold 
greater in the rabbit than in the ferret, whereas 
for ethylmorphine N-demethylase, biphenyl 
2-hydroxylase and ethoxyresorufin O-deethylase the 
reverse was true. Benzo(a)pyrene hydroxylase and 
biphenyl 3- hydroxylase activities were similar in 
both species. Differences between the two species 
were also seen iB vivo. In the ferret both 
biphenyl 4-hydroxylase and the aminopyrine
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jN-aemecnyrase activities were approximately 2 -i:old 
that in the rabbit (see section 5).
Beagle dog
Very few studies on the microsomal mixed 
function oxidases of the dog liver have been 
reported, Dohi et al. (1973) reported that the 
cytochrome P 4 5 0  content of dog hepatic microsomes 
was 0.67* 0.07 nmole per mg microsomal protein.
This is higher than that found in the present 
study. Forber et al.(1976) studied the 
ethylmorphine N-demethylase activity in the male 
beagle dog and reported an activity of 
approximately half that found in the present study. 
In the present study the drug metabolising activity 
of the dog was comparable to that of other species 
of similar body weight except that the activities 
of all three enzymes which are thought to be 
catalysed by the cytochrome P 4 4 8  forms of 
cytochrome P 4 5 0  (i.e. benzo(a)pyrene hydroxylase, 
biphenyl 2 -hydroxylase and ethoxyresorufin 
O-deethylase) were higher in the dog.
£ig
Similarly very few studies of the hepatic 
microsomal enzymeas have been carried out in pigs. 
Those which have been reported tend to be for 
miniature swine (Forber et al., 1976; Litterst et
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al., 1976; Freudenthal et al., 1976). However 2 
studies in the domestic pig have been reported by 
Short and co workers (Short and Davis 1970; Short 
and Smith 1973). These workers reported cytochrome 
P 4 5 0  and b^ levels of 0.3 and 0.7 nmole/mg protein 
respectively, which are similar to those found in 
the present study. The pig is of similar body 
weight as man but in the present study the majority 
of enzyme activities were from 2 -to 1 0 -fold lower 
in the pig. Similar differences were seen between 
the sheep and the pig suggesting that the pig has a 
low drug metabolising activity.
Eumstn
In contrast to the dog and pig a number of 
studies have been carried out on the drug 
metabolising capacity of human hepatic microsomes. 
In the present study the levels of cytochrome P 4 5 0  
and b^ in human microsgmes were 92 and 70% 
respectively of the rat values. A number of 
studies have reported human hepatic cytochrome P 4 5 0  
levels of under 0.31 nmoles per mg protein which is 
approximately 35% of the average value in the rat 
(Alvares et al., 1969; Ackermann and Heinrich 1970; 
Nelson et al., 1971; Raj et al., 1971; Ackermann 
1972; Schoene et a l ., 1972; Remmer et al.', 1973; 
Guengerich et al., 1981). Two studies reported 
values that were approximately 70% of the rat value 
(Pelkonen et a l ., 1973a; Kremers et a l ., 1981) and
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a further study by Pelkonen (1973) found even less 
difference in the cytochrome P 4 5 0  values of human 
and rat microsomes.
Similarly a wide variation in the reported 
cytochrome b^ levels is also seen. The value found 
in the present study is similar to that reported by 
Pelkonen et al. (1974) and Alvares et al. (1969) 
(0.34 and 0.35 nmoles/mg protein respectively). 
Lower levels, however, have been reported by Raj et 
al. (1971) and Ackermann and Heinrich (1970) (0.20
and 0.15 nmoles/mg protein respectively). The 
reports for NADPH-cytochrome c reductase are also 
conflicting. Kremers et al. (1982) reported that 
the activity per mg microsomal protein was greater 
in human liver than in rat liver. Similar results 
were also seen in the present study. Other studies 
found the activity in the human to be between 
60-100% of that in the rat (Pelkonen et al., 1973; 
1974; Guengerich et al., 1981). Nelson et al. 1971 
and Schoene et al. (1972) found a low reductase 
activity in man being 30-50% of that found in the 
rat.
In the present study the ethylmorphine 
N-demethylase activity found in the human liver 
samples was 87% of that found in the rat liver. 
Davies et al. (1973) reported an average 
ethylmorphine N-demethylase activity in human liver 
of 0.35/imoles HCHO/mg protein per hour which is
10,1
Ackermann (1972) also found low levels of 
ethylmorphine N-demethylase activity in man being 
2 0 % of that seen in the rat.
Hence it appears that while the reports in the 
literature are conflicting the majority found low 
levels of cytochrome P 4 5 0  and b^ and ethylmorphine 
N-demethylase activity in human liver compared to 
rat liver, whereas NADPH-cytochrome c reductase 
activity was not greatly different in the human and 
rat liver. This suggests that the high cytochrome
P 4 5 0  level and ethylmorphine N-demethylase activity 
found in human liver samples in the present study 
are not truly representative for man. For this 
reason when studying the relationship between 
microsomal mixed function oxidase activity and body 
weight the relationships with cytochrome P 4 5 0  and 
ethylmorphine N-demethylase were determined with 
and without the human data.
The only other microsomal mixed function 
oxidase enzyme determined in the present study for 
which human data has been reported in the 
literature to any great extent is benzo(a)pyrene 
hydroxylase. In the present study the activity in 
the human liver was approximately 7-fold and 4 -fold 
greater than the rat when expressed per mg 
microsomal protein and per g liver respectively. 
This is in contrast to that reported in the
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literature. Pelkonen et al. (1973) found the 
benzo(a)pyrene hydroxylase activity per g liver was 
similar in rat and man whereas Kuntzman (1966) 
found the rat to have a 4-fold greater activity 
than man. Kremers et al. (1981) found the 
benzo(a)pyrene hydroxylase activity (expressed per 
mg protein) in the rat to be 1 0 -fold greater than 
in man. This further suggests that the human liver 
samples studied in the present study have an 
abnormally high level of mixed function oxidase 
activity. The reason for the high activity is 
unknown as the samples were obtained from subjects 
who were not known to be drug takers. The 
incidence of smoking (which also induces 
benzo(a)pyrene hydroxylase activity due to 
benzo(a)pyrene being present in cigarette smoke) 
(Nebert et al., 1981) among the subjects is not 
known.
Pelkonen et al. (1974) also studied aniline 
and hexobarbital binding to human cytochrome P 4 5 0 . 
These workers reported a K s for aniline of 0.71mM 
which is much less than that found in the present 
study (2.46mM). These workers found that with 
hexobarbital many samples of human microsomes did 
not produce a type 1 binding spectra. This was not 
found in the present study, as 6 samples gave a 
type 1 binding spectra with hexobarbital. The K s 
for hexobarbital determined by Pelkonen et al 
(1974) was similar to that obtained in the present
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study (0.26mM and 0.39mM respectively).
The human liver samples were obtained 
similarly to those used by Kremers et al. (1982)
i.e. at a similar time after death from Kidney 
transplant donors, and kept frozen at -80°C until 
assayed. After death, drug metabolising enzyme 
activity is known to decrease (Creaven and 
Williams, 1963; Leadbeater and Davis, 1964) .
Storage of the liver may also cause loss of enzyme 
activity (Leadbeater and Davis, 1964; Levin et al., 
1969; Bartosek, et al., 1980), hence the reason for 
the high enzyme activity in the human samples 
determined in the present study is unknown.
Zoo animals (serval, fallow d e e r , sooty manoabey,
Studies on the in vitro hepatic drug 
metabolising activities of these species do not 
appear to have been previously reported. Only 
single liver samples were obtained for each species 
hence only tentative conclusions can be drawn from 
the results. Low levels of cytochrome P 4 5 0  and b 5  
and NADPH-cytochrome c reductase activity were seen 
in the leopard and serval. These species also had 
low ethylmorphine N-demethylase and biphenyl 
4-hydroxylase activities. Biphenyl 2- and 3- 
hydroxylase activities, however, were relatively 
high compared to the other species studied. The
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serval, leopard and tallow deer were the only 
species studied that had greater biphenyl 
2-hydroxylase than 4-hydroxylase activity. These 3 
species also had a high ethoxyresorufin 
O-deethylase activity but only the leopard had a 
high oenzo(a)pyrene hydroxylase activity. Hence, 
with the exception of the sooty mangabey, liver 
samples from the zoo animals had low activities of 
the cytochrome P ^ g - d e p e n d a n t  enzymes but high 
activities of the so called cytochrome
P 4 4 g-dependant enzymes. Species differences in 
induction are known to occur. Alvares et al.
(1970) showed that 3-methylcholanthrene 
pretreatment caused a 4- to 5- fold increase in 
benzo(a)pyrene hydroxylation in the rat, a 2- fold 
increase in the mouse and guinea-pig, but no 
significant increase in the rabbit. Other workers 
have also found the rabbit and hamster to have a 
lower responsiveness of benzo(a)pyrene hydroxylase 
to 3-methylcholanthrene treatment (Gram et al., 
1967; Nebert and Gelboin, 1969; Nebert et al., 
1973). The high activity of the biphenyl
2-hydroxlase and ethoxyresorufin O-deethylase in 
the leopard, serval and fallow deer may be due to 
the susceptibility of these species to induction of
t*ie P448 forms of cytochrome P 4 5 0 . Alternatively 
Zoo animals may be exposed to more inducers than 
laboratory animals.
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Relationship Between Microsomal Mixed Function 
Ox_ida_se Activity anc} £ocly Weight
A signficant inverse correlation with the 
logarithm of body weight was found for cytochrome
P450' ethylmorphine N-demethylase and biphenyl 
hydroxylase (2-, 3 - f 4- and total hydroxylase). No 
correlation with body weight was seen with 
cytochrome b^, NADPH-cytochrome c reductase, 
ethoxyresorufin O-deethylase, benzo(a)pyrene 
hydroxylase, nor with the non-mixed function 
oxidase enzymes, UDPGA transferase and alcohol 
dehydrogenase. When ethylmorphine N-demethylase 
and the biphenyl hydroxylases were expressed per 
nmole cytochrome P 4 5 0  the relationship with body 
weight was no longer significant. These results 
indicate that the relationship between body weight 
and ethylmorphine N-demethylase and the biphenyl 
hydroxylase enzymes is due to the level of 
cytochrome P 4 5 0 . The fact that benzo(a)pyrene 
hydroxylase and ethoxyresorufin O-deethylase, which 
do not appear to be dependant on the P 4 5 0  form of 
cytochrome P 4 5 0 , and also UDPGA transferase and 
alcohol dehydrogenase, which are not part of the 
mixed function oxidase system and hence not 
dependant on cytochrome P450, were not correlated 
with body weight further suggests that the P 4 5 0  
form of cytochrome P 4 5 0  is a major factor in the 
relationship between mixed function oxidase
activity and body weight. The only exception to 
this was Diphenyl 2-hydroxylase which showed a 
significant correlation with body weight which was 
no longer apparent when the activity was expressed 
per nmole cytochrome P450, and did not show a 
significant rank correlation with cytochrome P 4 5 0 .
Although there was a statistically significant 
linear relationship between body weight and enzyme 
activity in vitro, individual species often did not 
closely follow the trend. Since the activity of 
the drug metabolising enzymes is known to be 
affected by a number of factors and that 
immunologically distinct forms of cytochrome £ 4 5 0  
exist in different species (Guengerich et al.,
1981) which differ in their capacity for induction, 
such variation is expected. The relationship 
between enzyme activity and body weight is 
discussed more fully in the final Discussion 
chapter (section 8 ).
Correlation of the Trends in Species Differences in 
Mixed Function Qxidasg Activity
By comparing the pattern of species 
differences for a number of enzymes it is possible 
to gain some information on the relationship 
between different enzymes and the involvement of 
factors such as cytochrome P450, cytochrome b 5 and 
NADPH-cytochrome c reductase. Significant positive
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correlations (rg ) were seen between ethylmorphine 
N-demethylase and biphenyl 4- and 3- hydroxylase 
activities. These enzymes also showed a positive 
correlation (rs ) with cytochrome P 4 5 0  levels and 
NADPH-cytochrome c reductase activity indicating 
that these two components of the mixed function 
oxidase system may be rate-limiting in the 
activities of ethylmorphine N-demethylase, biphenyl 
4- and 3-hydroxylases. Ethoxyresorufin 
O-deethylase and benzo(a)pyrene hydroxylase showed 
no correlation (rg ) with cytochrome P 4 5 0  nor with 
the cytochrome P^g- d e p e n d a n t  enzymes which further 
supports the theory that ethoxyresorufin 
O-deethylase and benzo(a)pyrene hydroxylase are 
catalysed by a form or forms of cytochrome P 4 5 0  
other than cytochrome P 4 5 0  (Burke and Mayerf 1975; 
Oesch et al., 1972 Parkinson and Safe, 1981).
Relationship 
hyd£oxyl£5££
Biphenyl 2-hydroxylase activity did not 
correlate significantly with cytochrome P 4 5 0  levels 
nor with the cytochrome P ^ g - d e p e n d a n t  
ethylmorphine N-demethylase. Yet biphenyl
2 -hydroxylase activity did correlate with that of 
the biphenyl 4- and 3- hydroxylases both of which 
showed a significant correlation with cytochrome
P 4 5 0 . Also the 2-hydroxylase activity showed a 
significant inverse correlation with body weight
cytochrome £450 and di
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which no longer occurred when the activity was 
expressed per nmole cytochrome P 4 5 0 . This 
conflicting evidence concerning whether or not 
Diphenyl 2-hydroxylation is catalysed by cytochrome
P 4 5 0  is also evident in the literature, Creaven 
and Parke (1966) and McPherson et al. (1976) found 
that in the rat phenobarbital pretreatment induced 
biphenyl 4-hydroxylase activity whereas
3-methylcholanthrene induced primarily biphenyl 
2 -hydroxylase activity, indicating that the
4-hydroxylase was cytochrome P 4 5 0  dependant and the
2 -hydroxylase was cytochrome P 4 4 g-dependant. 
However, Burke et al. (1975) showed that in both 
rat and hamster phenobarbital pretreatment 
selectively induced Diphenyl 4-hydroxylase and that
3-methylcholanthrene induced both biphenyl 2- and
4-hydroxylase. Atlas and Nebert (1976) found this 
also to be true in mice. These workers suggested 
that in the non-induced animal the 4-hydroxylase 
was predominately catalysed by cytochrome P 4 5 0  and 
the 2 -hydroxylase predominately by cytochrome P 4 4 Q, 
whereas in the 3-methylcholanthrene treated animals 
the 4-hydroxylase is predominately catalysed by 
cytochrome P 4 4 3 . This theory is supported by the 
work of Burke and Mayer (1975) who, using a 
partially purified mixed function oxidase system, 
showed that cytochrome P 4 5 0  catalysed biphenyl 
4-hydroxylase activity but not biphenyl
2-hydroxylase' or ethoxyresorufin O-deethylase, 
whereas cytochrome P44g catalysed all 3 enzymes.
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However, further work by Burke and Prough (1976) 
found that in the non-induced hamster biphenyl 2 - 
and 4-hydroxylase are catalysed by either the same 
enzyme or cofactors whereas in the induced animal 
they are catalysed by different enzymes or possibly 
cofactors. Also several workers have found 
Diphenyl 2-hydroxylase activity in rats to be 
induced by phenobarbital pretreatment (Burke and 
Prough, 1978; Billings and McMahon , 1978; Haugen , 
1981; Fry, 1981). Fry (1981) found the the 
increase in biphenyl 2 -hydroxylase activity induced 
by phenobarbital was due to the increase in the 
cytochrome P 4 5 0  levels since when the 2 -hydroxylase 
activity was expressed per nmole cytochrome P 4 5 0  
the activity was the same as in the non-induced 
animal, indicating that biphenyl 2 -hydroxylase can 
be catalysed by cytochrome P4 5 0 . However, after 
B-naphthoflavone pretreatment the 2-hydroxylase 
activity was increased above the increase in 
cytochrome content. Biphenyl 4-hydroxylase 
activity expressed per nmole cytochrome P 4 5 0  was 
similar after both phenobarbital or 
^-naphthoflavone pretreatment. Hence for biphenyl
2 -hydroxylase the inductive effect of polycyclic 
aromatic hydrocarbons is more complex than a simple 
increase in cytochrome P 4 4 8 /P 4 5 0 levels. Possibly 
the kinetics of the 2 -hydroxylase is different when 
catalysed by cytochrome P44g than by cytochrome
P450*
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Studies using inhibitors have shown that in 
the rat and hamster basal activities of biphenyl 4- 
and 2 -hydroxylase are dependant on one (or more) 
forms of cytochrome P 4 5 0  other than cytochrome 
P448' whereas after induction with polycyclic 
hydrocarbons, such as 3-methylcholanthrene, the two 
hydroxylases are dependant on cytochrome P 4 4 Q 
(Atlas and Nebert, 1976; Burke and Prough, 1976) .
In the mouse however both basal and induced
2 -hydroxylase activity appears to be associated 
solely with cytochrome P 4 4 8  (Atlas and Nebert,
1976) .
With the development of HPLC and GLC systems 
which distinguish the 3-hydroxy as well as the 2- 
and 4-hydroxy metabolite of biphenyl, the effect of 
inducers on biphenyl 3-hydroxylase has been 
studied. Haugen (1981) found that phenobarbital 
produced a marked increase in 3-hydroxybiphenyl 
compared to the 2- and 4-hydroxybiphenyls. After
3 -methythlcholanthrene pretreatment the
3-hydroxylase was induced to a similar extent as 
the 2 -hydroxylase, both being greater than the
4-hydroxylase. Toftgard et al. (1980) also found a 
similar enhancement of the 2- and 3-hydroxylase 
with 3-methylcholanthrene but they found 'no marked 
induction of the 3-hydroxylase after phenobarbital 
pretreatment. These workers also found that the
4 -hydroxylase was not induced by either 
phenobarbital or 3-methylcholanthrene.
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Halpaan-Wood et al. (1981b) also found in the rat, 
no induction of biphenyl 4-hydroxylase by 
phenobarbital although the 2- and 3-hydroxylases 
were induced. 3-methylcholanthrene and Arochlor 
1254 induced all three hydroxylases the most marked 
effect seen with the 2-hydroxylase. In the mouse 
phenobarbital had no effect on any of the biphenyl 
hydroxylases. In vivo studies by the same workers 
(Halpaan-Wood et al., 1981a) found in the rat that 
biphenyl 3-hydroxylation was increased and biphenyl
4-hydroxylation decreased by phenobarbital 
pretreatment whereas in the mouse this inducer had 
no effect on biphenyl metabolism.
B-Naphthoflavone, however, induced all 3 
hydroxylases in the rat to similar extents.
In conclusion it appears that the biphenyl 2-,
3- and 4-hydroxylases can be catalysed by
cytochrome P 4 5 0  or cytochrome P 4 4 8  an<  ^ that 
pretreatment with inducers may only alter the 
affinity of the hydroxylase for either cytochrome, 
Nebert et al. (1981) have shown that different 
forms of cytochrome P 4 5 0  will all catalyse the same 
substrate but at different rates.
The lack of consistency.in the effect of 
various inducers on biphenyl metabolism reported in 
the literature is difficult to resolve but may be 
due in part to the further metabolism of the 
monohydroxybiphenyls to the diols and triols some
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of which have been shown to be m d u c e a  by 
phenobarbital or 3-methylcholanthrene (Halpaan-Wood 
et al., 1981 a,b) but have been measured in only 
very few studies.
The present study tends to support the theory 
that biphenyl 4- hydroxylase is predominately 
catalysed by cytochrome P 4 5 0  whereas biphenyl 
2 -hydroxylase is catalysed by a cytochrome other 
than P 4 5 0 . Biphenyl 3-hydroxylase correlates with 
cytochrome P 4 5 0  levels but to a lower extent than 
biphenyl 4-hydroxylase, indicating that although 
the 3-hydroxylase is predominately catalysed by 
cytochrome P 4 5 0  it may also be catalysed by other 
forms of cytochrome P450. The activity of all 3 
biphenyl hydroxylases were correlated with each 
other, indicating that their activities were 
dependant in some way on each other. This does not 
appear to be due to the availability of reducedt
cytochrome P 4 5 0  since the biphenyl 2 -hydroxylase 
activity was not correlated with the 
NADPH-cytochrome c reductase activity.
Neither biphenyl 2-hydroxylase or 
ethoxyresorufin O-deethylase activities showed a 
signficant correlation with cytochrome P 4 5 0  levels 
in the different animal species, but the two 
enzymes correlated signficantly with each other. 
This supports the work of Burke and Mayer (1975) 
who showed that both enzymes are preferentially
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catcu.ysea oy cytocnrome ^44g rather than P450.
Benzo(a)pyrene hydroxylase
Several investigators have suggested that the 
Diphenyl 2-hydroxylase and benzo(a)pyrene 
hydroxylase are catalysed by similar enzyme systems 
(Matsubara et al., 1974; Burke and Bridges 1975; 
Burke and Prough, 1976) . However, no correlation 
was seen between these two enzyme activities in the 
present study, although a significant positive 
correlation was seen between biphenyl 3 “hydroxylase 
and benzo(a)pyrene hydroxylase. The fluorimetric 
assay of the biphenyl metabolites used in the 
earlier studies did not distinguish between the 2 - 
and 3-hydroxybiphenyls and possibly the 
relationship seen with benzo(a)pyrene hydroxylase 
in the earlier studies was mainly due to the 
biphenyl 3-hydroxlase. The mechanism of the 
relationship is unknown since although biphenyl 3- 
hydroxylase showed a significant correlation with 
cytochrome P 4 5 0  no such correlation was seen with 
benzo(a)pyrene hydroxylase. This is in contrast to 
a number of studies which have shown the basal 
activity of benzo(a)pyrene hydroxylase to be 
catalysed by cytochrome P 4 5 0  (Goujon et al., 1972; 
Wiebel et al., 1971; Burke and Prough, 1976).
Benzo(a)pyrene can be metabolised to a number 
of metabolites including phenols, dihydrodiols,
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q u m o n e s  ana epoxides. Ttie fluorescence method o£ 
measuring benzo(a)pyrene metabolism used in the 
present study only measures the phenolic 
metabolites. Dehnen et al. (1973), however, showed 
that there was a constant relationship between 
total benzo(a)pyrene metabolism and the formation 
of fluorescent metabolites. It has been suggested 
that the metabolism of benzo(a)pyrene to the 
relatively inactive monohydroxy derivatives occurs 
via cytochrome P 4 5 0  whereas further metabolism to 
the highly reactive carcinogenic 
7 ,8-epoxide-9, 1 0 -diol metabolite occurs via 
cytcohrome P44g (Parke and Ioannides, 1982). In 
the present study the benzo(a)pyrene hydroxylase 
activity showed no correation with cytochrome ? 4 5 g 
indicating that the hydroxylase activity determined 
included the formation of the diols and epoxides as 
well as the monohydroxyl metabolites.
Cytochrome b^
Cytochrome b^ levels correlated significantly 
with cytochrome P450 and NADPH-cytochrome c 
reductase activity but not with any of the mixed 
function oxidases studied. Cytochrome b g is thought 
to act in mixed function oxidations by mediating 
the input of the second electron to the cytochrome
P 4 5 0 -oxygen-substrate complex. (Hildebrant and 
Estabrook 1971; Correia and Mannering, 1973a,b,c) 
(see fig 1, Section 1). Cytochrome b^ normally
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serves as an intermediary electron carrier for NADH 
Out, at least for fatty acyl Co A desaturation in 
microsomes, cytochrome b^ acts as an intermediary 
for NADPH as well as NADH electron flow (Oshino and 
Omura, 1973). Hence it is possible that the source 
of the second electron may be mediated via 
cytochrome b 5 by either NADPH-cytochrome c (P4 5 0 ) 
or NADH -cytochrome b^ reductases. The significant 
correlation between cytochrome P 4 5 0 , b^ and 
NADPH-cytochrome c reductase activity seen in the 
present study further indicates an interaction of 
these 3 components during mixed function oxidation. 
However cytochrome b^ levels showed no correlation 
with the other mixed function oxidase activities 
studied which indicate that this cytochrome is not 
a limiting factor in these oxidation reactions.
NADPH-cytochrome c rgdngtLasg
It has been suggested that the reduction of 
cytochrome P 4 5 0  via NADPH-cytochrome c (P4 5 0 ) 
reductase was the rate-limiting step in the mixed 
function oxidase system(Hoitzman et al., 1968; 
Davies et al., 1969).. Gigon et al. (1968;1969) 
found that ethylmorphine stimulated 
NADPH-cytochrome c reductase activity and that the 
difference in activity closely paralleled the rate 
of ethylmorphine N-demethylation. Other workers 
have also found a correlation between the 
stimulation of the reductase activity and the rate
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or suDstrate metabolism witn otner type i 
substrates (Sitar and Mannering, 1973; Thompson and 
Holtzman, 1977? Degkwitz et al., 1969? Hewick and 
Fouts, 1970), which indicates that NADPH-cytochrome
c P^450) reductase activity is the rate-limiting 
factor in the metabolism of type 1  substrates. 
However, type 2 substrates inhibit NADPH-cytochrome
c P^ 450) reductase activity which indicates that 
the reductase is not rate-limiting in the oxidation 
of type 2 substrates. Gillette et al. (1973) 
suggested that although the reductase is the 
slowest step in mixed function oxidase it is not 
necessarily the rate-limiting step, as cytochrome
P 4 5 0  can be reduced in the absence of substrate and 
also occurs in the oxygenated and active oxygen 
form in the absence of substrate. In a review of 
the data on NADPH-cytochrome c (P450) reductase 
Holtzman (1979) suggested that the reductase may be 
rate-limiting in some reactions, such as for the 
rapidily metabolised substrates, but not for 
others. In the present study ethylmorphine 
N-demethylase, biphenyl 3- and 4-hydroxylases 
activities correlated significantly with 
NADPH-cytochrome c reductase activity which may 
indicate that the reductase activity is 
rate-limiting in these reactions. However, 
NADPH-cytochrome c reductase activity did not 
appear to be involved in the relationship between 
the activity of these enzymes and body weight. 
Biphenyl 2-hydroxylase and ethoxyresorufin
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O-deethylase activities did not show a significant 
correlation with NADPH-cytochrome c reductase 
activity. This is in agreement with the work of
Burke and Mayer (1975) who showed, using
\
solubilised preparations of cytochrome £ 4 4 3 , that 
both substrates can be metabolised independently of 
NADPH-cytochrome c reductase.
In the present study benzo(a)pyrene 
hydroxylase activity correlated significantly with 
NADPH-cytochrome c reductase activity. Literature 
data concerning the role of NADPH-cytochrome c 
reductase activity in benzo(a)pyrene hydroxylation 
is conflicting. Glazer et al. (1971) found that 
treatment of rat liver microsomes with an antibody 
to NADPH-cytochrome c (p 4 5 0 ) reductase inhibited 
benzo(a)pyrene hydroxylase activity. Whereas 
Guengerich et al. (1981) found that the reductase 
antibody produced only slight inhibition of the 
hydroxylase in the rat but resulted in inhibition 
to varying degrees with human microsomal 
preparation.
It has now been suggested that benzo(a)pyrene 
metabolism to the highly reactive '.bay-region^ 
oxygenated metabolites may also occur via one 
electron flavoprotein oxidations inducing 
flavoproteins such as NADPH-cytochrome c (P4 5 0 ) 
reductase (Parke, 1982). Hence it is possible that 
the relationship seen in the present study between
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benzo(a)pyrene hydroxylase activity and 
NADPH-cytochrome c reductase activity is due to the 
above reaction occuring.
In the present study the reductase activity 
towards cytochrome c was measured whereas in the 
mixed function oxidase reactions cytochrome P 4 5 0  is 
the substrate for the reductase. Differences in 
reductase activity between the two substrates are 
known to occur (Flynn et al., 1972) and hence may 
effect the correlation between reductase activity 
and the mixed function oxidases.
Aniline and hexobarbital binding to cytochrome
No marked pattern of correlation between the 
binding kinetics of aniline or hexobarbital to 
cytochrome P 4 5 0  and enzyme activity was seen. The 
Afnax for aniline (a type 2  substrate) showed a 
significant inverse correlation with cytochrome
P 4 5 0 levels, ethylmorphine N-demethylase activity, 
biphenyl 4- and 3-hydroxylase activity. The latter 
also showed a significant direct correlation with
cytochrome P 4 5 0  and hence their correlation with 
aniline A m a x  may be as a result of their dependance 
on cytochrome P 4 5 0 . Species differences in aniline 
A m a x  also showed a significant direct relationship 
with body weight. No correlation with body weight 
was seen for aniline K s or hexobarbital binding 
kinetics. No correlation was seen between the A m a x
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or Ks for the two types of substrates. As the two
types of substrates are thought to bind at
different sites on the cytochrome P 4 5 0  molecule 
* *
this lack of correlation is expected.
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£QH£Itl2£I£H
A study of drug metabolism involving a large 
number of different species, in addition to giving 
information on individual species differences in 
the metabolism of different compounds, does reveal 
general trends in metabolism. This may be useful to 
the further understanding of the mechanism(s) of 
the metabolism.
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Fig 12 SPECTRAL BINDING OF ANII INF TO RABBIT 
MICROSOMES-AN EXAMPLE OF TYPE 2 BINDING
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Fig 13. SPECTRAL BINDING OF ANILINE TO CYTOCHROME
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FIG 14 SPECTRAL RINDING OF HEXOBARBITAL TO
RABBIT MICROSOMES -  AN EXAMPLE OF TYPE 1
BINDING
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Fig 15 SPECTRAL BINDING OF 
ANILINE TO CYTOCHROME P^ rQ 
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Fig 16. SPECIAL BINDING OF 
HFXOBARBITAL TO CYTOCHROME 
R r p . IN'WASHED LIVER MICROSOMES 
FROM SOOTY M ANIG AB EY
Table 11. ROPY AND LIVER WEIGHT DATA FOR THE SPECIES
STUDIED
Species & strain
Body 
weiaht ( a )
Liver Liver/bodya 
weiaht ( q ) weiaht ratio
Microsomal 
protein/q live
Mouse-CD1 (13) 3B± 2 2.0 i  0.2 52.6 14.4 ♦ 5.6
Gerbil- mongolian (3) 6 5 1 5 2.4 i  0.2 37.0 2 4 .8 1 5.1
H am ster-syrian  (6 ) 139 ±11 5.7 i  0.5 41.0 23.6 i  6.7
Rat - w is ta r  albino(12) 2 3 5 i 60 10.511.9 44.6 23.6 i  4.2
Guinea pig - dunkan 3A2123 13.1 i1 .7 38.3 27.2 i  6.5
har tely (6)
Ferret-alb ino (A) 1 8 8 8 ±28A 56 i  12.3 29.7 18.0 12.6
Rabbit-dutch mixed(6) 192A ± 12A 58110.6 30.1 12.4 i  3.5
Serval (1) 7 3 2 5 120 16.4 15.2
Sooty m angabey (1) 7 800 - - 12.8
Dog-beagle (3) 10567 ± 1A01 349169 33.0 14.4 1 2.7
Fallow deer (1) 35500 190 5.3 29.6
Leopard (1) A 0000 - - 14.4
S h eep-su ffo lk (A ) A2225 i  3A A1 630 14.9 18.314.1
Pig (3) 64 0 0 0 * 1200* 18.7 28.412.9
Human (6) 70000* 11.2 3.4
Results are m e a n iS D .
<£
estim ated value.
Value in parenthesis indicate the number of liver samples  
studied
a-x103
k-m g
Table 12 SPECIES DIFFERENCES IN CYTOCHROME P^ Q CONTENT
OF W ASHED HEPATIC MICROSOMES
nmoles cytrochrome P^ pq per
SDecies ma microsomal 
protein
g liver total liver  
w eiah t
Mouse (13) 1.33 i  0.20 27.9 i  11.0 58 i  20
Gerbil (3 ) 1.23 i  0.08 27.6 i 4.1 67 1 16
H a m s te r  (6 ) 1.47 i  0.27 30.01 9.0 186 i  41
Rat (8) 0.73 ♦ 0 .20 2 5.7110.7 311 i  159
Guinea pig (3 ) 1.48 i O.40 38.7 ±4.1 501 118
Ferret (4 ) 0.29 ♦ 0 .07 5.3 i  6.1 285 i 48
Rabbit (6 ) 0.81 i 0.19 11.8*3.1 672 1 151
Serval (1 ) 0.17 2.6 308
Sooty m angabey(1) 0 .55 7.1 -
D o g (3) 0 .4 8  i  0.02 6 .9 *  1.7 2670 i  511
Fallow deer (1) 0.63 18.7 3559
Leopard (1) 0 .15 2.1 -
Sheep (4) 0.64 i  0.03 10.6* 1.0 6 7 0 2 *6 6 5
Pig (3) 0 .43  t 0.02 12.510.4 1 5 0 5 2 1 504
H um an(6 ) 0 .6 7  i0 .07 7.8 * 1.8 -
Results are m ean i S.D.
Figures in parenthesis indicate the number of anim als in each
experim ent. A ll determ inations were carried out in duplicate.
Table 13. SPECIES DIFFERENCES IN CYTOCHROME b5 CONTENT
OF WASHED HEPATIC MICROSOMES
nmoles Cytochrome br  £>er
Species mg microsomal a liver total liver
protein w eight
Mouse ( 7 ) 0.46 : 0.08 9.8 i  4.6 19: 8
Gerbil . n.d. n.d. n .d .
H a m s te r  (3 ) 0.78 i  0.14 13.5 i 3.2 78 : 14
Rat (13) 0.43 : 0.11 12.9 i  3.6 1 3 8 :6 0
Guinea pig ( 3 ) 0.72 ; 0.04 16.1 i  1.4 209 : 11
Ferret (4 ) 0.29 i  0.10 5.5 i  2.4 297 :9 7
Rabbit (6 ) 0.82 :0 .1 6 11.9 1 2.5 676 :114
Serval (1 ) 0.12 1.8 218
Sooty m angabeyO ) 0.26 4.9 -
Dog ( 3 ) 0.33 i  0.02 4.4 i  1.5 1900: 603
Fallow deer (1 ) 0.48 14.1 2700
Leopard (1) 0.13 1.9 -
S h e e p (4 ) 0.82 i  0.11 17.9: 0.3 11300:117
Pig ( 3 ) 0.38 i  0.01 10.8 : 0.5 13000:551
H u m an  (6 ) 0.30 i 0.01 5.2 i  1.4 _
Results are mean i  S.D.
Figures in parenthesis indicate the num ber of anim als in each 
experim ent. A ll determ inations were carried out in duplicate. 
n.d.= not determined
Table 14. SPECIES DIFFERENCES IN ETHYLMQRPHINE
N-DEM ETHYLASE ACTIVITY IN WASHED HEPATIC MICROSOMES
jumoles Eormaldehyde produced per hour per
S pecies j r
Mouse ( 6 )
Gerbil ( 3)
H a m s te r  (6 )
Rat U )
Guinea pig ( 3 )  
Ferret ( 4 )
Rabbit (6 )
Serval (1 )
Sooty m angabeyO )  
D o g ( 3 )
Fallow  deer (1) 
Leopard (1)
S h e e p (4 )
Pig ( 3 )
H u m a n  (6 )
microsomal g liver 
protein
0.96 0.22 7.5i1.5
0.36 0.04 8.3 i1.7
0.60 0.04 13.4i 5.3
0.78 0.09 17.9i 3.6
0 .72 0.17 18.913.7
0.34 0.02 6.010.5
0.19 0.04 2210.6
0.13 2.0
0 .30 3.8
0.34 : 0.03 4 .8 10.4
0 .17 5.0
0 .02 0.3
0 .2 2 i 0.06 3.4 1 1.0
0.15 i 0.01 4.3 i0.3
0 .6 8 10.24 9.1 i2.4
total liver nmole
w e ig h i ^ - ^ 4 5 0
15 i  3 0.271 0.06
20 1 6 0.30 10.03
7 5 i2 7  . 0.4010.10
213 i6 6 0.79 i0 .29
247i 32 0.49i 0.05
337 i64 1.20i 0.26
118128 0.17i 0.0 5
235 0.76
- 0.56
18841177 0.7210.15
965 0.27
- 0.13
2145 i  639 0.2810.13
5164 i  381 0.34i 0.04
1.16 i 0.18
Results are mean t S.D.
Figures in parenthesis indicate the number of animals in each
experiment. A ll determ inations were carried out in duplicate.
Table 15. SPECIES DIFFERENCES IN NADPH- CYTOCHROME
c REDUCTASE ACTIVITY IN W ASHED HEPATIC
MICROSOMES 
pmoles Cytochrome c reduced per m in  per
S pecies mg microsomal g liver total liver
protein weight
Mouse ( 9 ) 0.3A : 0.03 6.69 i0 .7 0 16 i  2
Gerbil ( 3 ) 0 .39  i  0.03 8.86 i  1.A6 22 i  5
H am ster  (6 ) 0 .A 5 i  0.16 9.A9 i  2.A5 5A 1 15
Rat (A) 0 .2 7  ♦ 0.03 5.61 10.39 59 i  8
Guinea pig ( 3) 0 .5 0  10.08 13.38 i0 .7 7 176 i  32
Ferret (A ) 0 .1 7  i  0.05 3.13 i  1.23 170 i5A
Rabbit (6 ) 0 .3 8  i  0.05 A.26 i  0.86 2 5 0 1 67
Serval (1 ) 0.06 0.99 119
Sooty m an gab eyO ) 0 .08 1.05 -
D o g ( 2 ) 0.2A i  0.003 3.22 i  0.92 1390 i  37A
Fallow deer (1) 0.13 3.98 757
Leopard (1 ) 0.07 0.95 -
Sheep(A) 0.38 i  0.05 5.8 i  0.37 3650 i  23A
Pig ( 3 ) 0.33 i  0.0A 10.17 i  1.09 1220011310
Hum an (6 ) 0.35 i 0.06 A .92 i  1.32 -
Results are mean i S.D.
Figures in parenthesis indicate the number of anim als in each
experiment. A ll determ inations were carried out in duplicate.
Table 16. SPECIES DIFFFRFNCFS IN BIPHFNYL 7 - HYDROXYLASE
ACTIVITY IN HEPATIC MICROSOMES
nmole 2 - Hvdroxvbiphenvl per hour per
Species mq microsomal a liver total liver nmole
protein w eiaht ^ - ^ 4 5 0 -
Mouse ( 6 ) 9.29 i  2.59 69 : 8.8 141 ; 29 2.65 ; 0.53
Gerbil ( 3) 8.29 i  2.94 182 i  53.5 441 ; 129 6.76 ; 2.35
H a m s te r  (6 ) 14.94 i  1.76 328 ; 95.9 1853 ; 482 10.12 ; 2.59
Rat ( 6 ) 4.12 ; 1.94 77 ; 29.4 6 88 ; 200 4.65 ; 1.47
Guinea pig ( 3 ) 7.06 ♦ 1.23 148 i 45.9 1876 ; 323 3.76 ; 0.76
Ferret ( 2 ) 5.42 i  1.41 103 ; 1.7 4865 ; 588 16.12 ; 4.47
Rabbit (6 ) 2.59 t 0.41 37 ; 5.3 2141 ; 418 3 .2 9 ;  0.82
Serval (1 ) 5 .82 58 6947 22.53
Sooty mangabey (1) 1.65 21 - 3.00
Dog ( 3 ) 8.76 i  3.47 116 ; 59.4 47970;28810 17.82; 9.59
Fallow deer (1) 2.35 57 10730 3.00
Leopard (1) 5.65 45 - 21.52
S h e e p (4 ) 2.65 i  1.00 51 ; 18.8 32330; 11820 4.76 ; 1.53
Pig ( 3 ) 1.12 i  0.65 33 ;  19.4 39580; 23010 2 .6 5 ; 1.59
H u m a n (6 ) 1.82 ; 0.71 23 ; 4.7 - 3 .12; 1.12
Results are mean ; S.D.
Figures in parenthesis indicate the number of animals in each
experiment. A ll determ inations were carried out in duplicate.
Table 17 SPECIES DIFFERENCES IN BIPHENYL 3-HYDROXYLASE
ACTIVITY IN HEPATIC MICROSOMES
nmole 3-Hvdroxvbiphenyl per hour per
Species ma microsomal .g liver total liver nmole
protein weight - ^ - ^ 5 0
Mouse ( 6 ) A.76 t 0.9A 37 i 2.3 7 6 1 6 1.35 i  0.06
Gerbil ( 3 ) A .A 1 i  1.29 98 1 21.8 2 3 5 iA 7 3.65i 1.12
H a m s te r  (6 ) 11.29 i 3.71 231 1 17.1 1318 i106 7.A1 i  2.00
Rat n.d. n.d. n.d. n.d.
Guinea pig (3  ) A .71 i 1.18 12A 115.9 16001135 3.18 i 0.29
Ferret ( 2 ) 2.06 i 0.A7 A0 i  A.1 18761182 6 .2 3 i  1.6A
Rabbit (6 ) 1 .8 8 t  0 .29 28 i  5.3 1588 i365 2.A1 i 0.59
Serval (1 ) 3.53 35 A235 13.70
Sooty m an gab eyO ) 1.35 17 - 2.A7
D o g ( 3 ) A .06 i  0.88 511 8.8 20680 1 66A1 7.88 i  2.9A
Fallow deer (1) 0.9A 22 A235 1.18
Leopard (1) 2.29 18 - 8.59
Sheep(A ) 3.23 10.65 65 115.9 A10A1 19935 6.18 11.29
Pig ( 3 ) 0.82 i 0.A7 25112.9 29600 11558 2.00 11.12
H u m a n { 6 ) A.88 i 2.A7 68137.1 - 9 .06 i 3.9A
Results are mean ♦ S.D.
Figures in parenthesis indicate the number of animals in each 
experim ent. A ll determ inations w ere  carried out in duplicate. 
n.d.= not detected.
Table 18. SPECIES DIFFERENCES IN BIPHENYL 4-HYDROXYLASE
ACTIVITY IN HEPATIC M1CR0S0MES
nmoles 4-HvdroxvbiDhenvl per hour per
SDecies ma microsomal g liver total liver nmole
protein w eight c* L J 450
( * 1 0 2 ) ( *103)
Mouse ( 6 ) 4 8 .9 ;  12.1 3.8 i  0.3 0.8 i  0.1 ' 13.611.3
Gerbil ( 3 ) 29.1 i  13.0 6.3 i  2.5 1.5 ± 0 .5 24.0i11.1
H a m s te r  (6 ) 64.5 117.7 14.6 i  2.4 8.3 ±1.3 46.4 113.5
Rat ( 6 ) 36.6 i 6.8
00
•
o
 +1
o
• 6 . 5 ;  1.0 44.4 i  7.2
Guinea pig ( 3 ) 21.5  i  7.5 5 .6  i  1.4 7.2 10.9 14.5 i2 .4
Ferret ( 2 ) 8 .7  i  3.9 1.6 i0 .5 7 .7  ±2.4 8.7 i  3.9
Rabbit (6 ) 22.1 i 6 . 5 3.3 ♦ 1.4 19.5 ±9.6 29.2 112.5
Serval (1 ) 4.9 0.5 5.9 19.0
Sooty m angabeyO ) 3.1 0.4 - 5.7
D o g ( 3 ) 36.5 i  15.9 4.4 i  1.2 177.9170.0 70.6 i  39.4
Fallow  deer (1) 1.6 0.4 7.2 2.1
Leopard (1) 1.1 0.08 - 4.2
S h e e p (4 ) 20.5 i  4.2 3.1 i  1.2 269.1 1 84.9 39.9 i  9.5
Pig ( 3 ) 3.0 i  0.5 0.9 1-0.2 107.1 120.2 7.1 1 1.4
H u m a n  (6 ) 28.0 i  12.0 3.7 ±1.5 ~ 49.1 117.7
Results are mean ♦ S.D.
Figures in parenthesis indicate the number of animals in each
experiment. A ll determ inations were carried out in duplicate.
Table 19 SPECIES DIFFERENCES IN TOTAL BIPHENYL
HYDROXYLASE ACTIVITY IN HEPATIC MICROSOMES
nmoles Total hydroxvbiphenyl per hour per
Species ma microsomal
protein
a liver 
( * 1 0 2 )
total liver 
WfiighL 
( * 1 0 3 )
nmole
-sy-t-Aso
Mouse ( 6 ) 62.9 *15.1 4 .9 ;  0.4 1 .0 ;  0.2 17 .5; 1.2
Gerbil ( 3 ) 49.1 *16 .9 9 .2 ;  3.1 4.0 ;0 .7 34 .5 ;  14.4
H a m s te r  (6 ) 95.9 i22 .4 20.2 ;3.3 11.4 ;1 .7 63.9 ±17.4
Rat ( 6 ) 40.7 i  8.2 7.8 ;0.9 7.2 ;0.9 48.8;10.6
Guinea pig ( 3 ) 31.9 ±11.1 8.4 ;2.0 10.7 ;1 .2 21.4 ;  3.2
Ferret ( 2 ) 16.2 i  5.8 3.1 ;o.7 14.5 ±3.2 48.4 ± 18.2
Rabbit (6 ) 26.5 i  6.8 3.9 ;1.4 23.2;10.4 34.9; 13.5
Serval {1 ) 14.3 1.4 17.1 55.5
Sooty m angabeyO ) 6 .2 0.8 - 11.1
D o g ( 3 ) 49.2 1 18.2 6.1 ;  1.4 2460; 90.0 96.2; 480
Fallow deer (1) 4.9 1.2 22.2 6.2
Leopard (1) 9.0 0.7 - 34.2
Sheep (4 ) 20.5 i  4.2 4 .3 ;  1.3 269.0; 85.0 39.9 ; 9.5
Pig ( 3 ) 4.9 i  1.0 1 .5 ;0 .3 179.0 ;36.0 11.9 ; 2.8
H u m a n (6 ) 33.6 ± 10.9 4.5 ;1 .4 - 59.8 ;17.8
Results are mean i S.D.
Figures in parenthesis indicate the number of animals in each
experiment. A ll determ inations were carried out in duplicate.
Table 20. SPECIES DIFFERENCES IN BIPHENYL METABOLISM
IN VITRO -  RATIO OF 2-. 3 - AND 4-HYDR0XYB1 PH EN YL
M E T A B O L IT E S
Ratio of 2 -. 3- and 4-hvdroxvbiphenyl 
2 -OH /4  -OH 2-OH/3-O H 3 -O H /4 -O H
Species
Mouse
Gerbil
H a m ste r
Rat
Guinea pig 
Ferret 
Rabbit 
Serval
Sooty mangabey 
Dog
Fallow deer 
Leopard
Sheep
Pig
Hum an
0.19 
0.29  
0.22 
0.11 
0. 33 
0 .6 3  
0.12 
1.25  
0 .53  
0 .24  
1.43  
5.00  
0.13  
0.37
0.07
1.96
1.86
1.32
1.49
2.63  
1. 37
1.64 
1.22 
2.13
2.50  
2 .44
0 .8 2
1.35
0 .37
0.10
0.15
0.16
0.22 
0.24  
0 .09  
0 .76  
0 .43  
0.11 
0.57  
2.05  
0.16  
0 .27
0.18
Table 21. SPECIES DIFFERENCES IN ETHOXYRESQRUFIN 0 -  
DEETHYLASE ACTIVITY IN WASHED HEPATIC M 1CR0S0M ES
pmoles Resorufin produced per min per
Species mq microsomal 
protein
a liver  
( *103)
total liver 
weight 
M 0 3)
Mouse (6 ) 93 i 2 0 1.85*0.41 4 i  1
Gerbil ( 3 ) 150 *5 3 3.33 i  0.97 8 * 2
H a m s te r  (5 ) 112 i  17 2.84 i  0.88 16 i  4
Rat ( 3 ) 145 i  48 2.89 i  0.96 31 ♦ 13
Guinea pig ( 3 ) 170 *2 1 4.71 ± 0.66 62 i  14
Ferret ( 4 ) 223 * 60 393 * 0 6 4 218 i  44
Rabbit (6 ) 92 i 19 1.06 i  0.41 62 i  28
Serval (1 ) 270 0.52 62
Sooty m angabey(l) 25 0.32 -
D o g ( 2 ) 300 * 15 4.02 i  0.88 1743 * 349
Fallow deer (1 ) 500 14.62 2 7 7 8
Leopard (1) 176 2.54 -
S h eep(4 ) 45 i 7 0.57 *. 0.10 358 i  66
Pig ( 3 ) 2 8 *  5 0 .8 0  .* 0.13 961 *164
H u m a n {6 ) 51 *'16 0 .4 8 *0 .1 9 -  -
Results are mean ♦ S.D.
Figures in parenthesis indicate the number of animals in each
experiment. A ll determ inations were carried out in duplicate.
Table 22. SPECIES DIFFERENCES IN BENZO(a)PYRENE
HYDROXYLASE (A A H ) ACTIVITY IN WASHED HEPATIC MICROSOME
pmoles 3-Hydroxybenzo(a)pyrene per hour per
Species ma microsomal 
protein
41 liver 
( * 1 0 3 )
total liver
weight
(*1 0 4 )
□mole
^ ■ ^ S O
Mouse ( 3 ) 225 i 124 1.64 i  0.71 0.35 10.18 59 i  20
Gerbil n.d. n.d. n.d. n.d.
H a m s te r  (3 ) 123 i 20 3.29 10.96 1.80 10.46 90 i  10
Rat ( 3 ) 39 *8 0.78 i0.14 0.84 10.15 57 i  13
Guinea pig n.d. n.d. n.d. n.d.
Ferret (A ) 97 i 56 1.95 11.34 9.16 16.24 330 ± 190
Rabbit (6 ) 98 -3 0 1.19 i0.67 7.02 *4.44 102 150
Serval (1 ) 36 0.55 6.60 550
Sooty m angabeyO ) 70 0.93 - 130
D o g ( 2 ) 300 1130 4.40 11.19 191.1 152.4 740 i290
Fallow  deer (1) 19 0.55 10.4 291
Leopard (1) 190 2.64 - 1260
S h e e p (4 ) 380 i 50 7.43 i2 4 4 467.01153.0 693 1222
Pig n.d. n.d. n.d. n.d.
H u m a n  (6 ) 280 i  43 3.2510.59 - 428 i  69
Results are mean ♦ S.D.
Figures in parenthesis indicate the num ber of animals in each 
experim ent. All determ inations w ere  carried out in duplicate. 
n.d.= not determ ined
Table 23. SPECIES DIFFERENCES IN UDPGA TRANSFERASE
ACTIVITY IN WASHED HEPATIC MICROSOMES
Dmoles 1-NaDhthol alucuronide per m in d<
m a m icrosom al q liver total liver
Species protein weiaht
M ouse (-4) 1.12 i 0.20 13.2 1 2.1 26 i  5
Gerbil n.d. n.d. n.d.
H a m s te r  (3 ) 1.47 i0 .2 7 42.1 115.3 229 i 66
Rat ( 3 ) 1.78 10.24 32.8 i 8.9 270 i8 4
Guinea pig n.d. n.d. n.d.
Ferret n.d. n.d n.d.
Rabbit ( 6 ) 0.95 10.16 10.9 13.2 627 1209
S erval (1 ) 0.41 4.1 494
Sooty m angabeyO ) 8.21 105.1 -
Dog n.d. n.d. n.d.
Fallow  deer n.d. n.d. n.d.
Leopard ( 1 ) 0.75 6.0 -
Sheep n.d. n.d. n.d.
Pig (1 ) 1.09 32.2 38640
H u m an ( 6 ) 2.05 1O.66 16.6 1 3.3 -
Results are mean i S.D.
Figures in parenthesis indicate the num ber of anim als in ea
experim ent. A ll determ inations were carried out in duplicate.
n.d. - not determined.
Table 24. SPECIES DIFFERENCES IN HEPATIC ALCOHOL
DEHYDROGENASE ACTIVITY
umoles Ethanol oxidised per m in per
Species mg m icrosom al 
protein
.g jiv e r . to ta l liver  
weight 
( * 103)
M ouse n.d. n.d. n.d.
Gerbil ( 2 ) 4.4 i 1.5 103 i4 6 0.2 1,0.1
H a m s te r  ( 6 ) 24.9 +14.7 648 i103 3.7 1 0.6
Rat (A ) 4.1 1O.8 107 1 3 0 1.1 1 0.3
Guinea pig ( 3 ) 5.9 i  1.7 155 i  27 • 2.0 1 0.3
Ferret n.d. n.d. n.d.
Rabbit n.d. n.d. n.d.
S erva l (1 ) 3.7 42 5.1
Sooty mangabey n.d. n.d. n.d.
D o g ( 2 ) 19.1 i  7.2 243 126 84.9 19.2
Fallow  deer ( 1) 7.4 193 36.7
Leopard (1 ) 7.7 77 -
Sheep (2 ) 10.9 1 1.3 185 i2 5 116.5 115.8
Pig ( 3 ) 22.6 i3.8 682 i116 818.0 1139.6
H u m an n.d. n.d. n.d.
Results  are mean t S.D.
Figures in parenthesis indicate the num ber of anim als in each 
experim en t. A ll determ inations w ere  carried out in duplicate, 
n.d. = not determ ined.
Table 25. SPECIES DIFFERENCES IN ANILINF BINDING TO
W ASHED HEPATIC MICROSOMES (TYPE 2 B IN D IN G )
A niline binding kinetics
S pecies
M ouse (3 )
Gerbil ( 3 )
H a m s te r  (3 )
Rat (5 )
Guinea pig (1 ) 
Ferret (3 )
Rabbit (6 )
S erval (1 )
Sooty m angabeyO ) 
Dog ( 2)
Fallow  deer (1) 
Leopard (1)
S heep(A )
Pig (2 )
H u m an  (A)
J<S-
( m M )
1.86 10.01 
1.02 10.10 
1.71 10.09
1.80 10.26 
1.60 
2.32 10.42
3.38 10.52 
2 .2 5 1 
.2
2.67 i0 .5 8  
2.05  
1.60
1.98 10.82
3.70 10.00
2.46 10.61
n-2
-^m ax-
(AO.D.*10 /nmole cyt. R j-q)
1.47 i0.11
1.51 10.23
1.55 10.62
1.23 10.26
1.24
3.48 10.37
2.42 i0 .77
0 .6 4 1 
.2
2.74 10.03
2 .80
4 .2 0
1.64 10.17
2.88 10.11
2.27 10.62
Results are mean i S.D.
Figures in parenthesis indicate- the num ber of anim als in each 
experim ent.
unusual binding spectra produced see fig  13 
2 - unusual binding spectra produced see fig 15
Table 26. SPECIES DIFFERENCES IN HEX0BARB1TAL BINDING
TO W ASHED HEPATIC MICROSOMES (TYPE 1 B INDING  )
Hexobarbital binding kinetics
S pecies J<s~ A m ax_
(m M ) ( A *10 /n m o le  cyt. I ^ q )
Mouse (3 ) 0.37 t 0 11 0.A7 ; 0.08
Gerbil ( A) 0.17 : 0.05 0.68 *0.12
H a m ste r (3 ) 0,10 ♦ 0.01 0.66 ♦ 0.10
Rat (3 ) 0.12 10.01 1.56 ♦0 .62
Guinea pig ( 3) 0 .29 .*0.03 0.88 .* 0. 26
Ferret (2 ) 0.13 10.02 0.A8 i  0.001
Rabbit (6 ) 0 .38  10.17 1.A8 ♦0.79 -
Serval n.d. n .d . 
.1
Sooty m angabeyO ) .1
D o g ( 2 ) . 2 .2
Fallow  deer (1 ) 0 .09 0.63
Leopard n.d. n.d.
S h eep(3 ) 0.28 .♦ 0,09 1.A2 i  0.35
Pig (2 ) 0.20 .♦ 0.08 2 00 10.28
H um an (A ) 0.39 * 0.08 1 A3 ♦0 .26
Results are m ean ♦ S.D.
Figures in parenthesis indicate the number of anim als in each 
experim ent.
-unusual binding spectra produced see fig 16
j
L - n o  binding spectrum  w as produced w ith  dog m icrosom es.
iu u ic  * ./, m L  r\c.LMi iwiNon i r  d l  I YVtitiIN OUUT W b l O H I  A N U  UK Ut j
METABOLISING ACTIVITY IN  VITRO
X K
K X  K
g liv e r nmole cyt, %
-0 .6A 6
-0 .3 3 6 (n s )
-0 .5A 2 0 268 (ns)
Enzvm e a c tiv ity  Correlation coefficient for the relationship
hetween body weiaht (loa) and enzyme
a c tiv ity  (log) per
ma microsomal protein
Cytochrome R ^ q (153-
♦ hum an -0 .635
-h u m an  -0.689
Cytochrome b^ (15) -0 3 7 0
Ethylmorphine N-demethylase(15)
♦ human -0 .510“
-h u m an  -0 .6 5 5 “ “
NADPH cytochrome c reductase (15)-O.A19(ns)
Biphenyl 2-hydr0xylase (15) -0 .7 0 6 “ “
Biphenyl 3 - hydroxylase (1 A)
♦hum an -0-573
hum an -0 .6 9 2 ““
Biphenyl A-hydroxylase (15) «
♦ hum an -0 .638
-hu m an  -0 .7A 7“ “
Total biphenyl hydroxyiase (15)
♦ hum an -0 .6 9 5 “ “
-h u m an  -0 .7 9 6 * ““
Ethoxyresdrufin 0-deethylase (15)-0.178(ns.)
Benzo(a)pyrene hydroxylase (12) 0.095 (ns.)
UDPGA transferase (9) -0 .003(ns)
Alcohol dehydrogenase (10) 0 .355  (n.s.)
0.351 (ns.)
0 .670“ “ 0.0A6 (ns)
■0.528
•0.616'
0 218 (ns)
•0.622“ 0.278(ns)
•0.707“ “
0 .670“ “ 0.13 A (ns)
0 .736“ “
0.325(ns)
0.172(ns)
0.153(n.s)
0.236 (ns.)
Binding kinetics  
A n ilin e  Ks (13)
m ax (13)
Hexobarbital Ks (11) 
A m a x  ^
0 .5 0 0  (n s )
0 .6 9 0 “’' 
0.131 (ns.) 
0 535 (ns.)
Figures in parenthesis indicates the sam ple number. 
PC0.001; “ * P <0.01; “P <0.05;X  X  X
Table 28. SPECIES VARIATION IN VITRO IN THE 
COMPONENTS OF THE DRUG METABOLISING
SYSTEM
Varia tion  Between the
A c tiv ity expressed per
ComDonment mn microsomal g liver nmole
protein -PA5C
Cytochrom e P^cn 9.9 18. A
Cytochrome b^ 6.8 9.9
Ethylm orphine N-dem ethylase A8.0 63.0 9.2
NADPH cytochrome c reductase 7.7 1 A.O
UDPGA transferase 20.0 25.5
Biphenyl A-hydroxylase 60.8 176 .8 33.6
Biphenyl 3-hydroxylase 13.7 13.1 11.6
Biphenyl 2-hydroxylase 13. A 1 5 . 5 8.6
Ethoxyresorufin O-deethylase 20.0 A5.7
Benzo(a)pyrene hydroxylase 20.0 1 3 . 5 22.1
Alcohol dehydrogenase 6.7 16.3
A n ilin e -cy to ch ro m e Ben binding kinetics
Ks 3.6
A fn ax 3. A
Hexobarbital-cytochrom e 1^50 binding kinetics
Ks A.3
^ m a x A.2
fold difference between the lowest and highest value.
lUUie £.C7. iu rm tz .L M  I iu in  u r  ^ r n u t : ^  U lU -h K h lN U i^  FIN M IL K U b U M A L
MIXED FUNCTION OXIDASE SYSTEM USING THE SPEARMAN 
RANK CORRELATION COEFFICIENT (Rc )
Enzym e Act ivi ty
EthvlmorDhine N-demethvlase versus
_Bs_ Sianifica
biphenyl A-hydroxylase 0.81 < 0.01
biphenyl 3- hydroxylase 0.73 < 0.01
biphenyl 2 - hydroxylase 0.42 n.s.
ethoxyresorufin O-deethylase 0.12 n.s.
benzo(a)pyrene hydroxylase 0.29 n.s.
NADPH cytochrome c reductase 0.55 <0.05
cytochrome P450 0.73 < 0.01
cytochrome b 0.21 n.s.
spectral binding of cytochrome ^ 50w ith  aniline
A m ax -0-5] <0 .05
Ks -0 .28 n.s.
spectral binding of cytochrome ^ p w ith  hexobarbital
A m a x  -0.24 n.s.
Ks 0.21 n.s.
Biphenyl 4 -hydroxylase versus>
biphenyl 3 -hydroxylase 0.80 < 0.01
biphenyl 2 -hydroxylase 0.57 < 0.01
ethoxyresorufin O-deethylase 0.07 n.s.
benzo(a)pyrene hydroxylase 0.38 n.s.
NADPH cytochrome c reductase 0.69 < 0.01
cytochrome P ^ q 0.71 < 0.01
cytochrome be 0.40 n.s.
spectral binding of cytochrome ^59 with aniline
A m a x -0.52 <0.05
^s - 0.18 n.s.
spectral binding of cytochrome with hexobarbital
A m ax - 0.12 n.s.
Ks 0.12 n.s.
continued
tmzyrne m c i i v u y
B iphenyl 3-hydroxylase versus:- 
biphenyl 2 - hydroxylase 
ethoxyresorufin O-deethylase  
benzo(a)pyrene hydroxylase 
NADPH-cytochrome c reductase 
cytochrome P450 
cytochrome
spectral binding of cytochrome
spectral binding of cytochrome *450
Biphenyl 2-hvdroxvlase versus:- 
ethoxyresorufin O-deethylase 
benzo(a)pyrene hydroxylase 
NADPH-cytochrome c reductase 
cytochrome P^^q 
cytochrome b^
spectral binding of cytochrome
benzo(a)pyrene hydroxylase 
NADPH-cytochrome c reductase
450
J2s- iiqnincunce i
0.72 <0.01
0.12 n.s.
0.59 <0.05
0.53 <0.05
0.58 <0.05
0.07 n.s.
.w ith  aniline
Amax "0-64 <0.05
Ks - 0.44 n.s.
. with hexobarbital
Amax ‘ 0-36 n.s.
Ks -0.26 n.s.
0.46 <0.05
0.23 n.s.
0.28 n.s.
0.41 n.s.
0.07 n.s.
-.with aniline
Amax "0-40 n.s
Ks -0 .52 n.s.
■.with hexobarbital
Amax -0.62 <0.05
Ks -0.21 n.s.
-0.39 n.s.
-0-34 n.s.
-0.24 n.s.
-0 .25 n.s.
cytochrome 
cytpchrome
spectral binding of cytochrome PcnWith aniline
A m a x  0-07
K s -0 .16
spectral binding of cytochrome ^ g W ith  hexobarbital
A max
K.
- 0 . 5 9
- 0 . 2 7
n.s.
n.s.
< 0 .0 5
n.s.
continued
En zy m e  Act iv i ty Rc SignificoncelP)
NADPH-cytochrome c reductase 0.58 < 0 .0 5
cytochrome P ^ g 0.23 n.s.
cytochrome b^ 0 .2 5 n.s.
spectral binding of cytochrome Prn with aniline
A max 0.10 n.s.
Ks 0.06 n.s.
spectral binding of cytochrome Pcgwith hexobarbital
Am ax 0.01 n.s.
Ks 0.75 < 0 .0 5
NADPH-cvtochrome c reductase versus
cytochrome P ^ g 0.85 <0.01
cytochrome br 0.81 <0.01
spectral binding of cytochrome P -n w ith aniline
A mQX -0.31 n.s.
Ks -0 .2 8 n.s.
spectral binding of cytochrome P/cg w ith hexobarbital
A m ax 0.04 n.s.
Ks 0.33 n.s.
Cytochrome F^rg versus
< 0 .0 1cytochrome be 0.70
spectral binding of cytochrome R ™  w ith aniline
< 0 .0 5Am ax -0 .5 5
Ks - 0 .4 0 n.s.
spectral binding of cytochrome P450 Aw ith  
A max
hexobarbital 
-0 .25  n.s.
Ks 0.21 n.s.
Cytochrome br versus:-
spectral binding of cytochrome B rn with aniline
Am ax -0.24 n.s.
Ks -0.12 n.s.
spectral binding of cytochrome B cq with hexibarbital
A m ax 0.01 n.s.
Ks 0.01 n.s.
Aniline versus hexobarbital spectral binding wi th  cytochrome - A  50
Am ax 0-36 n.s.
K 0.31 n.s.
5) SPECIES DIFFERENCE IN  CEIiS HfilABDLISU JLN 3U3ZQ
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Studies on drug metabolism in vitro have sh n 
that for certain xenobiotics the rate of metabolism 
when expressed per mg microsomal protein or per g 
liver was inversely correlated with body weight 
(log:log p l ot). The present study was carried out 
to determine whether the same relationship exists 
in vivo. Two enzymes, aminopyrine N-demethylase 
and biphenyl 4-hydroxylase, were studied. Biphenyl 
4-hydroxylase and another N-demethylase, 
ethylmorphine N-demethylase, both showed an inverse 
relationship with body weight in vitro (section 4). 
Aminopyrine N-demethylase activity was measured in 
the mouse, rat (Wistar albino), gerbil, hamster, 
guinea-pig, ferret and rabbit. Biphenyl 
4-hydroxylase activity was measured in all the 
above species except the gerbil. Male young adult 
animals were used througout.
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EXPERIMENTAL
Biphenyl 4-hydroxylation
In vivo biphenyl metabolism was studied after 
oral gastric gavage administration in the mouse, 
hamster, rat (Wistar albino), ferret and rabbit; 
and after intravenous administration to the rat 
(Wistar albino), guinea-pig and ferret. A suitably 
sensitive assay for measuring biphenyl in plasma 
samples was not found hence biphenyl metabolism was 
determined from the production of biphenyl 
metabolites . Preliminary studies in the rat and 
rabbit showed that no unconjugated hydroxybiphenyl 
was detectable in the plasma at any time point 
studied (limit of detection.approximately; lng of 
4-hydroxybiphenyl, and 5ng of 2- and
3-hydroxybiphenyl). Hence the hydroxybiphenyl 
levels were determined after acid hydrolysis of the 
plasma samples (see section 2). 2- and
3-Hydroxybiphenyls were not detected in the plasma 
from any species. Hydrolysis of 2-, 3- and
4-hydroxybiphenyl standards did not cause any loss 
of these metabolies hence the lack of 2- and 3- 
hydroxybiphenyl in the plasma was not due to loss 
during hydrolysis. Biphenyl metabolism in vivo was 
therefore, estimated from the plasma 
4-hydroxybiphenyl levels. The total 
4-hydroxybiphenyl production per ml plasma was 
determined by plotting the plasma 4-hydroxybiphenyl
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levels against time and measuring the area under 
the curve using the trapezoid method (as described 
by Clarke and Smith, 1981). Plasma samples were 
not collected for the same length of time for all 
animal species due to the early deaths of some 
animals from the anaesthetic. The anaesthetic 
used, urethane, causes respiratory distress in some 
animals and death occurs if the animals are not 
linked to a respirator. Urethane does not affect 
the hepatic drug metabolising activity directly but 
it is possible that the respiratory distress 
affected the oxygen supply to the tissues.
However, no marked differences in the rate of 
4-hydroxybiphenyl production was seen in the 
animals who died early when compared to those who 
survived for longer periods.
Because of the different periods for which the 
plasma samples were collected the area under the 
curve was calculated up to the maximum period 
common to all species. This allowed the comparison 
of the results from one species to another. The 
maximum period after oral administration of 
biphenyl was 120min and after intravenous 
administration was 50min. The peak plasma level, 
time of peak plasma level and initial rate of 
4-hydroxybiphenyl production (initial slope of the 
curve) were obtained from the graph of the 
plasma 4-hydroxybiphenyl levels versus time.
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Aminopyrine N-demethylase activity iji vivo was 
determined by injecting [^C-dimethyl] aminopyrine 
intraperitoneally and measuring the rate of 
expired as described in section 2. The time of the
1 4  _ _
peaK CC>2 expiration was determined from the plot 
of (DPM)/0.375 mmole CO 2  expired versus time.
The decline in expiration was plotted
semi-logarithmically to obtain a straight line from 
which the half-life for the decline was determined. 
As a constant volume of expired CO 2 was collected 
species differences in the ventillation rate did 
not have to be accounted for. The half-life (t^/2 ) 
for the decline in ^ C C >2 expiration gives a measure 
of the rate of demthylation of aminopyrine, the 
longer the half-life the slower the rate of 
demethylation.‘
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Elsiisnyl 4-Hydroxylation
The graphs of the mean plasma 
4-hydroxybiphenyl levels versus time after oral 
and, where relevant, intravenous administration of 
biphenyl in the six species studied are shown in 
figs 17-22. The peak plasma level, time of peak 
plasma level, initial rate of and total 
4-hydroxybiphenyl production in the different 
species after oral and intravenous biphenyl 
administration are given in tables 30 and 31 
respectively. To account for the species 
differences in liver/body weight ratio the results 
for each species were divided by this ratio (the 
ratios were determined from the In vitro studies, 
see table 11 section 4). The corrected results 
were expressed as a percentage of the rat value.
The total 4-hydroxybiphenyl production (after 120 
or 50 min) was determined in the different species 
because a) it is a more accurately determined value 
than the initial rate which is determined by the 
gradient method; and b) it gives an indication of 
the short term bioavailability of the compound. 
Complete bioavailability could not be determined as 
blood collections were not continued till the 
4-hydroxybiphenyl levels had returned to zero in 
all species.
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After oral administration of biphenyl the rate 
of 4-hydroxybiphenyl production determined from the 
plasma levels depends on the rate of absorption of 
biphenyl from the gut as well as on the rate of 
metabolism. In the rat and ferret, in which 
4-hydroxybiphenyl production was measured after 
both oral and intravenous administration of 
biphenyl, the effect of absorption on the rate of 
4-hydroxybiphenyl production was determined. The 
area under the curve up to the peak plasma level 
was determined after intravenous biphenyl (in the 
case of the rat the peak plasma level was taken as 
the last determined) and compared to the area under 
the curve for the same period of time after oral 
biphenyl administration. It can be seen (table 32) 
that 4-hydroxbiphenyl production after oral 
biphenyl as a percentage of the value after 
intravenous administration of biphenyl was similar 
in the ferret and rat suggesting a similar rate of 
absorption in both species. This is also suggested 
by the fact that both the total and initial rate of 
4-hydroxybiphenyl production in the ferret as a 
percentage of 'that in the rat was similar after 
both intravenous and oral biphenyl administration 
(10-15%).
As so few species were studied either after 
oral or intravenous administration of biphenyl, for 
the study of the relationship between biphenyl 
metabolism in vivo and body weight of the animal
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biphenyl administration were, combined and plotted 
against body weight (log/log plot). To enable the 
results to be combined they were expressed as a 
percentage of the rat value. Figs 23 + 24 show the 
relationship between body weight and initial rate 
and total production of 4-hydroxybiphenyl corrected 
for liver:body weight ratio. It can be seen from 
these graphs that the rate of 4-hydroxybiphenyl 
production was significantly inversely related to 
body weight only when the results from the mouse 
are excluded. The rate of 4-hydroxybiphenyl 
production after oral biphenyl administration was 
very low in the mouse compared to the rat and 
hamster. This low value may be due to poor 
absorption of biphenyl since in the mouse there was 
a delay of approximately 40 mins before the plasma 
levels of 4-hydroxybiphenyl began to rise 
appreciably compared to a delay of less tha 10 mins 
in other species. 4-Hydroxybiphenyl production 
after intravenous administration of biphenyl 
unfortunately was not determined in the mouse.
For some animals blood collections were 
terminated early due to death of the animal (from 
the anaesthetic) and the peak plasma levels of 
4-hydroxybiphenyl were not seen. However, in those 
animals where a peak in the 4-hydroxybiphenyl level 
was seen there was no relationship between the peak 
plasma level nor the time of the peak plasma level
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production (as determined from the total and the 
initial rate of 4-hydroxyt>iphenyl production) .
Aminopyrine N-Demethylation
The time of the peak 14C02 expiration and the 
half life (tl/2) for the decline in ^ 4C02 
expiration for the seven animal species are shown 
in table 33. The graphs of the decline in 14C02 
expiration for each species are shown in figs 
25-31. The time of the peak 14C02 expiration did 
not closely parallel the tl/2 value. To account 
for the species differences in liver/body weight 
ratio the tl/2 was divided by the ratio for that 
species. When the logarithm of the tl/2 values 
were plotted against the logarithm of the body 
weight for each species there was a significant 
positive relationship between the two parameters 
(r=0.848; P<0.01) (fig.32). Since the tl/2 values 
are inversely related to the rate of 
N-demethylation the results show that the in vivo 
aminopyrine N-demethylase activity is inversely 
related to body weight. Although there was a 
general relationship between N-demethylase activity 
and body weight, individual species were found to 
deviate from the general trend. The activity in 
the hamster was lower and that in the ferret higher 
than expected from the general trend. This 
individual deviation from the general trend was
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the in vitro metaoolism.
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Biphenyl Ar.hy droxy 1 ati^n
Plasma metabolities of biphenyl
Biphenyl metabolism in vivo was determined as 
the rate of 4-hydroxybiphenyl production since no
2- or 3-hydroxybiphenyl was detected in the plasma 
of any of the six species studied. Most of the in 
vivo studies on biphenyl metabolism reported in the 
literature have measured the urinary excretion of 
biphenyl and its metabolites. In these studies all 
three hydroxybiphenyls and also some di- and 
trihydroxy metabolites were detected (Meyer and 
Scheline, 1976; Meyer et al., 1976b; Meyer, 1977; 
Halpaap et al., 1978). In the four animal species 
studied (rat, guinea-pig, rabbit and pig) the 
4-hydroxybiphenyl excretion was 10-60 times greater 
than that of the 2- and 3-hydroxybiphenyl. As the 
urinary metabolite profile closely mirrors the 
plasma profile these results indicate that the 
absence of the 2- and 3-hydroxybiphenyl in the 
plasma samples in the present study was due to them 
occurring at concentrations below the limit of 
detection.
No free 4-hydroxybiphenyl was detected in the 
plasma of the rat or rabbit at any time after 
biphenyl was administered orally. This was either
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due to complete and rapid conjugation or that the 
levels of the unconjugated metabolite were below 
the limit of detection. If true the latter would 
indicate that the majority of the 4-hydroxybiphenyl 
is excreted in the conjugated form. Literature 
data on the conjugation of biphenyl metabolites in 
vivo are conflicting. Meyer and co workers found 
that in the guinea pig, rat, rabbit and pig less 
than 6% of the total 4-hydroxybiphenyl excreted in 
the urine was in the unconjugated form (Meyer and 
Scheline, 1976; Meyer et al., 1976b; Meyer, 1977). 
Conversely other workers have found the level of 
unconjugated 4-hydroxybiphenyl to be 12-76%.
(Meyer et al., 1976a; Halpaap et al., 1978).
The biphenyl dose was given on a body weight 
basis and the results were expressed per ml plasma. 
This assumes that the ratio of plasma volume to 
body weight is constant for all species. Bischoff 
et al. (1971) did find a constant relationship with 
body weight. But Dreyer and Ray (1910; 1911; 
quoted by Mellet, 1969) found a constant 
relationship with body surface area but not with 
body weight. These authors found that the smaller 
animals have a larger blood volume relative to body 
weight. Hence the rate of 4-hydroxybiphenyl 
production determined from the 4-hydroxybiphenyl 
concentration per ml plasma may be lower than the 
true rate in the smaller animals and hence the 
species differences in biphenyl 4-hydroxylase
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activity in vivo may be greater than reported in 
the present study.
Factors affecting plasma 4-hydroxybiphenyl levels
After an oral dose of a compound plasma levels 
of the metabolites are often dependant on factors 
other than the rate of metabolism. These factors 
include:-
a) Rate and extent of absorption from the gut. In 
two animal species (ferret and wistar albino rat) 
4-hydroxybiphenyl production was determined after 
both oral and intravenous administration of 
biphenyl hence the rate of absorption of biphenyl 
could be determined. The rate was similar for both 
species. For the other species differences in the 
rate of absorption could not be determined.
However, there was no apparent delay between 
biphenyl administration and the appearance of 
4-hydroxybiphenyl in the plasma in any of the 
species studied apart from the mouse, suggesting a 
fairly rapid rate of absorption in these species. 
Biphenyl is highly fat soluble and therefore would 
be expected to be rapidly and completely absorbed. 
Literature data suggests that biphenyl is well 
absorbed in the rat, rabbit and pig (Meyer and
Scheline, 1976; Meyer, 1977; Meyer et al., 1976).
However, in the guinea pig 14% of the dose was
excreted in the faeces as biphenyl. This
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constituted unabsorbed Diphenyl as no biliary 
excretion of biphenyl was seen (Meyer, 1977) . In 
the present study Diphenyl was given orally to two 
guinea pigs but no metabolites were seen in the 
plasma of either animal. 4-Hydroxybiphenyl was 
seen in the plasma of guinea pigs after intravenous 
administration (at l/10th the oral dose) hence 
unless gastric absorption of biphenyl in the guinea 
pig is very slow (plasma collections were made up 
to 60 min after the biphenyl dose) the reason for 
the lack of biphenyl metabolites in the guinea pig 
after oral dosing is not known.
b) Tissue uptake and rate of excretion. Tissue 
uptake of biphenyl and its metabolites appears to
i
be negligible. Meyer et al. (1976a) using 
l^C-labelled biphenyl found less than 1% of the 
Diphenyl dose in the body tissues of the rat after 
96 hours. Excretion of biphenyl and its 
metabolites can occur via two routes:-biliary and 
urinary. Literature data suggests that biliary 
excretion of Diphenyl and its metabolites varies 
between species being greater in the smaller 
species (Meyer et al., 1976b; Meyer, 1977; Meyer 
and Scheline, 1976a) (Similar species differences 
in biliary excretion is also seen with 
chloramphenicol, Glazko, 1965) . These species 
differences in biliary excretion would result in 
lower plasma levels of Diphenyl metabolites in the 
smaller animals.
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Urinary excretion of biphenyl metabolites does 
not appear to vary greatly between animals species. 
Meyer and coworkers found the urinary excretion of 
biphenyl metabolites to be between 22-31% of the 
dose in all 4 species studied (Meyer and Scheline 
1976, Meyer et al., 1976b, Meyer 1977).
c) Further metabolism of 4-hydroxybiphenyl. The 
mono-hydroxy metabolites of biphenyl are known to 
be further metabolised to a number of dihydroxy, 
trihydroxy, methoxy-monohydroxy and 
methoxy-dihydroxy metabolites (Meyer and Scheline, 
1976) . A diagram of the possible pathways of 
biphenyl metabolism is shown in fig 33 . 
4-Hydroxybiphenyl is further metabolised to 
3,4-dihydroxy-, 4 , 4 '-dihydroxy-,
3 ,4,4'-trihydroxy-, 3-methoxy-4-hydroxy- and
3-methoxy-4,4'-dihydroxybiphenyl. Most of these 
metabolites have been found in the urine from the 
rat, mouse, guinea pig , rabbit and pig;
4 , 4 '-dihydroxybiphenyl is a major metabolite being 
second only to 4-hydroxybiphenyl in most species 
(Meyer and Scheline, 1976; Halpaan et al., 1978; 
1981a, 1981b; Meyer, 1977; Meyer et al., 1976b).
The extent of the further metabolism of
4-hydroxybiphenyl varied with the different 
species, being greater in the mouse and rat than in 
the other species. This would again tend to reduce 
the plasma levels of 4-hydroxybiphenyl in the
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smaller species.
Hence species differences in the i n  vivo biphenyl 
4-hydroxylase activity can only be estimated from 
the present results. When the experiment was 
carried out it was hoped that the plasma levels of 
biphenyl would be determined in addition to the 
4-hydroxybiphenyl levels, since the rate of 
disappearance .of biphenyl is indepedendant of the 
rate of absorption and of the rate of excretion 
(very little biphenyl was excreted in the bile or 
urine in the studies by Meyer and coworkers). 
However, in the time available a suitable method, 
fluorescence nor HPLC, could not be developed which 
would accurately measure biphenyl extracted from 
plasma. However, the plasma levels of 
4-hydroxybiphenyl do show that the production of 
this metabolite of biphenyl was much greater in the 
rat than in the rabbit and ferret, and that the 
4-hydroxybiphenyl production, either as the total 
(after 120 or 50 min) or the initial rate, was 
inversely related to body weight. The exception in 
this was the mouse which had a much lower rate of 
4-hydroxybiphenyl production than the rat or 
hamster.
Although the i n  vivo metabolism of biphenyl is 
due to the activity of the mixed function oxidases 
of a number of the body tissues, the liver is the 
major site of biphenyl hydroxylation (Litterst et
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al., 1975; Chhabra et al., 1974). Hence, because 
the biphenyl dose was given on a body weight basis 
and the ratio of liver to body weight is not 
constant in all species the results were corrected 
for the differences in the ratio.
Comparison of biphenyl 4-hydroxylase activity in 
vivo and in vitro
The jja vivo results followed quite closely the 
in vitro species differences in biphenyl 
4-hydroxylase activity (see table 18, section 4). 
The mouse also had a low activity in vitro 
(approximately 50% of the rat value when expressed 
per g liver) hence the low activity in vivo may be 
due to poor metabolism rather than poor absorption. 
But since the activity of the mouse is very low 
(approximately 2 0 % that of the rat) and that a 
delay in the appearance of 4-hydroxybiphenyl in the 
plasma occurred after oral administration in the 
mouse it is suggested that the low
4-hydroxybiphenyl production in this species is due 
to a combination of poor absorption and poor 
metabolism. Further studies determining the rate 
of 4-hydroxybiphenyl production after intravenous 
administration of biphenyl in the mouse are 
required. Most other species studied showed a 
similar pattern of activity in vivo and in vitro: 
the activity in the rat being half that in the 
hamster and approximately 5-fold in the ferret in
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ootn studies, however, tne rabbit naa tne lowest 
activity in vivo whereas in vitro this species had 
an activity twice that of the ferret. Also the 
activity in the guinea pig was lower(compared to 
the other species) in vivo than in vitro. The 
activity in vivo was determined after intravenous 
administration of biphenyl and hence the low 
activity can not be accounted for by poor 
absorption, in vitro the magnitude of the species 
differences was approximetely 9 -fold (when 
expressed per g liver) . This compared to a 12.5-to 1.7- 
fold difference in vivo (results corrected for 
differences in liver: body weight), and this 
difference may be an underestimation due to species 
differences in the plasma volume: body weight 
ratio, biliary excretion of, and : further 
metabolism of 4-hydroxybiphenyl.
Possible reasons for the greater species 
differences in biphenyl 4-hydroxylation in vivo 
compared to in vitro include:-
1) Availability of cofactors; in vitro the 
cofactors NADP and glucose 6 -phosphate required for 
the reduction of cytochrome P 4 5 0  are added to the 
microsomal system and hence are not limiting.
However it is possible that in vivo these cofactors 
are limiting. Factors involved in energy 
metabolism such as NAD dehydrogenase and succinate 
dehydrogenase activities are known in mammals to
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decrease with increasing body weight (Krasovskii, 
1976) and the NAD/NADH ratio in guinea pigs is 2.5- 
fold lower than in the rat (Hanson, 1980), hence it 
is possible that NADPH availability is also 
inversely related to body weight resulting in lower 
mixed function oxidase activity in the larger 
animals An vivo.
2) Extrahepatic metabolism of biphenyl being 
greater in the smaller species. However, studies 
by Litterst et al (1975) and Chhabra et al. (1974) 
using microsomes from the kidney, lung and 
intestinal did not show the mouse, rat and hamster 
to have a greater biphenyl 4-hydroxylase activity 
than the guinea pig or rabbit.
3) Tissue binding of biphenyl being greater in the 
larger species.
4) Urinary excretion of 4-hydroxybiphenyl occuring 
at a faster rate in the larger species.
Further study is required to determine the 
importance of these factors in biphenyl
4-hydroxylation In vivo.
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Aminopyrine N-Demethylation
The major route of metabolism of aminopyrine 
in vivo is via N-demethylation to give
4-aminoantipyrine (fig 34) (Brodie and Axelrod, 
1950; Lauterberg and Bircher, 1976; Sultatos et 
al., 1978). The formaldehyde formed is excreted 
from the body mainly via the expired air as CO 2  (La 
Du et al., 1955). Formaldehyde is converted to CO 2  
via a number of steps (Waydhan et al., 1978). 
However, the initial demethylation process is the 
rate limiting step since the subsequent reactions 
involved occur at a much faster rate (Aebi et al., 
1963) . Needy (1964) showed that after giving 
4 C-formaldehyde intraperitoneally to rats 82% of 
the dose was found in the expired air. The rate of
^ C 0 2  exhalation after the administration of 
[^ •4C-dimethy] -aminopyrine has been used as a 
measure of the rate of demethylation of aminopyrine 
in vivo and has been shown to parallel the rate of 
plasma clearance of aminopyrine (Lauterberg and 
Bircher, 1976; Sultatos et al., 1978) and the rate 
of aminopyrine N-demethylation in vitro in isolated 
hepatocytes (Stewart and Inaba, 1979) . The major 
site of N-demethylation of aminopyrine in vivo is 
the liver (Lauterberg and Bircher, 1976) and the 
rate of ^ C C >2 exhalation after the administration 
of [^4C-dimethyl] aminopyrine has been shown to be 
a sensitive indicator of liver damage (Hepner and
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Vesell, 1974; Bircher et al., 1976; Galizzi et al., 
1978; Sultatos et al., 1978) and of induction of 
the mixed function oxidases by phenobarbital 
(Houston et al., 1981).
Hence the rate of ^ C 0 2 exhalation gives a 
good measure of the rates of N-demethylation in 
vivo. The tl/2 for the decline in 14C02 expiration 
has been suggested as the most sensitive indication 
of the rate of demethylation (Sultatos et al.,
1978; Wilson et al., 1979; Houston et al., 1981). 
This method is also independant of the rate of 
absorption and hence is not affected by species 
differences in absorption of the aminopyrine from 
the peritoneal cavity. That such differences do 
occur is suggested by the species differences in 
the time of peak ^ C 0 2 expiration. The peak in the
14 __
C02 expiration is dependant on the rate of both 
absorption and metabolism. Since the time of the 
peak did not parallel the rate of metabolism as 
determined from the tl/2 , suggests that species 
differences in the rate of absorption occurs. The 
hamster had a delayed peak suggesting a slow rate 
of absorption whereas the rabbit had an early peak 
compared to its rate of metabolism suggesting a 
fast rate of absorption.
In the present study urine collections were 
not made since Brodie and Axelrod (1950) found only 
3% of an aminopyrine dose and Needy (1964) found
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only ± ^ - u %  0 1  a lormaiaenyoe dose was excreted on 
the urine.
Houston et al. (1981) have shown that the • 
demethylation of aminopyrine occurs in two steps 
via the secondary amine monomethylaminoantipyrine. 
They showed that the second demethylation step, ie 
of the monomethylaminopyrine, has a longer 
half-life than the first demethylation of 
aminopyrine and to determine the rates of both 
demethylation steps requires CC>2 sampling for a 
period of 5-6 hours. In the present study CO 2  
sampling was carried out over a period of 2 hours a 
similar period to that used by Lauterberg and 
Bircher, (1976), Sultatos et al., (1978), Wilson et 
al.. (1979)]. Values obtained from this short 
period gives a composite of the two demethylation 
rates. Hence in the present study the species 
differences found relate to the overall rate of 
N-demethylation of aminopyrine.
The in vivo metabolism of aminopyrine appears 
to occur predominately in the liver. Lauterburg 
and Bircher (1976) found that rats with 2/3 of 
their liver removed had half the aminopyrine 
N-demethylase activity of normal rats suggesting 
that approximately 83% of the In vivo N-demethylase 
activity is due to hepatic metabolism. For this 
reason the results of the present study were 
corrected for species differences in the liver/body
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weight ratio. It was found that similarly to 
biphenyl 4-hydroxylase activity, aminopyrine 
N-demethylase activity decrease with increasing 
body weight.
Comparison of N-demethvlase activity in vivo and in 
vitro
Aminopyrine N-demethylase activity was not 
studied in vitro in the present study. Comparison 
of the results to literature data for the activity 
in vitro was difficult due to the conflicting 
results reported by different workers. Kato (1968) 
reported that the rate of aminopyrine 
N-demethylation in vitro was greater in the mouse 
being more than 3-fold that in the rat and 8-fold 
that in the rabbit. Quinn et al. (1958) found the 
activity in the mouse, rat, guinea pig, rabbit and 
dog decreased with increasing body weight.
Litterst et al. (1975) found the highest 
demethylase activity in the hamster and that of the 
rabbit was higher than the guinea pig. Similar 
differences in aminopyrine N-demethylase activity 
in the rabbit and guinea pig were reported by 
Oppelt et al. (1970) and Miranda et al. (1979) . A 
recent study by Poland et al. (1981) also found a 
high demethylase activity in the hamster but the 
activity in the rat was approximately half that in 
the guinea pig and mouse. Whereas in the present 
study a low activity was found in the hamster and
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When the species differences in aminopyrine 
N-demethylase activity in vivo are compared to the 
differences in ethylmorphine N-demethlase activity 
in vitro (see section 4) close similarities are 
seen (see table 34)• The major difference was seen 
in the gerbil which had a low ethylmorphine 
N-demethylase activity in vitro but a high 
aminopyrine N-demethylase activity in vivo. Also
the differences in N-demethylation in vivo were 
smaller than seen in vitro. The close similarity 
of the species differences of the two N-demethylase 
enzymes suggest that they are both controlled by 
similar factors.
The magnitude of the species differences in 
animopyrine N-demethylase activity in vivo 
( 4  -fold after correction for the differences in 
liver/body weight ratio) was less than that seen for 
ethylmorphine N-demethylase activity in vitro 
(5-fold). Species differences in vitro are likely 
to be greater than in vivo due to the fact that in 
vitro the studies were carried out at optimum 
conditions for the rat which may not be optimum for 
all species, whereas in vivo the conditions are 
optimum for each particular species studied.
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Both aminopyrine N-demethylase and biphenyl 
4-hydroxylase activities show an inverse 
relationship with body weight. For the biphenyl 
4-hydroxylase activity, however, the mouse only 
follows this relationship when the results are 
expressed per g liver. Whether the low activity in 
the mouse is due to poor metabolism or poor 
absorption is uncertain. For both enzymes the 
rabbit had a lower activity than the ferret. The 
magnitude of the species differences in biphenyl 
4-hydroxylase activity in vivo was far greater than 
in vitro. Whereas with aminopyrine N-demethylase 
the magnitude of the species differences was less than 
that seen with ethylmorphine N-demethylase activity 
in vitro. However, the species differences of both 
biphenyl 4-hydroxylase and aminopyrine 
N-demethylase activity In vivo paralleled quite 
closely the differences seen In vitro. Hence the 
species differences seen in vitro give a good 
indication of those which occur in vivo.
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Table 32. SPECIES DIFFFRFNCES IN THE BIOAVAILABILITY OF
BIPHENYL AFTER ORAL AND INTRAVENOUS ADMINISTRATION 
DETERMINED FROM THE PRODUCTION OF 4-HYDROBIPHENYL.
Time 4-Hvdroxvbiphenvl after Oral as %  
period Intravenous Oral Intravenous
S pecies (min) Biphenyl Biphenyl Value
(jug /  m l)
Rat (W/A) 70 159 73 46
Ferret 120 49 21 4 2
Table 3 3. SPECIES DIFFERENCES IN AMINOPYRINE
N-DEM ETHYLATION IN VIVO
Body t|. for the Decline in Time of Peak
S pecies Weight  ^ ^CC^ Expiration ^CCA Expiration
( g )  ( m in )  x liver/body weight (min)
ratio
Mouse ( 5 ) 37 18.1 ± 3.6 0.95 10.4 ±1.5
Gerbil ( 3 ) 63 20.9 i  3.9 0.77 11.5 ±1.5
Ham ster ( 6 ) 127 32.1 1 3.5 1.31 22.7 i + >0 OO
Rat (W/A) ( 5 ) 235 29.2 ± 6.7 1.30 11.8 ±1.3
Guinea pig(2) 308 43.3, 44.1 1.67 13 .1 , 19.5
Ferret (4 ) 2160 53.0 ±2.5 1.57 18.6 ±3.8
Rabbit ( 3) 2150 98.5 ±21.8 2 .9 6 10.5 ±0.6
Results  are m ean t S.D. except for the guinea pig.
Figures in parenthesis indicate the number of a n im a ls  in 
each experiment.
Table 34. SPECIES D IFFERENCES IN N -D E M E T H Y L A S E
A CTIV ITY IN VIVO A N D IN VITRO
In Vitro In Vivo
Species Ethylm orphine N- Am inopyrine N -
demethylase ac tiv itv demethvlase activitv
( 7 .  of ra t
x liver/bodv
value)
Mouse 123 161 137
Gerbil A 7 140 169
H am ster 7 7 91 99
Rat 100 100 100
Guinea pig 92 67 78
F e rre t 44 55 83
Rabbit 24 30 44
6) STRAIN DIFFERENCES JJJ HEPATIC DRDG METABOLISM Hj 
VITRO
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As well as species variations in the 
metabolism of xenobiotics, strain variations within 
a given species have been shown to occur. Morrow 
et al. (1949, 1950) have shown that ^ -glucuronidase 
activity varies between ten strains of mice. Rush 
et al. (1980) also found variations between three 
mice strains in cholesterol 7<*-hydroxylase activity 
in yjtiLO and cytochrome P 4 5 0  content (2 -fold 
difference) Gram et al. (1965) studed hepatic drug 
metabolism in six strains of rabbit and found marked 
differences in the rate of metabolism of a number 
of drugs An vitro. In some cases (eg hexobarbital, 
aminopyrine and amphetamine) the variation was more 
than 1 0 -fold. With such large strain variations 
the importance of the observed species differences 
in metabolism may be questionable.
To investigate the importance of strain 
differences in drug metabolism when compared to 
species differences, the in vitro activities of the 
components of the hepatic mixed function oxidase 
system were determined in four strains of rat, the 
Wistar albino, Lister black hooded, Zucker lean and 
Biorex rat. The Biorex rat has been bred.from the 
Wistar rat at Biorex Laboratories Ltd. All rats 
studied were male.
1-48
Table 35 shows the body weight, liver weight and 
microsomal protein concentration per g liver for 
the 4 strains of rat. The rats were all of similar 
age and weight although there was a significant 
difference between the body weights of the Biorex 
and Lister black hooded rats. This difference , 
however, was not seen in the liver weights due to 
the fact that the largest strain in terms of body 
weight, the Lister black hooded, had a 
significantly lower liver: body weight ratio 
compared to the other three strains. The 
microsomal protein concentration in the Biorex rat 
was also significantly lower than the Lister black 
hooded rat.
Cyt(?(?hc<?tn$ £ 450 and
Tables 36 and 37 show the hepatic microsomal 
content of the cytochromes P 4 5 0  and b^ respectively 
in the 4 strains of rat. When the cytochrome P 4 5 0  
content was expressed per mg microsomal protein the 
Biorex rat had significantly higher levels than the 
other 3 rat strains. However, this difference was 
not seen when the results were expressed per g 
liver.
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Similar results were found for cytochrome b^. 
When expressed per mg microsomal protein the 
cytochrome b^ content in the Biorex rat was 
significantly higher than the Lister black hooded 
and Zucker lean rats. But when the results were 
expressed per g liver this high level of cytochrome
in the Biorex rat was no longer seen, in fact it 
was significantly lower than the black hooded rat.
These differences in cytochrome concentrations 
when expressed per mg microsomal protein and per g 
liver are due mainly to strain differences in the 
microsomal protein concentrations. The Biorex rat 
had a significantly lower protein concentration per 
g liver than the Lister black hooded rat. The 
microsomal protein concentration of the Lister 
black hooded rat was also higher than the Wistar 
albino and Zucker rats but the difference did not 
reach significance. Hence when the results were 
expressed per g liver the Biorex levels were 
decreased and the Lister black hooded results were 
increased with respect to the other rats. When the 
results were expressed per total liver weight the 
Lister black hooded and the Wistar albino rats had 
the highest hepatic cytochrome levels.
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Ethylmorphine N-Demethylase Activity
Table 38 shows the hepatic ethylmorphine 
N-demethylase activity of the four rat strains. 
There was no significant difference in activity 
between the 4 strains when expressed per mg 
microsomal protein or per g liver. When expressed 
per total liver weight the Wistar albino rat had 
significantly higher levels than the Biorex and 
Lisher black hooded rats. When expressed per nmole 
cytochrome P 4 5 0  the activity of the Zucker lean rat 
was significantly higher than the Lister black 
hooded rat.
Biphenyl HydrpxyLa^g Activity
Biphenyl -2-hydroxylase activity;- when the 
activity was expressed per mg microsomal protein 
the black hooded rat had a significantly lower 
activity than the other 3 strains (see table 39) . 
The highest activity was found in the Biorex rat 
being significantly higher than both the Lister 
black hooded and the Zucker lean rats. When 
expressed per g liver and per total liver weight 
the difference between the Lister black hooded and 
the other three rat strains reduced slightly but 
was still significantly lower than the Biorex and 
Zucker lean rats. The results expressed per nmole 
cytochrome P 4 5 0  showed the same pattern of strain
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airrerences as wnen expressea per mg microsomal 
protein except for there being no significant 
difference between the Biorex and Zucker lean rats.
Biphenyl 3-hydroxylase activity:- this was only 
detected in the Zucker lean and Biorex rats.
3-Hydroxybiphenyl peaks were not detected when 
biphenyl was incubated with microsomes from Wistar 
albino and black hooded rats. Resolution between 
the 3- and-4-hydroxybiphenyl peaks was poor when 
samples from these 2 rat strains were measured. It 
is possible that the lack of 3-hydroxybiphenyl in 
these two rat strains is due to poor detection 
rather than poor metabolism to the
3-hydroxybiphenyl metabolism since Benford et al. 
(1980) found that Wistar rat microsomes when 
incubated with biphenyl produced 3-hydroxybiphenyl 
in addition to 2-and 4-hydroxybiphenyl.
In the studies on the Biorex and Zucker lean 
rats no significant differences were found between 
the two strains with respect to 3-hydroxybiphenyl 
production whether the results were expressed per 
mg microsomal protein, per g liver, per total body 
weight or per nmole cytochrome P450; however, the 
difference between the 2  rats were greater when 
expressed per mg microsomal protein (see table 40) .
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Bipheny1-4-hydroxylase activity:- when expressed 
per mg microsomal protein the Wistar albino and 
Biorex rats had significantly higher 4-hydroxylase 
activities than the Zucker lean and Lister black 
hooded rats (see table 41). However when the 
results are expressed per g liver the activity of 
the Zucker rat was significantly lower than the 
three other rat strains and there was no difference 
between the Lister black hooded and the Wistar 
albino and Biorex rats. The same pattern of 
results was seen when expressed per total liver 
weight. When expressed per nmole cytochrome P 4 5 0  
the results were similar to those per mg microsomal 
protein but with less variation (2.7-and 5.0- fold 
difference between the highest and lowest 
activities respectively).
Total biphenyl hydroxylation:- a similar pattern of 
strain differences was seen with total biphenyl 
hydroxylase activity as with biphenyl 4-hydroxylase 
(see table 42). This was expected since between 
70-95% of the total biphenyl hydroxylation was due 
to the activity of the 4-hydroxylase. The only 
exceptions were that when expressed per total liver 
weight there was no significant difference between 
the Zucker lean and Lister black-hooded rat, and 
when expressed per nmole cytochrome P 4 5 0  the only 
significant difference between the four strains was 
between the Wistar albino and Zucker lean rats.
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rnxs was aue tu une race tnac z nyaroxyoipnenyi 
production per total liver weight and per nmole 
cytochrome P 4 5 0  in the Zucker rat was much higher 
than in the Lister black hooded rat.
Ratio of 2-/4-hYdroxvbiphenvl production;- the 
results for the 4 rat strains are given in table 
43. It can be seen that there was more than a 
4-fold variation in the 2/4 hydroxybiphenyl ratio 
between the four rat strains. The Wistar albino 
and Biorex rats had the same ratio. But the ratio 
in the Zucker lean rat was more than twice, and in 
the Lister black hooded rat less than half the 
value in the Wistar and Biorex rats.
. Ethoxyresorufin O-Deethylase Activity
Table 44 shows the ethoxyresorufin 
O-deethylase activity in washed hepatic microsomes 
in the four strains of rat. When the activity was 
expressed per mg microsomal protein the Biorex rat 
had significantly higher deethylase activity than 
the other three rat strains. When the activity was 
expressed per g liver the Biorex rat continued to 
have the highest activity but was no longer 
significantly higher than the Wistar albino rat 
(this was due to a large standard deviation in the 
Biorex rat results rather than a decrease in the 
difference between the activities of the two rat 
strains). When expressed per total liver the
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pattern of results were the same as for the results 
per g liver,
Benzplajgyreng Hydroxylase Activity
Benzo(a)pyrene hydroxylase activity in the 
Lister black hooded rat was significantly higher 
(4-to 9-fold) than in the other three rat strains 
(see table 45). Significant differences also 
occurred between the Wistar albino and Zucker lean 
rats. These differences existed whether the 
activities were expressed per mg microsomal 
protein, per g liver or per total liver weight.
NADPH-Cytochrome c Reductase Activity
Table 46 shows the NADPH-cytochrome c activity 
in washed hepatic microsomes in the four strains of 
rat. When the activity was expressed per mg 
microsomal protein the Zucker lean rat had 
significantly lower activity than the other three 
rat strains. When expressed per g liver the Zucker 
lean rat continued to be significantly lower than 
the Wistar albino and Lister black hooded rat but 
not of the Biorex rat. The activity in the Lister 
black hooded rat was signficiantly higher than the 
other three rat strains when expressed per g liver. 
When expressed per total liver weight the results 
were similar to those per g liver. The high 
NADPH-cytochrome c reductase activity in the black
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hooded rat when expressed per g liver was due to 
the high microsomal protein concentration per g 
liver.
Aniline and Hexobarbital binding to microsomes
Table 47 shows the kinetic data for the 
binding of hexobarbital and aniline to washed 
hepatic microsomes in four strains of rat. With 
the aniline binding studies there was no 
significant difference in K between the fourb
strains. However, the A max was lower in the wistar 
albino rat than in the other three strains of rat 
out this difference only reached significance with 
the Zucker and black hooded rats.
With the hexobarbital binding studies there 
was no signficant difference in A _ a„ between the
luclX
four rat strains. But the Kg in the Wistar rat was 
higher than in the other three strains but this 
difference was only significant with the Zucker and 
Biorex rats.
UDPGA-transferase activity
Table 48 shows the UDPGA-transferase activity 
in washed hepatic microsomes in four strains of 
rat. When expressed per mg microsomal protein the 
black hooded rat has a significantly lower activity 
than the Wistar albino and Zucker rats. There were
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no otner differences oetween the rat strains. When 
expressed per g liver the activity in the black 
hooded rat was still significantly lower than the 
Zucker rat but no longer lower than the wistar 
albino rat.
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From the results it can be seen that there are 
considerable strain differences in the An vitro 
activity of a number of hepatic drug metabolising 
enzymes activities. These differences appeared to 
be greater when expressed per mg microsomal protein 
than when expressed per g liver. This was due in 
part to the differences in microsomal protein 
concentration between the four rat strains. The 
Biorex rat had a low microsomal protein 
concentration per g liver and hence the high 
cytochrome P 4 5 0  and bg content and high biphenyl
4-hydroxylase activity per mg microsomal protein 
seen in this rat strain were not seen when 
expressed per g liver. Conversely, the 
black-hooded rat had a high microsomal protein 
concentration per g liver and hence the low 
activities of biphenyl 2-and 4-hydroxylase and 
UDPGA transferase per mg microsomal protein were 
also not seen when expressed per g liver. However, 
when the activity in the Lister black hooded rat, 
expressed per mg microsomal protein, was similar to 
the other strains, e.g. NADPH-cytochrome c 
reductase, or higher, e.g. benzo(a)pyrene 
hydroxylase, then strain differences are greater 
when expressed per g liver. There was very little 
variation in liver weight between the four rat 
strains hence the enzymes activities expressed per 
total liver tended to parallel those per g liver.
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Tne role of cytochrome P 4 5 0  levels in the 
strain differences in enzyme activities is unclear. 
Strain differences in biphenyl 2-hydroxylase 
activity were similar whether expressed per mg 
microsomal protein or per nmole cytochrome £ 4 5 0 , 
but with biphenyl 4-hydroxylase activity the strain 
differences were decreased when expressed per nmole 
cytochrome £ 4 5 0 * Biphenyl 2-hydroxylase has been 
shown to be associated with cytochrome £ 4 4 3  and 
biphenyl 4-hydroxylase associated with cytochrome 
P 4 5 0  (Creaven and Parke, 1966; Parke and Rahman, 
1970; McPherson et al., 1974; Burke et al., 1977). 
In the present study biphenyl 4-hydroxylase but not 
biphenyl 2 -hydroxylase activity was correlated with 
cyctochrome P 4 5 0  levels (see table 29, section 4). 
Hence possibly the strain differences in biphenyl
4-hydroxylase activity were due to the differences 
in cytochrome P 4 5 0  levels. However, ethylmorphine 
N-demethylase activity, which was also correlated 
with cytochrome P 4 5 0  levels in the different 
species (see table 29), showed a greater strain 
difference when expressd per nmole cytochrome P 4 5 0  
than per mg microsomal protein.
As seen with the species differences, biphenyl 
2-hydroxylase and ethoxyresorufin O-deethylase 
activities showed similar strain differences, but 
benzo(a)pyrene hydroxylase activity, which has also 
been shown to be associated with cytochrome P 4 4 3
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(Atlas and Nebert, 1976) , showed a different 
pattern of strain differences.
Table 49 shows the extent of the variation 
between the four rat strains for the various 
parameters studied. It can be seen that the 
variation was greater when the results were 
expressed per mg microsomal protein than per g 
liver weight (except for benzo(a)pyrene hydroxylase 
and NADPH-cytochrome c reductase). This may be due 
to the fact that there were significant differences 
in the microsomal protein concentration per g liver 
but not in liver weight between the four rat 
strains. Strain variation occurred both in the 
phase 1  reactions (mixed function oxidation) and in 
the phase 2  reactions (e.g. glucuronidation).
There was a 2-fold variation in the cytochrome P 4 5 0  
levels (per mg microsomal protein) between the four 
rat strains. Similar results were found by Vainio 
a n d H i e t a n e n  (1974) (between the Wistar albino and 
Gunn rat) and by Greenspan and Baron (1981)
(between the spontaneously hypotensive rat and 
Wistar Kyoto rat). NADPH-cytochrome c reductase 
activity varied 2 .8 -fold between the four rat 
strains in the present study. Similar results were 
found by Gold and Windell (1975) between Fischer 
and Sprague-Dawely rats (2-fold) but both Vainio 
and Hietanen (1974) and Greenspan and Baron (1981) 
found no strain variation in reductase activity per 
mg protein. However, Greenspan and Baron (1981)
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did find the same strain variation m  ethylmorphine 
N-demethylase activity as found in the present 
study (1.4-fold) but they found no variation in 
ethoxyresorufin O-deethylase activity per mg 
protein whereas a 6 .6 -fold variation was found in 
the present study. Similarly Vainio and Hietanen 
(1974) found only a small variation (1.3-fold) in 
benzo(a)pyrene hydroxylase activity per mg protein 
between the Wistar albino and Gunn rat compared to 
the 9.5-fold variation found in the present study. 
Hence it appears that strain differences in the 
components of the mixed function oxidase system 
average approximately 2 -fold, with the exception of 
the biphenyl hydroxylases, ethoxyresorufin 
Ordeethylase and benzo(a)pyrene hydroxylase which 
showed much larger variations.
When expressed per g liver strain differences 
in enzyme activity ranged from 1 . 2  to 4 -fold with 
an average of 2.5-fold (excluding benzo(a)pyrene 
hydroxylase which has a very large strain variation 
which was not representative of the variation of 
the other enzymes). Species differences for the 
same parameters are shown in table 28, section 4. 
For different species the variation in enzyme 
activity was greater when expressed per g liver 
than per mg microsomal protein. When expressed per 
g liver the species differences.ranged from 
9.9^ to 176.8-fold with an average of 42.8-fold. With 
the cytochrome P 4 5 0 - substrate binding kinetics
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there was approximately a 4-fold difference between 
the species compared to a 2 -fold difference between 
the strains.
For many of the components of the mixed 
function oxidase system studied the Biorex rat had 
the highest and the Zucker lean and Lister black 
hooded the lower activities. The rat strain most 
similar to the Biorex rat was the Wistar albino 
rat. This was expected since the Biorex rat was 
bred from the Wistar albino rat.
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Strain differences in enzyme activity do not 
appear to be due to differences in any one 
component of the electron transport system 
associated with the mixed function oxidase. It is 
possible that the differences are due to a 
combination of these parameters.
Greater strain differences occurred when the 
results were expressed per mg microsomal protein 
than per g liver. The opposite was seen with 
species differences. The strain differences in the 
components of the mixed function oxidase system 
varied from 1.2- to 4.1-fold with an average of 
2.5-fold. This compared to species differences of 
9.9-to 176.8-fold with an average of 42.8-fold.
The cytochrome P ^ g - s u b s t r a t e  (aniline and 
hexobarbital) binding kinetics varied approximately 
2-fold between the rat strains compared to 
approximately 4-fold between the different species. 
Hence the importance of species differences in the 
cytochrome P ^ g - s u b s t r a t e  binding kinetics are 
questionable when strain differences are taken into 
account. However for the enzyme activities, strain 
differences are minimal compared to species 
differences and would not greatly alter the pattern 
of species differences seen.
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Table 49. STRAIN VARIATION IN VITRO IN THE
C O M P O N E N T S  OF THE DRUG METABOLISING
SYSTEM
Variation Between the 4 Rat Strains
A ctiv ity  expressed per
Com ponm ent me1 microsomal g liver
protein
Cytochrome P^cn 2.0 1.8
Cytochrome bg 1.8 1.5
Ethylmorphine N-demethylase 1.4 1.2
NADPH cytochrome c reductase 2.8 4.0
UDPGA transferase 3.4 2.4
Biphenyl 4-hydroxylase 5.0 2.9
Biphenyl 2-hydroxylase 9 .0 3.6
E thoxyresorufin O-deethylase 6 .6 3.8
Benzo(a)pyrene hydroxylase 9 .5 18.1
A n ilin e  - cytochrome ^450 binding kinetics
Ks 1.1
Hexobarbital-cytochrome F ^ q binding kinetics
Ks 2.2
A 1 AA m ax 1
 ^ - fold difference between the lowest and highest value.
7) STBAIiJ DIFFERENCES UJ DRDG METABOLISM JH VIVO
Strain differences in the mixed function 
oxidase system have been shown to occur is vitro 
(see section 6)• Literature data shows that strain 
differences also occur is vivo- Lush and Lovell 
(1978) found differences in hexobarbitone and 
phenobarbitone sleeping times in 15 different 
inbred strains of mice, however Graham et al.
(1981) did not find such differences when they 
repeated the work in three of the mice strains used 
by Lush and Lovell. Quinn, et al. (1958) found 
greater than a 2-fold variation in the biological 
half-life of antipyrine between 8 strains of female 
rats. Jori et al (1971) also observed a 2-fold 
difference in aminopyrine N-demethylase activity in 
vivo between the Sprague Dawley and Long Evans 
strains of female rats.
In the present study the is vivo activity of 
aminopyrine N-demethylase and biphenyl 
4-hydroxylase were determined in four strains of rat 
(Wistar albino, Zucker lean, Lister black hooded 
and Biorex) to determine the importance of strain 
differences when studying species differences in 
drug metabolism is vivo- Male young adult rats 
were used throughout the study.
165
In vivo biphenyl 4-hydroxylation was studied 
after oral (by gastric gavage) administration in 
four rat strains and after intravenous 
administration in three rat strains. Plasma 
4-hydroxybiphenyl levels were determined after acid 
hydrolysis by the method described in section 2.
As with the species differences study no 2-, or
3-hydroxybiphenyls were seen in the plasma from any 
four strains of rat. The possible reasons for the 
absence of these biphenyls are discussed in section 
5. Figs 35-38 show the mean plasma hydroxybiphenyl 
levels after oral and intravenous biphenyl 
administration in the four rat strains. The peak 
plasma level, time of peak plasma level, initial 
rate of 4-hydroxybiphenyl production were 
determined from the results of the individual 
animals. The total 4-hydroxybiphenyl production 
per ml of plasma in 120 mins after oral 
administration and in 50 mins after intravenous 
administration of biphenyl were also determined 
from the results of the individual animal by 
measuring the area under the curve using the 
trapezoid method. The results for the four rat 
strains after oral and intravenous administration 
of biphenyl are given in tables 50 and 51 
respectively. Table 52 gives the liver body weight 
ratio for the four rat strains determined
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rrom tne jlb vitro studies, it can be seen that tne 
ratio is not constant hence to correct for these 
differences the total (after 120 or 50 min) and the 
initial rate of 4-hydroxybiphenyl production were 
divided by the liver: body weight ratio and 
expressed as a percentage of the Wistar albino rat 
value.
With the Biorex rat after oral biphenyl and 
the Wistar albino and Lister black hooded rats 
, after intravenous biphenyl administration the blood 
collections were not continued for sufficient time 
(mainly due to death of the animal) to obtain the 
peak plasma levels.
After oral biphenyl the highest biphenyl 
4-hydroxylase activity was in the Lister black 
hooded rat and the lowest in the Biorex rat however 
the difference was only significant for the total 
4-hydroxybiphenyl production (in 120 min) after 
correction for the differences in liver: body 
weight ratio. After intravenous biphenyl 
administration the highest activity was also in 
Lister black hooded rat (after correction for 
liver:body weight ratio) when determined from the 
initial rate of 4-hydroxybiphenyl production. 
However, the total 4-hydroxybiphenyl production (in 
50 mins) was highest in the Wistar albino rat. The 
4-hydroxybiphenyl production in the Zucker lean rat 
was very low after intravenous biphenyl
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administration. Although the strain differences in 
the peak plasma (after oral biphenyl) paralleled 
the differences in the total and initial rate of 
4-hydroxybiphenyl production the time of the peak 
levels did not appear to bear any relation to the 
rate of metabolism. The variation in biphenyl 
4-hydroxylase activity between the four strains 
after oral biphenyl was approximately 2-fold. 
Variation between the Wistar albino, Zucker lean 
and Lister black hooded was 1.5- to 1.8-fold after oral 
biphenyl compared to 2.6-t.o.3.6-fold after intravenous 
biphenyl administration (results corrected for 
differences in liver:body weight ratio). One would 
expect greater strain variation after oral biphenyl 
than after intravenous biphenyl administration due 
to differences in absorption. Biphenyl was 
injected intravenously in a 10% corn-oil: saline 
(0.9%) emulsion and the variation in biphenyl 
metabolism after intravenous administration may 
have been due to poor homogeneity of the emulsion.
After orally administered biphenyl the plasma 
levels of 4-hydroxybiphenyl in the Lister black 
hooded rat showed an initial peak between 35-55 min 
and a larger peak at approximately 200 min after 
the biphenyl dose. A similar pattern of two peaks 
were seen with the Wistar albino and with 2 out of 
3 of the Zucker lean and Biorex rats. Two plasma 
peaks were also seen after intravenously 
administered biphenyl in the Wistar albino and
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Zucker lean rats. The time of the initial and 
smaller peak was approximately 33 min and 20 min 
after the Diphenyl dose in the Wistar albino and 
Zucker lean rats respectively. Hence the peak 
seen at approximately 25 mins after the 
intravenous biphenyl dose in the Lister black 
hooded rat was taken to be the initial peak. The 
experiment terminated after approximately 45 min 
due to death of the animals (death was due to the 
anaesthetic) and the second and major peak was not 
seen.
To determine strain differences in the 
absorption of biphenyl from the gut the 
bioavailability after oral and intravenous biphenyl 
administration was measured. The area under the 
curve after intravenous biphenyl was compared to 
the area under the curve for the same period after 
oral biphenyl administration for the Wistar albino, 
Zucker lean and Lister black hooded rats 
(intravenous studies were not carried out in the 
Biorex rat). The results are shown in table 53.
The 4-hydroxybiphenyl production after oral 
biphenyl as a percentage of that after intravenous 
biphenyl administration was similar in all three 
rat strains. The percentage was highest in the 
Zucker lean rat but this may be due to an 
abnormally low metabolism after intravenous 
biphenyl administration in this rat (see table 51) 
rather than a high rate of. absorption. The
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bioavailability after oral biphenyl as a % of that 
after intravenous biphenyl was approximately 15% 
higher in the Lister black hooded rat than in the 
Wistar rat. Also the initial rate after oral 
biphenyl as a percentage of that after intravenous 
biphenyl (accounting for the differences in dosage) 
in the Lister black hooded rat was approximately 
20% higher than in the Wistar albino rat. These 
results suggest that abosption in the Lister black 
hooded rat was 15-20% greater than in the Wistar 
albino rat.
Aminopyrine N-Demethyla_tion
Aminopyrine N-demethylation in vivo was 
determined by injecting [^C-demethyl]aminopyrine 
intraperitoneally and measuring the ^ 4CC>2 expired 
as described in section 2. The time of the peak 
■^4CC>2 expiration and the half-life (tl/ 2 ) of the 
decline in expiration were determined as
described in section 5. Figs 38-42 show the 
decline in ^ 4C0 2  expiration for the four strains of 
rat. The results are given in table 54. There were 
no significant differences between the four strains 
either in the tl/2 or time of peak 14C02 
expiration. Also the strain differences in the 
time of peak ^4CC>2 expiration paralleled quite 
closely the differences in tl/2 with the exception 
of the Wistar albino rat. There was approximately 
a 1.25-and 1.4-fold difference in the tl/^ and time
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of peak j'‘4C0 2  expiration respectively between the 
four rat strains. However as can be seen from 
table 35 (section 6) the liver:body weight ratio is 
not constant for all four rat strains. To correct 
for these differences the tl/2 were divided by the 
liver:body weight ratio. The only difference this 
correction caused was that the Lister black hooded 
rat instead of the Biorex rat had the highest 
aminopyrine N-demethylase activity In vivo. Also 
"the difference in the tl/2 between the 4 strains 
was increased to 1.4-fold.
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LipJxenyl A:^3ydX££yia£igii
The strain differences seen in the rate of 
4-hydroxybiphenyl production after oral biphenyl 
administration may be due to differences in the 
rates of absorption and tissue uptake of biphenyl 
and excretion (bilary and urinary) as well as to 
differences in rates of metabolism. The rate of 
4-hydroxybiphenyl production after intravenous 
biphenyl administration was carried out in three of 
the four rat strains and bioavailability studies 
showed the absorption of biphenyl in the Lister 
black hooded rat was 15-20% faster than in the 
Wistar albino rat. The Zucker lean rat showed an 
abnormally low rate of 4-hydroxybiphenyl production 
after intravenous biphenyl compared to that after 
oral biphenyl administration hence the rate of 
absorption of biphenyl could not be estimated in 
this rat strain.
The reason for the 2 peaks in the plasma 
4-hydroxybiphenyl levels is unknown. The first 
peak was minor and did not occur in all animals 
hence it is not seen on the graphs of the mean 
plasma 4-hydroxybiphenyl levels (figs 35-38). As 
stated in the previous chapter, biliary excretion 
of 4-hydroxybiphenyl is higher in the rat compared 
to other species, and hence the two peaks may be 
due to enterohepatic circulation.
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However, for the second and major peak to be due to 
enterohepatic circulation a high rate of 
reabosrption of biphenyl or 4-hydroxybiphenyl into 
gut would be required. Meyer and Scheline (1976) 
found in Wistar albino rats only trace amounts of 
biphenyl in the bile and no evidence of 
reaosorption of 4-hydroxybiphenyl from bile. In 
the present study the only species other than the 
rat to show any. evidence of 2 plasma peaks in 
4-hydroxybiphenyl levels was the hamster.
The strain differences in biphenyl 
4-hydroxylase activity in vivo paralleled those 
found In vitro with the exception of the Biorex 
rat. In vitro the Wistar albino and Lister black 
hooded rat had similar biphenyl 4-hydroxylase 
activity per g liver. These two rat strains also 
showed a similar activity In vivo when the 
differences in absorption were taken into account. 
Also the activity of the Zucker lean rat was 
approximately 55% of that of the Lister blackhooded 
rat both In vitro and In vivo- However the 
activity in the Biorex rat in vivo was 
approximately 67% of the Wistar albino rat whereas 
in vitro the reverse was true. The reasons for the 
difference in activity in vitro and in vivo in the 
Biorex rat may be due to differences in the rate of 
absorption, tissue uptake and excretion of biphenyl 
and its metabolites compared to the other rat 
strains.
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4-hydroxybiphenyl is further metabolised in 
vivo to 4 , 4 '-dihydroxybiphenyl which in rats is the 
major metabolite (Meyer and Scheline, 1976; 
Halpaan-wood et al., 1981a, 1981b). But 
Halpaan-Wood et al. (1981b) showed that in rats in 
vitro the 4,4'-diol is not found hence the biphenyl 
4-hydroxylase activity determined in vitro gives a 
higher value than when determined in vivo. In the 
present study comparisons were made between the 
pattern of rat strain differences in vivo and in 
vitro rather than the actual rates of biphenyl 
4-hydroxylation hence if the rate of further 
metabolism of 4-hydroxybiphenyl in vivo is similar 
in all four rat strains then the pattern of strain 
differences in vitro and in vivo would be similar. 
It may be that in the Biorex rat the rate of 
further metabolism of 4-hydroxybiphenyl in vivo is 
greater than in the other three rat strains 
resulting in an apparent lower rate of 
4-hydroxybiphenyl production.
The variation in the rate of biphenyl
4-hydroxylation in vivo after oral biphenyl 
administration was approximately 2-fold between the 
four rat strains (when corrected for differences in 
liver:body weight ratio). This compares to a 
species variation (between hamster and rabbit) of 
approximately 15-fold. Hence strain differences in 
the in vivo metabolism of biphenyl do not negate
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the observed species differences.
Aminop yrine- Er.Demethyla^ion
The rate of aminopyrine N-demethylation (as 
determined from the half-life of the decline in
14
*co2 expiration) was highest in the Lister 
blackhooded rat and lowest in the Zucker lean rat 
(after the results were corrected for differences 
in the liver: body weight ration). The strain 
differences in N-demethylase activity in vivo 
paralleled quite closely to those seen In vitro 
using ethylmorphine as substrate. The major 
difference between the in vivo and in vitro studies 
was with the Biorex rat which had a high activity 
in vivo but a low activity in vitro. Jori et al. 
(1971) studying imipramine N-demethylase activity 
in 4 strains of rat also found that the differences 
in vivo followed those seen in vitro. Since the 
patterns of both species and strain differences in 
aminopyrine N-demethylase activity in vivo follow 
closely those seen in ethylmorphine N-demethylase' 
activity in vitro it suggests that either these two 
enzymes have a similar strain and species 
distribtuion or that they are the same enzyme with 
different substrates.
The in vivo strain difference in 
aminopyrine-N-demethylase activity tl/ 2  was 1.3 - fold 
and that for the species difference was 4 - fold - ie.
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the species differences in N-demethylase in vivo 
was approximately 3-fold the strain differences. 
Hence strain differences in the rat are unlikely to 
affect the relationship between the species 
differences in N-demethylase activity and 
oodyweight. However further study is required to 
assess the strain differences in vivo of other 
species which are known to have large strain 
differences in vitro such as the rabbit which 
showed a 17-fold difference in aminopyrine 
N-demethylase activity between 6 different strains.
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The in vivo strain differences for both 
biphenyl 4-hydroxylase and aminopyrine 
N-demethylase followed those seen in vitro with the 
exception of the Biorex rat. Also the Lister 
blackhooded rat had the highest activity in vivo 
for both enzymes. The magnitude of the strain differences were 
small for both enzymes (1.4-to-2-fold) .. Similar 
results were also found by jori et al. (1971) who 
showed a 1.4-fold difference in imipramine 
N-demethylase activity between four strains of rat.
Hence for the rat strain differences are not 
important when assessing species differences in 
biphenyl 4-hydroxylase and N-demethylase 
activities.
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Table 52. STRAIN D1FFFRFNCFS IN LIVER/BODY WEIGHT RAT)
S tra in
W is ta r  a lb ino  
Z u c k e r  le a n  
Lister black hooded 
Biorex
L iv e r /B o d y  W e ight ratio  
M 0 3 )
44.6
45.2
35.3  
43.5
Table 53. STRAIN DIFFERFNf.FS IN THF BIOAVAILABILITY OF
BIPHENYL AFTER ORAL AND INTRAVENOUS ADMINISTRATION 
(DETERMINED FROM THE PRODUCTION OF 4-HYDROXYBIPHENYU
Rat Strain Time 4-Hydroxybiphenyl After  
Period Intravenous Oral 
(min) Biphenyl B iphenyl
( jug /  m l )
Oral as  %
Intravenous
Value
W is ta r  70
albino
Zucker lean 80
159
105
73
60
46
57
Lister 40
black hooded
55 30 54
Table 54. STRAIN DIFFERENCES IN AM1N0PYRINE
N- DEMETHYLAT10N IN VIVO
Rat Strain fy  for the Decline in ^CCA Time of Peak
Expiration CCA Fxpiration
(m in )  xliver/body weight ( m i n )
ratio
W istar ( 5 )  
albino
29.2 i  6.7 1.30 i  0 .29 12 ♦1
Zucker lean (5 ) 27.3 - i  4.0 1.23 i  0.18 17 i4
Lister ( 4 )  
black hooded
27.5 ♦ 2.4 0.97  i  0.08 15 11
Biorex (5 ) 25.6 i  6.6 1.11 i0 .2 8 14 t2
Results are mean ♦ S.D.
Figures in parenthesis indicate the number of anim als  
in each experiment.
8) DISCUSSION
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Relationship Between Body and Rate of Mixed
Function Oxidase Activity
The present study has shown that the activity 
of certain mixed function oxidases (ethylmorphine 
and aminopyrine N-demethylases, biphenyl 2-, 3- and 
4-hydroxylases) show a significant inverse 
relationship with body weight, when plotted on a 
logarithmic scale, both in vitro and ifl vivo. 
Cytochrome P 4 5 0  concentrations also showed an 
inverse correlation with body weight, and when the 
in vitro activities of the above enzymes were 
expressed per nmole pytochrome P ^ 0 the 
relationship with body weight was nullified. This 
indicates that the relationship between hepatic 
mixed function oxidase activity in vitro and body 
weight is due to differences in hepatic cytochrome
P 4 5 0  concentrations. Furthermore, the Amax of 
aniline showed a direct relationship with body 
weight and an indirect relationship with cytochrome
P 4 5 0  levels. Those enzymes which showed a 
relationship with body weight are all cytochrome
P 4 5 0 -dependant, with the exception of biphenyl 
2 -hydroxylase which has been shown to be catalysed
by the £ 4 4 3  form of cytochrome P 4 5 0  (Burke and 
Prough, 1976). Indeed all the enzymes except 
biphenyl 2 -hydroxylase showed a significant 
correlation with cytochrome P 4 5 0  levels in the
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different species. Other mixed function oxidases 
studied, ie. Denzo(a)pyrene hydroxylase and 
ethoxyresorufin O-deethylase, which appear to be 
catalysed by a form of cytochrome P 4 5 0  other than 
P 4 5 g, showed no correlation with the cytochrome 
P 4 5 0  levels in the different species and did not 
show any significant relationship with body weight. 
Also, no relationship with body weight was seen' 
with alcohol dehydrogenase or UDPGA transferase 
activities, which are not part of the mixed 
function oxidase system and hence not cytochrome
P 4 5 0  dependant. Other components of the mixed 
function oxidase system include NADPH-cytochrome c 
(P4 5 0 ) reductase and cytochrome b^. Neither of 
these showed any significant relationship with body 
weight further indicating that the relationship 
between mixed function oxidase activity and body 
weight is due to the level of cytochrome P 4 5 0  in 
the different species.
Oxygen and the Mixed Function Oxidase System
The mixed function oxidase system is oxygen 
dependant (Jones, 1981) and the rate of oxidation 
is dependant on the concentration of oxygen as well 
as the carbon substrate. The overall reaction can 
be given as
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RH + 02 + 2e 2H~ > ROH + H2o
Substrate oxidised
substrate
2e~ = l/202
therefore Rate = K[RH][02 ]1,5 (from Parke +/'
Ioannides 1982)
Hence the supply of oxygen may be a rate 
limiting factor in the mixed function oxidase 
system. Jones (1981) has reported that Km for 
oxygen for a number of substrates of the mixed 
function oxidase system is above 10pM and since the 
average hepatic oxygen concentration in man is 35jiM 
(Kessler et al., 1973) the oxygen concentration 
would be rate limiting in the metabolism of these 
compounds. Booth et al. (1967) have showed that 
the hepatic oxygen consumption in different animal 
species varied inversely with the body weight of 
the species. This data in conjunction with the 
data obtained in the present study and that 
reported by Walker et a l . (1978) indicates that the 
rate of mixed function oxidase activity is 
dependant on the rate of tissue oxygen consumption 
resulting in a greater rate of oxidase activity in 
the smaller animals compared to the larger species.
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The present study showed that cytochrome P 4 5 0
concentrations were inversely correlated with body
weight of the animal species investigated.
Longmuir et al. (1980) have shown that the level of
cytochrome P 4 5 0  was induced by increasing the
tissue oxygen tension. Hence in the non-induced
animals the cytochrome P 4 5 0  level may be a direct
result of the tissue oxygen tension or to the rate
of oxygen metabolism of the species. Intracellular
oxygen is very toxic to the cell due to its ability
to be reduced to reactive species such as superoxy
anion, peroxide and the hydroxyl radical, which
results in cellular damage, mutations and possibly
tumours (Chance et al., 1979). Oxygen free
radicals have also been implicated in the natural
ageing process or biological systems by causing
repeated cellular damage (Harman & Eddy, 1979;
Frank and Massaro, 1980). Wickramsinghe and Villee
(1975) suggested that cytochrome P 4 5 0  is involved
in the detoxification of intracellular molecular
oxygen. The cytochrome P^g-substrate complex
accepts oxygen and converts this to superoxy anion
which is then readily converted to peroxide by
superoxide dismutase and further converted to water
by catalase (Chance et a l ., 1979). Oxygen in the
tissues is liable to activation, by the merest 
2+traces of Fe , into hydroxyl radicals which are 
highly cytotoxic and not detoxicated by the enzymes 
superoxide dismutase and catalase . It is possible 
that primitive cytochrome P 4 5 0  was more concerned
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with the metabolism of molecular oxygen than with 
the detoxification of environmental chemicals and 
hence the levels of cytochrome P450 were dependant 
on the tissue oxygen tension and/or metabolism.
The reason why no correlation with body weight 
was seen with NADPH-cytochrome c reductase, UDPGA
transferase and alcohol dehydrogenase activities
/
may be due to the fact that they were determined in 
vitro. All three enzymes are oxygen dependant in 
as much that they are all dependant upon the 
cellular redox state. UDPGA transferase is rate 
limited by the concentration of the substrate 
UDP-glucuronic acid, which is formed in a NAD+ 
dependant process (Moldeus et al., 197 8).
Similarly alcohol dehydrogenase is NAD+ dependant 
(Meyer et al., 1975) and cytochrome c reductase is 
NADPH dependant. However the in vitro activities of 
these enzymes are determined in the presence of 
exogenous substrate and cofactors and hence are not 
rate limiting, in vivo, where these factors may be 
rate limiting, the activity of NADPH-cytochrome c 
reductase, UDPGA transferase and alcohol 
dehydrogenase may be related to body weight. 
Ioannides et al. (1982) have reported that the in 
vivo metabolism of glyceryl trinitrate, which 
occurs via glutathione S-transferase and hence is 
dependant on NADPH for the regeneration of 
glutathione, is inversely correlated with body 
weight.
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In the present study a greater correlation 
between enzyme activity and body weight was seen in 
vivo than 1b vitro. The 1b vivo studies were 
carried out in only a few animals species which 
covered only a limited range of body weight, 
whereas in the 1 b vitro studies the relationship' 
with body weight was seen only when animal species 
of widely differing body weights were studied. The 
in vitro studies were carried out in the presence 
of exogenous cofactors (at levels optimium for the 
rat), whereas 1 b vivo the cofactors may be rate 
limiting. In addition, metabolism 1b vivo also 
involves other factors such as extrahepatic 
metabolism blood flow, protein binding, tissue 
storage etc., which may also act to enhance the 
inverse relationship with body weight.
The observation that cytochrome P 4 5 0  but not 
cytochrome is related to body weight and is
possibly regulated by the level of oxygen 
metabolism in the animal species further indicates 
that cytochrome P 4 5 0  is the normal physiological 
cytochrome involved in mixed function oxidation and 
that cytochrome P ^ g  and other similar forms of 
cytochrome P 4 5 0  are a result of a change in the 
normal metabolism via the mixed function oxidase 
system as suggested by Parke and Ioannides (1982) .
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Differences in the rate of mixed function 
oxidase activity are known to occur between
different strains of the same species as well as
between different species. These strain 
differences can be very large. Gram et al. (1965) 
found greater than a 10-fold difference in 
hexobarbital and aminopyrine metabolism among six 
strains of rabbit and Brown et al. (1978) found a 
4-fold difference in ethymorphine N-demethylase 
activity between 4 strains of mice. In the present 
study four strains of rat were studied and the 
activity of the mixed function oxidases varied from 
a 0-to 10- fold difference in the in vitro 
activity. With such large strain differences 
within a species the relevance of differences 
oetween species may be questioned. However the 
species differences seen in the present study were
greater than 10-fold for most enzymes and for
ethylmorphine N-demethylase and biphenyl 
4-hydroxylase the variation was 48- and 60- fold 
respectively. The studies jj2 vivo showed only a 2- 
to 3- fold difference between the rat strains 
whereas the species differences among only five 
species, all of relatively low body weight, were 
approximately 17-fold. Hence strains differences 
are unlikely to seriously modify the general trend 
seen in species differences particularly when the
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number of species studied is large.
Strain differences, however may be important 
when extrapolating data from one animal species to 
another particularly to man which is known to show , 
wide individual variation and also is frequently 
exposed to inducing agents of various types and, 
concentrations (Conney et al., 1980). For example, 
Pelkonen et al. (1974) found a 10-fold variation in 
cytochrome P 4 5 0  concentration, a 4 -fold variation 
in cytochrome b^ concentration and 9 -fold and 
7 -fold variations in benzo(a) pyrene hydroxylase 
and aminopyrine N-demethylase activity respectively 
in liver samples from 2 0  patients who were not 
taking drugs regularly. In the present study 
variation in enzyme activity of the 6 human liver 
samples was approximately 2- to 3-fold. However, 
Krasovskii (1976) , who also found a relationship 
between the logarithms of a number of biological 
parameters and body weight-, calculated the 
regression equations for 8 6  biological parameters 
and found that the predictability for humans was 
within a factor of 2.5 for all but 4 of the 
parameters.
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Determination of the potential toxic hazard of 
a compound in humans relies, at present, on studies 
carried out in animals, and extrapolation of the ' 
data to man. However, it is well known that "the 
interpretation of animal data in predicting human 
responses is an inherently dissatisfying 
experience with many important uncertainties" 
(Reichsman and Calabrese, 1978) . For many 
compounds the toxicity and/or the therapeutic 
potency is related to the rate of metabolism of the 
compound. The present study indicates that for 
certain compounds the rate of metabolism is related 
to body weight. Such a relationship may be a 
valuable aid in the determination of quantitative 
predictions of toxicity, or effective therapeutic 
efficacy in man, particularly when the animal 
studies are carried out in vivo. The present study 
found a close correlation between body weight and 
metabolism in vivo, whereas greater variation from 
the predicted correlation was observed in vitro, 
particularly with the human liver samples.
This inverse relationship between enzyme 
activity and body weight has already been 
recognised in the Soviet Union (Krasovskii, 1975; 
1976). Krasovskii has reported that a number of
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Diological parameters including enzymes associated 
with energy metaoolism and some of the mixed 
function oxidases are inversely related to body 
weight. Walker (1978) also found that the mixed 
function activity in different species is inversely 
related to body weight both in vitro and in vivo. 
The present study indicates that only the 
cytochrome P^ ^ -dependent enzymes show this / 
relationship to body weight, and this emphasises 
the importance of cytochrome P 4 5 0  in this 
relationship. Enzymatic activities catalysed by 
cytochrome P^^g, or other forms of cytochrome P 4 5 0 f 
do not appear to be related to body weight. As 
many of the toxic chemicals or carcinogens occur as 
a result of metabolism via cytochrome P^^g (Parke 
and Ioannides 1982) the potential usefulness of the 
relationship oetween mixed function oxidase 
activity and body weight in determining the 
toxicity risk in man may be questionable. However, 
many of the reactive intermediates of toxic 
chemicals produced via cytochrome P ^ g  are 
electrophiles, free radicals or free radical 
generators, which may cause tissue damage directly 
or indirectly by enhancing the basal level of 
tissue lipid peroxidation as a result of depleting 
intracellular glutathione and natural antioxidants 
such as Vitamin C and E and selenium, which are 
essential to the cellular defence system against 
oxygen toxicity. As tissue lipid peroxidation is a 
function of tissue oxygen concentration (Frank and
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Massaro, 1980; Freeman and Crapo, 1981) and the 
tissue oxygen metabolism is inversely related to 
body weight (Booth et al.f 1967) the rate of lipid 
peroxidation will be greater in the smaller animal 
species. It has been suggested that the incidence 
of spontaneous cancer is related to the rate of 
free radical formation (Totter, 1980). Hence ■ 
chemicals which cause an increase in cellulat lipid 
peroxidation will exhibit greater toxicity in the 
smaller animals such as rat and mouse compared to 
larger species such as man. This is of great 
importance in toxicity studies as testing for 
potential carcinogens is usually carried out in the 
mouse or rat because of convenience, cost and short 
life-span. However, if the relationship between 
toxicity, lipid peroxidation and body weight is 
unequivocably established the true risk to man of 
compounds shown to be carcinogenic in the mouse may 
in reality be quite small.
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